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An inflammation of the liver is called hepatitis, which can be the effect of certain 
chemicals, medication, alcohol abuse or a viral infection. The main cause of viral 
hepatitis was identified in 1989 as Hepatitis C virus (HCV). Hepatitis C was originally 
known as non-A non-B hepatitis 1. This thesis will concentrate on HCV. In the two 
decades following discovery, researchers have acquired quite some knowledge on the 
virus. How HCV is transmitted, the sequence of the viral genome and what it encodes, 
and the virus life cycle is starting to be unravelled. This resulted in the identification 
of several new drug targets. Still, much remains to be elucidated about the virus life 
cycle, including intracellular interactions of HCV-proteins with the host cell. 
Transmission, clinical course of infection  
and current treatment
Transmission of HCV is through exposure to infected blood. Healthcare related 
procedures are therefore a risk factor. To decrease healthcare-related infections, 
blood and blood-products have been screened for HCV since 1991. Presently the 
main risk factor in developed countries is intravenous drug usage, due to sharing of 
injecting equipment 2, 3. Additional risk factors include mother-to-child transmission, 
high-risk sexual behaviour and perhaps tattooing and body piercing 2.
When infected with HCV, three stages are described in the clinical course of infection. 
First, there is the acute phase. In about 20-50% of the cases the infection is cleared, 
depending on virus genotype and genetic background of an infected individual 4. For 
example, a genetic variation in the gene IL28b is strongly associated with spontaneous 
clearance of HCV 5. After 6 months, the infection is called a chronic infection and 
fibrosis will continue. Fibrosis is a process of regeneration of damaged liver tissue, 
through proliferation of connective tissue and rearrangement of extra cellular matrix 
components, which can result in progressive loss of liver function. Hepatic stellate 
cells play a major role in fibrinogenesis. As a result of inflammation and cell damage 
these cells are activated, ultimately leading to more production of extracellular 
matrix components 6. In this way, the chronic infection can slowly progress (20-30 
years) toward end stage liver disease, the third stage. Of the chronically infected 
people, 10-20% develop liver cirrhosis (scar tissue development) and of those 





patients with HCV-related cirrhosis the annual incidence rate of HCC is 1-4% 7. 
These percentages do not indicate a major healthcare problem. Yet, the World Health 
Organisation estimates that world-wide around 170 million people are infected with 
HCV, of whom 130 million are chronic HCV carriers. Each year around 2.3 to 4.7 
million people become newly infected 8. As a result HCV infection is currently the 
leading indication for liver transplantation 9. 
The present standard treatment of chronic HCV infection is a combination therapy of 
PEGylated interferon alpha and ribavirin. However viral eradication is only reached 
in 40-80% of the cases and side effects of the treatment are grounds for 10-15% of 
patients to discontinue the treatment 7. New medication is therefore being developed, 
their targets being the viral enzymes and host-virus interactions 10. In general, 
clinical trial phases are difficult to reach. The anti-viral drug development against 
HCV faces another challenge; that is the rapid evolution of the virus, resulting in 
quick emergence of resistance to the newly developed drugs. This rapid evolution 
of the virus is a consequence of high genetic diversity of the virus, an error prone 
polymerase (high mutation rate) and a high magnitude of replication 11-14. Hence, a 
better understanding of the viral proteins and the HCV lifecycle is needed.
Viral phylogenetics
HCV is a single-stranded positive-sense RNA virus. It belongs to the family of 
Flaviviridae, which includes the Flavi-, Pesti- and Hepacivirus genera 15. Well-known 
members of the Flavivirus genus are Yellow Fever, Dengue and West Nile virus. The 
genus pestivirus contains viruses infecting non-human mammals and includes bovine 
viral diarrhoea virus that is the closest relative of Hepaciviruses 15, 16. HCV is a member 
of the Hepacivirus genus, which is classified into 6 major genotypes (1-6) and related 
subtypes (a, b, c….) 17, 18. The three most prevalent subtypes among Dutch blood-donors, 
detected during screening, are 1a, 1b and 3a. Of these, type 1b is associated with blood 



























The viral life cycle
The host range of HCV are humans and closely related primates. HCV mainly infects 
hepatocytes 20, 21. The viral life cycle includes several steps, which are depicted in 
Figure 1.
Firstly, the virus life cycle starts with entry of the virus particle into the host cell. 
After that, the viral genome, of about 9.6 kb, is released from the virion via membrane 
fusion and uncoating (Fig.1). This is followed by translation of the viral genome 
using the host cell machinery, producing one large polyprotein of about 3000 amino 
acids at the endoplasmic reticulum (ER) membrane. The polyprotein is cleaved by 
viral and host proteases into at least 10 proteins. The genomic order of the proteins 
being: Core, E1, E2, p7, NS2, NS3, NS4a, NS4b, NS5a and NS5b (Fig.2). The 
next step is viral genome synthesis, called replication, which occurs on ER derived 
membranes (Fig.1). The ready produced genome is packaged into a new virion, a 
process associated with lipid droplets (Fig.1). Subsequent to virus particle assembly, 
the virion is released from the cell and can infect new hepatocytes (Fig.1).
These steps will be discussed in more detail in the next paragraphs regarding 
virus-host interactions including protein-protein interactions, membrane-protein 
interactions and modifications of viral proteins by the host-machinery.
Entry
Virus entry is the process that comprises all the steps from particle binding to the cell 
surface up to the delivery of the viral genome to the site of translation within the cell 
(Fig.1). Virus-host interactions herein will be described in this section.
Glycoproteins E1 and E2
The HCV particle has a size of about 50-60 nm 22 and comprises the viral genome, 
a capsid containing Core proteins and a host cell-derived membrane envelope 23. In 
the envelope the heterodimer complex of the two glycoproteins E1 and E2 is present, 
which is essential for virus entry (Reviewed in 24, 25). The glycoproteins are anchored 
Figure 1  -  The Hepatitis C virus life cycle
This figure illustrates the life cycle of hepatitis C virus. Abbreviations: very low density lipoprotein 
(VLDL), hepatitis C virus (HCV), glycosaminoglycans (GAG), low density lipoprotein receptor (LDL-
R), scavenger receptor class B type I (SR-BI), membranous web (MW), endoplasmic reticulum 
(ER), lipid droplet (LD). For more details, see main text.
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in the membrane envelope by transmembrane domains at the carboxy-terminal end 
of E1 and E2 26-29. Via binding to host-cell receptors, this complex mediates virus 
particle internalisation (Reviewed in 24). 
Binding of the virus particle to the cell surface
Initial virus attachment involves low affinity binding to receptors. For HCV, 
the receptors low density lipoprotein receptor (LDL-R), C-type lectins and 
glycosaminoglycans (GAGs) were shown to mediate this initial binding 30-33 (Fig.1). 
Proteoglycans, supramolecular complexes of ‘core’ proteins with covalently attached 
GAG chains, are ubiquitously expressed on the cell surface and for that reason may 
be the primary docking site for many viruses, including several of the Flaviviridae 
members, Dengue virus 34, classical swine fever virus 35 and tick-borne encephalitis 
virus 36. Heparin, a highly sulphated linear polysaccharide, is a GAG that was shown 
to associate with E1 and E2 of HCV 31. The negatively charged GAG is proposed to 
bind to positive-charged residues in the glycoproteins 31, 37-39
The envelope glycoproteins of HCV are highly glycosylated, up to 6 potential 
glycosylation sites are present in E1 and up to 11 sites in E2 40. Since C-type lectins 
contain a calcium-dependent carbohydrate recognition domain, these receptors could 
bind to virus carbohydrates (Reviewed in 41). DC-SIGN and L-SIGN, two C-type lectins, 
both interact with soluble E2 and with E1/E2 heterodimers on HCV pseudoparticles 32, 
33. The high mannose-type oligosaccharides on E1 and E2 are necessary for this binding 
32, 33. Expression of these C-type lectins on non-permissive cells, such as dendritic 
cells, lymphocytes and liver sinusoidal endothelial cells, suggests that they may act as 
capture receptors to deliver the virus particles to permissive cells 32, 42, 43. In addition, a 
liver-expressed C-type lectin, asialyglycoprotein receptor, was identified as a potential 
attachment factor 44, although its relevance in entry needs to be demonstrated.
Another receptor that can initiate virus particle binding to the host cell surface is 
the LDL-R, which is a receptor for the uptake of high, low and very low density 
lipoproteins (HDL, LDL and VLDL) 30.  It may seem surprising that this receptor 
takes part in the entry process, however, infectious in the serum circulating HCV is 
mainly associated with beta-lipoproteins 30, 45 (Fig.1). Moreover, highly infectious 
Lipo-Viro-Particles (LVPs) isolated from serum contain, in addition to the viral 





and ApoE 46, 47. No direct interaction between LDL-R and HCV glycoproteins has 
been reported; instead the binding of the LDL-R to ApoE seems to mediate entry 48. 
As HCV particles are associated with lipoproteins, the LDL-R was proposed to be 
an initial binding factor 30, 48-50. 
Essential entry co-factors
A different lipoprotein receptor is scavenger receptor class B type I (SR-BI), which 
was also suggested to be involved in HCV uptake (Fig.1). SR-BI is able to interact with 
E2 51-53. However, another study shows that HCV from sera of infected individuals 
attaches to SR-BI-expressing cells in an ApoB-dependent and E2-independent 
manner 54. Taken together, binding of the virus particle to SR-BI can potentially occur 
via direct or indirect interactions. In any case, blocking this scavenger receptor with 
antibodies reduces HCV entry into hepatoma cells, defining SR-BI as an essential 
entry co-factor 54-56. In fact, SR-BI expression levels might be rate limiting for HCV 
uptake 52, 57, 58, because overexpression of SR-BI enhances internalisation of HCV 
52, 58. It is noteworthy that alpha-interferon, in addition to other effects, decreases 
expression of SR-BI and LDL-R at the cell surface 59.
During HCV entry, SR-BI functions cooperatively with CD81 56, 60, a tetraspanin 
protein shown to bind directly to E2 61-63 (Fig.1). Moreover, SR-BI and CD81 can be 
indirectly linked to each other via soluble E2 or HCV pseudo particles containing 
E1/E2 heterodimers 64, pointing out dual binding to E2. CD81 is suggested to be a 
post-attachment co-receptor 65, 66, because HCV particles can attach to CHO cells 
expressing SR-BI, but not to CD81 expressing cells 66. Additionally, antibodies 
against CD81 inhibit virus entry at a post-binding step 65. After association with 
CD81, actin rearrangements are induced and the virus-receptor complex moves to 
the tight junctions, which are closely associated areas between cells forming a barrier 
to fluids in the extracellular space 67. 
Expression of both SR-BI and CD81 is required, but is not sufficient for HCV 
entry. This observation initiated a quest for other co-receptors 51. A lentivirus based 
repackaging screening was set up to identify genes that render HCV-resistant cells 
susceptible to HCV pseudoparticle infection, using a complementary DNA library 
derived from HCV permissive cells. With this approach two new co-receptors were 
identified that localise to the tight junctions: Claudin-1 and Occludin 57, 66 (Fig.1). 
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Claudins and Occludins play a role in the gate function of tight junctions, establishing a 
barrier to the apical-basolateral movement of ions and solutes through the intracellular 
space 68, 69. Co-immunoprecipitation experiments indicate Occludin interacts with E2 
70, 71. Interestingly, CD81 and Occludin are both able to bind directly to E2 and were 
shown to determine HCV species-specific tropism between human and mouse cells 57, 
72. Claudins comprise four transmembrane helices and have two extra-cellular loops 
that are involved in paracellular tightening and pore formation 69. The first and larger 
extra cellular loop of Claudin-1 was shown to be essential for HCV internalisation 66. 
In fact, the necessary motif in the extracellular loop was suggested to play a role in 
cell-cell contact 73, which might indicate a functional requirement of Claudin-1. No 
direct interaction with E2 could be observed, though Claudin-1 interacts with CD81, 
implying co-receptor complex formation 66, 74, 75. Together these four receptors seem to 
be the crucial entry co-factors for virus particle entry at the cell surface. 
Endocytosis, fusion and uncoating
The next step in entry is endocytosis of the virus particle, which occurs in a clathrin-
dependent manner 76 and requires an intact microtubule network 77, 78. The internalised 
virus particle is transported to the early endosome 77. At present, there is no data on 
whether one of the entry co-receptors is present in the endosome together with the 
virion. In the maturing endosome the pH will drop, which initiates fusion of the 
virus particle membrane with the early endosomal membrane 79, 80 (Fig.1). The exact 
mechanism of fusion is unknown, but it entails close contact of the two membranes 
to merge into one membrane. 
The envelope glycoproteins play a crucial role in fusion because they are presumed 
to be able to associate with both membranes directly. E1 and E2 are anchored into 
the membrane envelope 29, 81. Additionally, a still unidentified surface exposed 
hydrophobic peptide in the glycoproteins, the fusion peptide, probably makes contact 
with the early endosomal membrane. This fusion peptide destabilizes the membrane 
by insertion into the lipid bilayer and might prime fusion (Reviewed in 82). Several 
studies indicate hydrophobic peptides in E1 and E2 that could be the fusion peptide, 
though no consensus has been established 83-86.
The low pH in the endosome seems to induce conformational changes in the 





could be the fusion peptides, or otherwise the altered fold could bring the two 
membranes close together. Besides acidification, another trigger is likely needed 
to prime the envelope proteins for fusion as HCV infectivity is not affected when 
cell surface bound particles are temporarily exposed to low pH 87, 88. Furthermore, 
lipid composition of the virion and of the target membrane seems to play a critical 
role in fusion because cholesterol in the target membrane enhances the process 
56, 80. Additionally, internalisation, but not membrane attachment, of the virion is 
affected when cholesterol and sphingomyelin composition is changed in the virus 
particle 89, 90.
After membrane fusion, the nucleocapsid containing the HCV genome is released 
into the cytosol of the host-cell and the viral genome has to be delivered to the ER 
where, subsequent to uncoating, translation is initiated (Reviewed in 25, 91) (Fig.1). A 
recent report demonstrates that treadmilling microtubles are involved in a step after 
nucleocapsid release into the cytoplasm 78. Additionally, the HCV Core protein was 
shown to interact with the alpha- and beta-chains of tubulin 78. Taken together this 
implies that the HCV genome is transported to the ER via the interaction of Core 
with treadmilling microtubules.
Uncoating of the viral genome requires the disassembly of the nucleocapsid. Core 
is incorporated into the capsid after being proteolytically cleaved by signal peptide 
peptidases 92. This mature form of Core forms less stable viral capsids, which does 
not affect virus assembly, though might prepare the capsid to disintegrate in the 
newly infected cells 93. 
Translation of the polyprotein
After uncoating, the viral genome is exposed in the cytosol, where it can be captured 
by the translation machinery of the host cell and serve as a template for translation 
(Fig.1). 
Viral translation initiation
The open reading frame in the viral genome is flanked by highly conserved 5’- and 3’- 
non-translated region (NTR), which contain signals for translation and replication 94 
(Fig.2). In the 5’NTR an internal ribosome entry site (IRES) is found, which is a highly 
structured RNA domain of multiple stem-loops and a pseudoknot that initiates cap-
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independent translation 95-98. This IRES can be directly bound by the 40S ribosomal 
subunit, devoid of other translation initiation factors 99-101. The 40S ribosomal subunit 
is positioned onto the AUG at the ‘P’site in such a way that translation can start 
directly, without scanning or unwinding of the RNA 102. Subsequently, the 43S pre-
initiation complex is formed by recruitment of the eukaryotic initiation factor 3 
(eIF3) and eIF2-GTP-initiator tRNA complex 100, 103. Finally, the 60S subunit can 
join this complex after GTP hydrolysis and eIF2 release, to form the 80S ribosome 
that initiates translation 104.
In addition to the 5’NTR, the 3’NTR is also important for translation. The three 
regions described in the 3’NTR are the variable region, the poly (U/UC) tract and the 
98 nucleotide X-region 105, 106. The 3’NTR seems to enhance translation of the viral 
genome 107, 108. 3’NTR RNA-binding proteins, such as Insulin-like growth factor-
II mRNA-binding protein 1 (IGF2BP1) and polypyrimidine tract-binding protein 
(PTB) could be involved in increasing translation efficiency. PTB binds to itself and 
can associate with the X-region in the 3’NTR and three sites in the 5’NTR 109-111. In 
this way circulation of the genome can be mediated, which could enhance translation 
similar to other flaviviruses 112. A comparable mechanism is proposed for IGF2BP1 
113. Additionally, IGF2BP1 is co-immunoprecipitated with HCV RNA, 40S subunit 
and eIF3, implicating recruitment of eIF3 to the 5’NTR 113. Many proteins have been 
shown to associate with the 5’NTR. For example La autoantigen that binds close to 
the AUG start sequence, possibly promoting binding of the 40S ribosomal subunit 
to the IRES 114.
Polyprotein cleavage
During translation, one large polyprotein is synthesised that is processed co- and post-
translationally into at least 10 proteins (Reviewed in 115) (Fig.2). Host endoplasmic 
reticulum signal peptidase(s) release the structural proteins, core, E1 and E2, and 
the peptide p7 from the polyprotein (Reviewed in 116) (Fig.2). In the C-terminus 
of core protein a signal sequence is present, therefore additional processing of 
core is mediated by a signal peptide peptidase 92 (Fig.2). The non-structural 
proteins are separated by the viral proteases NS2-3 and NS3-4a (Reviewed in 116) 
(Fig.2). The cysteine proteinase NS2-3 forms a dimer with two composite active 
sites, which autocleaves at the NS2/ NS3 junction 117-119. Folding of this protease 





After NS2/ NS3 processing, the other non-structural proteins NS3 to NS5b are cleaved 
off by the NS3-4a serine protease, where NS4a functions as a co-factor to the NS3 
protease 121-125. Binding of NS4a to NS3 stabilizes the protease 126. Processing of NS3 
to NS5b occurs in the order of NS3/ NS4a, NS5a/ NS5b, NS4a/ NS4b and NS4b/ 
NS5a 121, 127. Cleavage at the NS4b/ NS5a might be facilitated by the interaction of 
NS4a with the NS4b/ NS5a polyprotein 128.
Membrane association of the HCV proteins
Since the HCV proteins originate from one polyprotein, their membrane topologies 
are related to each other. Additionally, each HCV protein contains intrinsic properties 
to determine their association with the lipid bilayer, mainly the membranes of the ER 
(Fig.2). This is discussed in the section below. 
Translation starts with the sequence of core. The capsid protein is observed at the ER 
and later in infection also on the surface of lipid droplets 92, 129, 130. Core is suggested 
to initially localise at one point of the lipid droplet, possibly an ER-lipid droplet 
contact site, and is subsequently loaded onto the lipid droplet 131. This re-localisation 
might be regulated by the cleavage of the signal sequence at the C-terminal end of 
core 92, 132. A domain essential for ER membrane association and targeting to lipid 
droplets, termed D2, was identified in the C-terminal one-third of core. This domain 
seems to fold upon interaction with the phospholipids into two amphipathic helixes 
that are in plane with the membrane 133-135 (Fig.2). Just behind the D2 domain a 
palmitoylation site was identified. This seems to be involved in the localisation of 
core to ER membranes that are closely associated with lipid droplets 136. A second 
function of the signal sequence at the end of core is directing the growing polyprotein 
to the rough ER 23. Via recognition of the signal sequence in core and binding to 
the ribosome by the signal recognition particle (SRP), the ribosomal complex is 
recruited to an SRP-receptor in the ER membrane. This is followed by docking of 
the ribosome with the nascent chain onto the translocon (Reviewed in 137). Now E1 
can be translocated into the ER. 
E1 and E2 contain a C-terminal transmembrane domain, which anchor and retain the 
proteins in the ER membrane 26, 27 (Fig.2). Both transmembrane domains contain two 
hydrophobic stretches separated by charged residues in a short hydrophilic segment 


























Figure 2  -  Hepatitis C virus genome organisation and membrane association of the proteins
The hepatitis C virus open reading frame is flanked by the 5’ and 3’ non-translated regions (NTR). 
Translation results in one large polyprotein that is cleaved by signal peptide peptidase (SPP), signal 
peptidase (SP), non-structural protein 2-3 protease (NS2-3) and NS3-4a protease (NS3-4a) into 10 
proteins. These can be roughly divided into structural proteins Core, envelope protein 1 and 2 (E1 
and E2), peptide p7 and non-structural proteins (NS) 2, 3, 4a, 4b, 5a and 5b. In the bottom panel the 






transmembrane domains form a hairpin like structure with their C-terminus facing 
the ER lumen. Upon cleavage the transmembrane domains form a single membrane-
spanning segment, with the C-termini on the cytosolic side 139. Correct folding of 
the E1E2 heterodimer depends on the transmembrane domains 28, 140, 141. E1 and E2 
are modified by glycosylation and possess up to 6 and 11 potential N-glycosylation 
sites respectively 40, 142. Several of these glycosylations contribute to the folding of 
the glycoprotein complex and receptor binding 40, 143, 144. Furthermore, ER chaperone 
proteins facilitate the assembly of the E1-E2 complex. Calnexin is such a protein and 
has been shown to interact with the HCV envelope proteins 145-147.
P7 is a polypeptide of two transmembrane domains connected by a short cytoplasmic 
loop and is mainly localised at the ER and partially at the plasma membrane 148. The 
N- and C-termini are towards the ER lumen 148 (Fig.2). Six p7 proteins fold into an 
ion-channel structure that resembles a flower, which is implicated in virus assembly 
and release 149-152.
The first non-structural protein to be translated is NS2, which also localises at 
the ER 153. Since the C-terminus of p7 is at the ER luminal side of the membrane, 
where cleavage by the signal peptidase takes place, the N-terminus of NS2 seems 
to be in the lumen of the ER 154 (Fig.2). The NS2/ NS3 junction is processed in 
the cytosol, where the NS3-4a protease resides, which would leave the C-terminus 
of NS2 at the cytosolic side of the ER membrane 117, 118 (Fig.2). However, in the 
N-terminal 96 residues of NS2, three to four transmembrane segments have been 
predicted 155. Unpublished, data from Jirasko et al. suggest this region contains three 
transmembrane segments and an alpha-helix associating with the membrane leaflet 
at the ER luminal side 156 (Fig.2). Instead, if this hydrophobic segment would span 
the membrane four times, post-cleavage reorientation is expected.
NS3 binds to the central domain of NS4a, which stabilizes the protease and through 
this interaction NS3 is associated to membranes 126, 157. In the N-terminus of NS4a, a 
hydrophobic domain is present that connects the complex to membranes 158 (Fig.2). 
This segment is inserted into the lipid bilayer, after cleavage of the NS3/ NS4a 
junction, with the N-terminus of NS4a towards the ER-lumen 159. Via the interaction 
with NS4a, NS3 co-localises with the ER and partially with mitochondria 158, 160. 
Another determinant for membrane association was identified in the N-terminus of 
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NS3, an amphipathic helix that was suggested to properly position the protease onto 
the lipid bilayer 159. 
NS4b is a multi membrane-spanning protein and it traverses the membrane 4 to 
5 times 161, 162 (Fig.2). The N- and C-termini are, as a consequence of polyprotein 
processing, at the cytosolic side of the ER membrane 161. Topology studies indicate 
four transmembrane domains in the central part of the protein (aa 70-190) 161, 162. In 
the N-terminal fraction of NS4b there is an amphipatic helix (aa 42-69) that also has 
the potential to translocate from the cytosolic side of the ER membrane into the lipid 
bilayer 162, 163 (Fig.2). Only a fraction of the NS4b pool adopts this transmembrane 
orientation with their amphipathic helix, which seems to be influenced by the 
expression of NS5a 163, 164. Another amphipathic helix is found in the N-terminus (aa 
6-29) that could mediate membrane association 165. Disruption of this helix alters the 
localisation of the other NS proteins 165. Furthermore, in the C-terminal part of NS4b 
(aa 191-261) two palmitoylation sites are suggested, which might be involved in 
protein-protein interactions or binding to membranes 166.
An amphipathic helix at the N-terminus of NS5a associates the protein to ER 
membranes and to lipid droplets 167, 168(Fig.2). The helix is embedded flat into the 
cytosolic leaflet of the membrane, with the hydrophobic residues facing the lipids 
and the charged residues towards the cytosol 169. This charged side might be involved 
in specific protein-protein interactions 169.
NS5b, an RNA-dependent RNA polymerase, resides at the cytosolic side of the ER 
and is anchored to the lipid bilayer through the last 21 amino acids of the protein 
170, 171 (Fig.2). These C-terminal residues of NS5b form a hydrophobic helix that is 
inserted into the lipid bilayer by a post-translational mechanism 170-172.
Replication
After translation of the polyprotein, replication can start, using the produced HCV 
proteins to synthesise new HCV RNA genomes (Fig.1).
From translation to viral replication
The positive-strand viral RNA genome is used as a template for both translation 





negative-strand synthesis goes from the 3’ to 5’ end. Therefore, there should be a 
switch between the two processes. It is possible that proteins binding to the RNA 
molecule regulate this functional change. A viral candidate could be core, which 
inhibits translation upon association to the IRES 173-175. Also host-cell proteins, 
involved in the regulation of replication and translation, could mediate the switch 109, 
113, 114, 176-181. Alternatively, there might be physical separation of the two processes, 
since replication seems to be shielded by membranes, while translation is not 182.
Membranous web
Replication of most, if not all, positive-strand RNA viruses occurs on intracellular 
membranes (Reviewed in 183). Immuno-electron microscopy experiments to determine 
the cellular localisation of HCV RNA revealed that the viral genome is located at 
specific membrane structures in the cytoplasm, which are also termed the membranous 
web 184 (Fig.1). These HCV-induced membrane alterations appear as small irregular 
vesicles that are closely packed together 184, 185. Furthermore, immunofluorescence 
analysis of newly synthesised RNA by bromouridine triphosphate labelling, 
indicated that replication takes place at cytoplasmic dot-like structures 184, 186. Both 
structures observed in electron and immunofluorescence microscopy contain HCV 
non-structural proteins that are involved in replication 184-186. Together this points 
towards the membranous web being the site of replication.
NS4b presumably is the HCV protein that induces these membrane alterations, 
because expression of this protein alone resulted in similar structures 185. In addition 
to some connections with the rough ER observed in electron microscopy, the 
localisation of NS4b to this organelle led to the supposition that the membranous 
web is derived from ER membranes 161, 185. Not only ER proteins are observed at 
the site of replication, also early endosomal proteins such as rab5 and rab7 are 
found, indicating recruitment of specific proteins towards the site of replication 
187, 188. Immunofluorescence experiments examining the diffusion of NS4b indicate 
two pools: ER associated and fast moving NS4b and slower moving NS4b, which 
is clustered in cytoplasmic foci 189. The latter could be the replicase, because they 
resemble the dot-like structures observed for HCV RNA 184, 189. The cytoplasmically 
localised HCV-related foci seem to be connected to the cytoskeleton of cells, which 




The exact components required for HCV replication are not known, but will entail 
the viral genome, non-structural proteins and cellular host-factors. The viral non-
structural proteins 3 to 5b are required for replication and form part of the replication 
complex 191, 192. They possess specific enzymatic activities, interact with each other 
and associate with host-cell proteins to facilitate the synthesis of new copies of the 
HCV genome 193, 194. A quantitative analysis of the replication complex indicates 
that of the total non-structural protein made, about 5% is actively participating in 
replication 182. Additionally, it was calculated that a replication complex consists of 
several hundreds of NS proteins, one negative-strand RNA and two to ten positive-
strand RNAs 182. The functions of the NS proteins and their host protein interactions 
in relation to the replication complex will be discussed here.
Besides protease activity, NS3 has RNA unwinding activity via its NTPase-RNA 
helicase domain 194. This DExH/D-box RNA helicase, at the C-terminus of NS3, is 
capable of unwinding dsRNA in the 3’ to 5’ direction 195, 196. While NS3 translocates 
along its substrate, ATP is utilised 197, 198. The NS4a protein acts as a cofactor, to promote 
binding of NS3 to the RNA substrate 199, 200. Also NS5b can interact with and modulate 
the helicase activity of NS3, depending on the stoichiometry of both proteins 201, 202. 
Additionally, there is a genetic interaction between NS3 and NS4b that is important 
for replication 203. The host-cell protein, creatine kinase B (CKB), forms a complex 
with NS3-4a, via direct interaction with NS4a 177. CKB, an ATP-generating enzyme, is 
suggested to support replication by enhancing NS3-4a helicase activity, through energy 
production 177. Another possibility to regulate enzymes is via protein modifications. 
The activity of NS3 helicase might to be controlled by methylation 204. 
Quinkert et al. showed that active replication complexes of HCV are protected from 
proteinases and RNases by membranes 182. As mentioned above, the membranous 
web is induced by NS4b 185, indicating a role for NS4b in shielding the replicase. 
Additionally, NS4b is suggested to be an important protein-protein interaction 
platform during replication, because NS4b is able to bind to the other non-structural 
proteins 193, 205. Moreover, recent data suggest that when NS4b loses the ability to 
form foci, NS3 and NS5a also display an altered localisation 163, 206, 207. The host cell 
early endosomal protein Rab5 can be co-immunoprecipitated together with NS4b. In 





The exact function of NS5a in replication is not known, but this zinc-binding 
phosphoprotein is indispensable for replication 192. NS5a has been shown to interact 
with RNA, other HCV proteins and multiple host-cell proteins 193, 208, 209. Several of 
these NS5a host cell-interacting proteins are involved in membrane transport, such 
as TBC1D20, a Rab1 GTPase activating protein 179, 210. Depletion of TBC1D20 or 
Rab1 resulted in decreased viral replication 179, 211. Since Rab1 is important for ER to 
Golgi trafficking of COPII vesicles 212, 213, the interaction might affect the membrane-
associated replicase. A second example is tubulin to which both NS5a and NS3 
associate. This interaction may possibly influence replication complex localisation 
190. Thirdly, NS5a has been shown to bind to the lipid kinase PI4KIIIα 176. SiRNA 
knockdown of PI4KIIIα inhibits replication and seems to reduce HCV induced 
membrane alterations 214-217. Taken together NS5a could, via host-cell interactions, 
assist in the formation of the replication complex.
The role of NS5b in replication is obvious, because it is the RNA-dependent RNA 
polymerase (RdRp), a key enzyme responsible for RNA synthesis 218-220. Crystal 
structures show that NS5b folds into the classical right-hand tertiary-structure with 
fingers, palm and thumb domains 221-223. RNA can bind in a groove in the centre of the 
protein, in between the fingers, palm and thumb domains 221-223. The RdRp can initiate 
RNA synthesis de novo, meaning the enzyme can start without the need for a primer 
224, 225. The activity of NS5b seems to be regulated by viral and host-cell proteins. 
NS3, NS4b and NS5b interact with one another 201, 205. In vitro experiments indicate 
that NS3 could stimulate NS5b template recognition, whereas NS4b seems to inhibit 
the NS3-NS5b complex, suggesting a balanced interaction to control replication 205. 
Both cyclophilin A and B are able to bind to NS5b and facilitate viral replication 180, 
181. For cyclophilin B a possible stimulatory mechanism has been suggested, which 
would be increasing the binding of NS5b to RNA 180, 226. The isomerase or chaperone 
activity of cyclophilin A might assist in proper incorporation of NS5b into the 
replication complex 227, 228. A different kind of host interaction with NS5b is that of 
protein kinase C related kinase 2 (PRK2), which is proposed to increase replication 
via NS5b phosphorylation 178, 229. 
Virus particle assembly and release
After copying of the HCV genome, the newly synthesised RNA has to be packaged 
into the virions, which is followed by secretion of the particles (Fig.1).
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From replication to assembly
In the switch from viral replication to virus particle production, NS5a has been 
suggested to play a major role 230, 231. NS5a has a basal- and a hyperphosphorylation 
level that seem to correlate with replication and assembly respectively because 
blockage of hyperphosphorylation stimulates replication 232-234, but hampers virus 
production 235, 236. Therefore, the change from RNA synthesis to assembly is apparently 
regulated by the phosphorylation status of this non-structural protein. A consequence 
of NS5a phosphorylation was investigated by Evans et al. 233. NS5a and also NS5b 
interact with VAP-A and -B, two proteins that function in membrane trafficking, 
lipid transport and microtubule stabilization 237-239. Moreover these proteins are 
required for viral replication 237, 240, 241. Upon phosphorylation of NS5a the interaction 
with VAP-A seems to be impaired, which results in decreased replication activity 
233. Therefore, the regulatory role of NS5a in the virus life cycle might be through 
specific interactions that are modulated by phosphorylation. Hyperphosphorylation 
of NS5a is influenced by the other HCV proteins NS3, NS4a and also NS4b 242, 243. 
Lipid droplets
Virus particle assembly is closely linked to lipid droplets in the cytosol of the cells 
244 (Fig.1). Two viral proteins, Core and NS5a are connected with lipid droplets, 
via amphipathic helixes in the C- and N-terminal domains, respectively 244, 245. 
Additionally, their association with lipid droplets is required for virus particle 
production 131, 244, 246. Core induces lipid droplet aggregation close to the nucleus, 
which might increase ER-lipid droplet interactions and enhance virus production 
247. Redistribution of lipid droplets is dependent on an intact microtubule network 
and dynein, a motor protein 247. Furthermore, plus and minus strand HCV RNA was 
shown to closely associate with lipid droplets, with around 5% of HCV RNA co-
purifying with lipid droplets 244. Together, these data suggest that assembly of virions 
is linked to lipid droplets. 
Lipid droplets are involved in VLDL production, an important function of hepatocytes. 
Apolipoprotein E, DGAT-1 (diacylglycerol acyltransferase), MTP (microsomal 
transfer protein) contribute to VLDL synthesis (Reviewed in 248). When these proteins 
are reduced or inhibited in HCV infected cells, virus production is hampered 249-
251. Given that virus particles are indicated to associate with apolipoproteins 30, 45, it 





Functions of HCV proteins in assembly and release 
All HCV proteins, except NS5b, seem to play a role in the assembly and/ or release 
of virus particles. The structural proteins core, E1 and E2 are part of the virions. The 
other HCV proteins seem to be accessory proteins, because mutations in p7, NS2, 
NS3, NS4b and NS5a influence infectious virus production 150, 230, 236, 252-256. Firstly, 
p7 exhibits ion-channel activity that is essential for assembly and release 149, 150, 152. 
The NS2 protease domain, but not its ability to cleave, is critical 150, 252. A mutation 
in the NS3 helicase domain, which does not affect its activity, reveals a function 
for NS3 in the assembly of virus particles 254. Interestingly, these data imply that 
both the NS2 protease and the NS3 helicase domains carry out a second function. 
Another mutational study suggests a regulatory function of NS4b in virus production 
253. Lastly, NS5a together with Core seem to play a crucial part in initiating genome 
packaging and nucleocapsid assembly. Serines in the last 20 amino acids of NS5a 
are required for an interaction with Core 257. Moreover, mutagenesis of these serines 
is deleterious for virus particle release, indicating their importance of the interplay 
between the two proteins 257. This protein-protein interaction might facilitate transfer 
of the viral RNA from the site of replication (where NS5a participates in replication) 
to the lipid droplets (where core is involved in lipid droplets redistribution) 244, 247. 
Moreover, in the presence of Core the viral RNA and other non-structural proteins are 
observed on lipid droplets, though in the absence this localisation fails 244. Again the 
phosphorylation of NS5a might determine the association with Core 257. One more 
interaction partner of NS5a is apolipoprotein E, indicating an additional connection 




In order for a virus to generate progeny, it needs components of the host cell. 
Therefore, interactions between the virus and host are essential. This relation 
between the virus and the host cell is clearly illustrated in the introduction, 
Chapter 1. The objective of the work described in this thesis was to study virus-
host interactions, at the level of protein-membrane association, protein-protein 
interactions and viral-protein modifications.
To study protein-membrane association, the NS4b protein was investigated. In 
the HCV proteome, this protein is required for replication and is essential for 
reorganisation of the host membranes, inducing the membranous web. NS4b interacts 
with the lipid bilayer in several ways. Chapter 2 addresses the membrane association 
of the carboxy-terminal domain of NS4b. 
Most viral proteins have more than one task in the virus life cycle and need to be 
tightly regulated. NS3 is a multifunctional protein as outlined in the Introduction and 
little is known about the regulation of its functions. We therefore set up experiments to 
examine the protein modifications of NS3. These studies are presented in Chapter 3.
The third subject we focused on, are protein-protein interactions between the virus 
protein NS3 and the host cell. Chapter 4 describes experiments to purify NS3 and 
interacting proteins in the context of replication. Several methods were explored and 
we identified two new NS3 interacting proteins. One of the interacting proteins is 
GLT25D1 and little was known about its cellular localisation. Since this is required 
to be able to examine the NS3-GLT25D1 interaction, we investigated the protein 
characteristics of GLT25D1, which is shown in Chapter 5. Subsequent studies on the 
interaction between NS3 and GLT25D1 are reported in Chapter 6.
All these interactions of the virus with the host cell are further reviewed in 
Chapter 7. The topics that will be discussed are the interactions of NS4b with the 
membrane, NS3 protein modifications, NS3 interactome studies and the implications 
of the newly discovered NS3 interacting proteins. Ultimately, this thesis indicates 
that the virus life cycle is regulated at the level of protein-membrane association, 
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Hepatitis C virus NS4b carboxy-
terminal domain is 
a membrane-binding domain




Willy J. M. Spaan





Hepatitis C virus (HCV) induces membrane rearrangements during 
replication. All HCV proteins are associated to membranes, pointing out the 
importance of membranes for HCV. Non-structural protein 4b (NS4b) has 
been reported to induce cellular membrane alterations like the membranous 
web. Four transmembrane segments in the middle of the protein anchor 
NS4b to membranes. An amphipathic helix at the amino-terminus attaches to 
membranes as well. The carboxy-terminal domain (CTD) of NS4b is highly 
conserved in Hepaciviruses, though its function remains unknown. A cytosolic 
localisation is predicted for the NS4b-CTD. However, using membrane-
floatation assays and immunofluorescence, we now show targeting of the 
NS4b-CTD to membranes. Furthermore, a profile-profile search, with an HCV 
NS4b-CTD multiple sequence alignment, indicates sequence similarity to the 
membrane-binding domain of prokaryotic D-lactate dehydrogenase (d-LDH). 
The crystal structure of E. coli d-LDH suggests that the region similar to NS4b-
CTD is located in the membrane-binding domain (MBD) of d-LDH, implying 
analogy in membrane association. Targeting of d-LDH to membranes occurs 
via electrostatic interactions of positive residues on the outside of the protein 
with negative headgroups of lipids. To verify that anchorage of d-LDH MBD 
and NS4b-CTD is analogous, NS4b-CTD mutants were designed to disrupt 
these electrostatic interactions. Membrane association was confirmed by 
swapping the membrane-contacting helix of d-LDH with the corresponding 
domain of the NS4b-CTD. Furthermore, the functionality of these residues 
was tested in the HCV replicon system. Together these data show that NS4b-
CTD is associated to membranes, similar to the prokaryotic d-LDH MBD, and 
is important for replication.





Hepatitis C virus (HCV) preferentially infects hepatocytes 1. Although this does not 
have a direct cytopathic effect, infection often becomes persistent, slowly progressing 
into chronic liver diseases like cirrhosis and hepatocellular carcinoma 2, 3. Phylogeny 
of HCV places this positive-sense RNA virus, within the genus Hepaciviruses of 
the family Flaviviridae 4. The single-stranded RNA genome contains one open 
reading frame flanked by two non-translational regions (NTRs) at the 5’ and 3’-
end. An internal ribosomal entry site in the 5’-NTR facilitates the translation of the 
polyprotein 5. Cellular and viral-encoded proteases process the polyprotein into three 
structural proteins (core and two glycoproteins, E1 and E2), a hydrophobic peptide 
p7 and six non-structural (NS) proteins 6, 7. 
During infection, the conformation of cellular host membranes changes in a number 
of ways. One of these membrane alterations is the membranous web (MW), composed 
of small vesicles embedded in a membrane matrix 8. Ultra structural analysis of 
HCV replicon cells in combination with labelling of viral RNA revealed that this 
membranous web is the site of RNA synthesis 8. 
The non-structural (NS) proteins NS3 to NS5b are required for viral replication 9. 
They localise to the cytosolic leaflet of membranes derived from the endoplasmic 
reticulum (ER) 10. NS3 possesses RNA helicase as well as protease activity. Membrane 
anchoring of NS3 is mediated through an amphipathic helix at the N-terminus of 
NS3 and a transmembrane segment in NS4a, which is also a co-factor for NS3 
protease 11, 12. New HCV RNA strands are synthesised by NS5b, the RNA-dependent 
RNA polymerase. NS5b is targeted post-translationally to membranes via a carboxy-
terminal hydrophobic domain 13, 14. NS5a, a peripheral membrane-binding protein, 
associates with lipids via an amphipathic helix at its amino-terminus 15. Importance 
for both replication and virus production has been suggested for NS5a 16, 17. A central 
role for the integral membrane protein, NS4b, in the formation of the membranous 
web was suggested when Egger et al. showed that very similar structures could be 
induced by the NS4b protein in the absence of any other HCV proteins 18. These 
NS4b induced structures were defined as swollen, partially vesiculated membranes 
and clustered aggregated membranes 19.  
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NS4b is a hydrophobic protein with a molecular weight of approximately 27 kDa and 
has a modular domain organisation with the amino- (N) and carboxy- (C) terminal 
ends being cytoplasmic and a central region, which is inserted in the ER membrane. 
A topology study of NS4b indicated that the central domain has four transmembrane 
segments 20, 21. The N-terminal part, approximately 70 to 90 amino acids long, has 
several reported functional properties. The extreme N-terminal segment of NS4b 
revealed the presence of a putative amphipathic helix (AH, aa 6 – 29), which mediates 
membrane association through its hydrophobic side 22. Disruption of this helix alters 
its ability to rearrange intracellular membranes and the localisation of HCV replication 
proteins 21, 22. The region next to this amphipathic helix is predicted to form a large 
amphipathic helix (aa 22 – 49), with the characteristics of a basic leucine zipper motif 
(bZIP) 23. The first 72 amino acids from the N-terminus of NS4b have been suggested 
to be involved in multimerisation 24, which may involve intramolecular leucine zipper 
interactions. A post-translational relocation of the N-terminus to the ER lumen was 
proposed for a fraction of the NS4b pool, giving the protein a dual transmembrane 
topology with either four or an extra fifth transmembrane domain (TMx) 20, 21. The 
C-terminal domain (CTD) of NS4b is oriented towards the cytosol and seems well 
conserved throughout hepaciviruses. Despite this sequence conservation not much is 
known about the CTD, though lately several studies describe possible characteristics 
of the domain 24-27. A genetic interaction between NS3 with the extreme C-terminus of 
NS4b has been postulated 27. Besides protein-protein interactions 24, 27, a protein-RNA 
interaction has also been suggested 25. Furthermore the CTD of NS4b is involved in 
RNA synthesis and virus production 26. 
The most widely suggested function for NS4b is the creation of a platform in the 
cell that concentrates the virus template, replication and host cell proteins, thereby 
increasing the efficiency of replication 18, 28. Alternatively, distortion of cellular 
membranes can reduce the transport of cell surface proteins in infected cells in order 
to escape from the host immune response 19. Other functions attributed to NS4b are 
inhibition of host as well as viral protein translation 29, 30 and modulation of NS5a 
hyper-phosphorylation 31. Clearly, NS4b is involved in a wide range of activities, 
which seem to point to a role in modulating the host cell environment either for 
evasion of the host response or optimising the setting for viral replication. 
In this study, we investigate the most conserved, though least characterised, domain 
of NS4b, the CTD. Expression of this domain in Huh7 cells, a human hepatoma cell 




line, revealed membrane targeting of the NS4b-CTD, in contrast to its predicted 
cytosolic localisation. Based on similarity with D-lactate dehydrogenase (d-LDH) 
membrane-binding domain and mutational studies, we suggest that the NS4b-CTD 
is a membrane-binding domain. The importance of this membrane targeting during 
replication was analysed in replicon studies. Taken together our results show that 
in addition to the N-terminus and the transmembrane domains, NS4b can associate 
with intracellular membranes via its CTD. Furthermore, mutational studies suggest 
that, for membrane targeting, positive residues in the NS4b-CTD interact with the 
negatively charged headgroups of lipids.






Reverse primer, as NS4b FL
NS4b-deltaCTD
Forward primer, as NS4b FL
Reverse primer, TAGTCTAGAGACCGACGCAGTATCGCTGCGCACACGAC
NS4b-CTD sub-Cys








To construct Myc-epitope-tagged expression plasmids, the sequence was amplified 
by PCR from pFK5.1Neo 32 or E.coli DNA using specific primers, see Table 1. The 
PCR products were digested with KpnI and XbaI and ligated into pCDNA3.1mychisB 
(Invitrogen) similarly digested with KpnI and XbaI. This resulted in the construction 
of expression vectors containing a 10-residue Myc-epitope-tag at its C-terminus. In 
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order to construct HA-epitope-tagged NS4b expression constructs, the Myc-epitope 
sequence was XbaI – PmeI cut and replaced with an XbaI – PmeI fragment coding for 
the HA-epitope.
Cell culture and transfection
Human hepatoma cell line Huh7 was grown in Dulbecco’s Modified Eagle’s 
Medium supplemented with non-essential amino acids, L-glutamate, Penicillin and 
Streptavadin. Cells were subcultured using trypsin and transfected using Fugene6 
(Roche) at a DNA/reagent ratio of 1/3, according to manufacturers’ instructions.
In vitro transcription, electroporation and selection of selectable replicon 
cells
In vitro transcription, electroporation and selection of G418-resistant cell lines was 
done as described previously 33.
Antibodies
The following antibodies were used anti-PDI (Stressgen), anti-Myc (mouse) 
(Invitrogen), anti-Myc (rabbit) (Roche), anti-GAPDH (SantaCruz), anti-Transferrin 
receptor, clone H68.4 (Zymed Laboratories Inc), anti-COX-IV (Abcam), anti-
Calnexin (BD) and anti-HA (Abcam).
Immunofluorescence microscopy
24 h post transfection cells were fixed with 3% paraformaldehyde (PFA) in PBS 
(154 mM NaCl, 1.4 mM phosphate, pH 7.5). PFA was quenched using 50 mM 
NH4Cl in blockbuffer, which contained 5% fetal calf serum (FCS) in PBS. The 
cells were permeabilised with 0.1% TritonX-100 in blockbuffer and stained with 
primary antibodies diluted in blockbuffer for 1h. Next, the coverslips were washed 
with glycinebuffer, 10 mM glycine in PBS, and incubated with secondary antibody 
diluted in blockbuffer for 1h. After washing with glycinebuffer, PBS and water, the 
coverslips were mounted with Prolong (Invitrogen) mounting medium. Fluorescence 
images were captured using a Zeiss Axioskop 2 fluorescence microscope equipped 
with the appropriate filter sets, a digital Axiocam HRc camera and Zeiss Axiovision 
4.4 software. Images were optimised with Adobe Photoshop CS2.
Membrane-floatation gradient
Transfected Huh7 cells were lysed after 24h in buffer that contained 20 mM 




Tris pH 7, 1 mM MgCl2, 15 mM NaCl and 240 mM sucrose using a ball bearing 
homogeniser (Isobiotec, Heidelberg Germany). Whole cells and cell debris 
was spun down at 500×g for 5 min and supernatant was collected. Cell extracts 
were mixed with sucrose to 80% w/v and overlaid with a linear sucrose gradient 
(80%- 10% w/v sucrose, 50 mM Tris pH 7, 1 mM MgCl2, 15 mM NaCl). After 
centrifugation in a SW41 tube for 15h at 100,000×g (Beckmann ultracentrifuge), 
500 µl fractions were collected from the top. The odd fractions were analysed by 
western blotting, either directly or subsequent to concentration. 200 µl of each 
fraction was concentrated using 9 volumes of ethanol and incubated overnight 
at -20 °C, followed by centrifugation at max in an Eppendorf 5417R for 1h. The 
protein pellets were dissolved in Laemmli-buffer.
SDS-Page and western blotting
After separation on SDS-PAGE gels, proteins were transferred to PVDF membranes 
(HybondP, GE-Healthcare) using a Semi-Dry blot apparatus (Biorad). Membrane 
blocking and antibody incubations were performed using 0.5% Tween-20, 5% non-
fat, dry milk (Campina) in PBS. Since all secondary antibodies were conjugated 
to horseradish peroxidase, the proteins were visualised using enzyme-catalysed 
chemoluminescence (ECL+, GE-Healthcare) and Fuji Super RX medical X-ray film.
Profile searches of sequence databases
COMPASS (http://prodata/swmed.edu/compass/), database pfam21.0, 0 PSI-blast 
iterations, E-value threshold was set at 10. Profile comparer (PRC; http://supfam.org/
PRC), database pfam22.0, E-value threshold was set at 10. HHpred (http://toolkit.
tuebingen.mpg.de/hhpred), selected database pfamA_22.0, 0 PSI-blast iterations.
Results 
NS4b carboxy-terminal domain localises to internal membranes
A well-conserved part of the HCV NS4b protein is the carboxy-terminal domain 
(NS4b-CTD), which is also conserved within the hepacivirus genus 23. Along with 
the expected cytosolic localisation, it proposes a separate function of the NS4b-CTD. 
To study the localisation of NS4b-CTD various constructs were made. To each 

























These constructs were transfected into Huh7 human hepatoma cells and analysed 
using immunofluorescence. Localisation of the constructs was first compared to the 
endoplasmic reticulum (ER), using Protein Disulphide Isomerase (PDI) as a marker. 
In Figure 1A, top left panel, Huh7 cells expressing full-length NS4b (NS4b-FL, 
aa 1-261) are shown. NS4b-FL has a perinuclear and reticular staining, typical for 
ER. Additionally, the pattern of NS4b-FL largely overlaps with PDI. This ER-like 
staining confirms the previously described localisation of native FL NS4b 20, 34. 
To our surprise, expression of the NS4b-CTD alone (aa 188-261) does not show 
a cytosolic staining, but displays small punctate or dot like structures throughout 
the cells (Fig.1A, CTD left panel). In the overlay of NS4b-CTD and PDI, some co-
localisation is seen between the two (Fig.1A, CTD right panel). Together with the 
small punctate staining, this suggests that the NS4b-CTD might be associated to 
membranes. 
Since the NS4b-CTD shows a dot like pattern, it might have an effect on the attachment 
to membranes or even localisation of NS4b-FL. Therefore, an NS4b lacking the CTD 
(NS4b-deltaCTD, aa 1-192) was constructed and examined in immunofluorescence. 
As shown in Figure 1A, NS4b-deltaCTD has a perinuclear and reticular staining, 
like NS4b-FL and PDI, indicating an ER-like localisation (Fig.1A). In addition, co-
transfections of NS4b-FL and NS4b-deltaCTD show similar localisation (data not 
shown). Together this implies that the absence of CTD does not seem to alter the 
localisation of NS4b. 
Two potential lipid modification sites for palmitoylation on cysteines, suggested 
by Yu and colleagues 24, might render the NS4b-CTD to membranes. We therefore 
investigated this possibility and mutated the two cysteines (cysteines 256 and 260) of 
the NS4b-CTD into serines (NS4b-CTD sub-Cys) (Fig.3A) and expressed this mutant 
in Huh7 cells. Localisation of the NS4b-CTD sub-Cys mutant was very similar to 
Figure 1  -  Expression of different NS4b proteins in Huh7 cells
Huh7 cells were transfected with NS4b full-length (FL, aa 1-261), deltaCTD (aa 1-192), CTD (aa 
188-261) or CTD substitution-Cysteines (CTD sub-Cys) and 24 h later processed for indirect im-
munofluorescence. Cells were double labeled with antibodies reacting against Myc-epitope-tag at 
the C-terminal end of each protein (in red) and A. protein disulphide isomerase (PDI) or B. Cyto-
chrome C oxidase subunit IV (COX-IV) (in green), in first and second panels respectively. Third 
panels show merged images.
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NS4b-CTD, exhibiting small punctate structures in the cells (Fig.1A). It shows that 
the dot-like membrane localisation of NS4b-CTD is caused by characteristics in the 
domain other than the cysteines at positions 256 and 260.
Membrane association of the carboxy-terminal domain of NS4b
Membrane association of proteins can be investigated in a membrane-floatation 
assay. In such an assay, a continuous-density gradient is loaded on top of a cell 
extract and subjected to centrifugation. Membranes and associated proteins float 
into the gradient, while cytosolic proteins stay in the loaded bottom fraction. To 
examine the suggested membrane-association characteristics of the NS4b-CTD 
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Figure 2  -  Membrane association of NS4b carboxy-terminal domain
Huh7 cells transfected with NS4b-CTD-Myc, NS4b-CTD tripleE-Myc or NS4b-CTD Helix-swap-Myc 
were subjected to sucrose density gradient centrifugation. Cell lysates were loaded under a sucrose 
gradient from 10-80% w/v and part of the lysate was used as a loading control (L). Fractions were 
taken from top (fraction 1) to bottom (fraction 23) and separated by SDS-PAGE. This was followed 
by immunoblot analysis for Calnexin, Transferrin Receptor (TfR), Cytochrome C oxidase subunit IV 
(COX-IV) and Glyceraldehyde 3-phosphate dehydrogenase (GAPDH). NS4b-CTD and NS4b-CTD 
tripleE were assayed using an antibody against Myc-epitope. M indicates where molecular weight 
marker was loaded.




assay, in which a cell lysate of Huh7 cells transfected with NS4b-CTD was used. 
Fractions were collected from the top (10%) to the bottom (80%) of the gradient 
and the odd fractions were analysed by western blotting. As a control for cytosolic 
proteins, glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used. As 
expected, GAPDH was retained in the bottom fractions 21 and 23 of the density 
gradient, where the cell extract was loaded (Fig.2). Calnexin, Transferrin receptor 
(TfR) and Cytochrome C oxidase subunit IV (COX-IV) are transmembrane 
proteins and float into the gradient, they are mainly observed in fractions 9 and 
11 (Fig.2). Since calnexin, TfR and COX-IV reside on different membranes in 
the cell (ER, the endocytic pathway and mitochondria), their distribution differs 
slightly (Fig.2). The NS4b-CTD is detected in fractions 7 to 13 and 21 and 23 
with its highest signal in fraction 11 (Fig.2). In conclusion, similar to membrane 
proteins the NS4b-CTD floats into the gradient, implying membrane association of 
the NS4b-CTD. Together, the punctate structures in immunofluorescence and the 
floatation into the membrane-floatation gradient, suggest association of the CTD 
of NS4b to membranes.
Cellular localisation of the NS4b carboxy-terminal domain
Since the CTD of NS4b only partially overlaps with the ER-marker, PDI (Fig.1A), 
we were interested in knowing on which other membranes the NS4b-CTD resides. 
Therefore, co-localisation studies with different organelle markers in Huh7 cells 
transfected with NS4b-CTD were performed. From the exocytic pathway, we 
examined the Golgi (Giantin) and the ER-Golgi intermediate compartment (ERGIC) 
and found no substantial co-localisation (data not shown). Similar results were 
obtained from co-localisation studies with markers from the endocytic pathway, 
such as Rab5 from early endosomes, mannose-6-phosphate receptor and LAMP1, 
proteins that resides in late endosomes and lysosomes (data not shown). Recently, 
lipid droplets were demonstrated to play an important role in the HCV life cycle 35. 
However, no co-localisation of lipid droplets and the NS4b-CTD was observed (data 
not shown). HCV proteins, Core, NS3 and NS4a are suggested to localise to or close 
to mitochondria 36, 37. For that reason, co-localisation of mitochondria and NS4b-
CTD was investigated. We could observe considerable similarity in patterns between 
COX-IV, a mitochondrial protein marker and the NS4b-CTD (Fig.1B). However, the 
overlap is not complete. Even though we did not specifically preserve the plasma 
membrane during immunofluorescence, we could occasionally see a fraction of 
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NS4b-CTD at the plasma membrane (Fig.1B. Inset). Taken together the CTD of 
NS4b seems to be mainly targeted to mitochondria, ER membranes and the plasma 
membrane.
Profile searches with an HCV NS4b carboxy-terminal domain alignment 
suggest similarity to Lact-deh-memb
The importance of the NS4b-CTD might be reflected by the sequence conservation 
within hepaciviruses. Its sequence conservation may also provide a clue to its 
function. Identification of potentially remote protein homologues can help to predict 
protein properties, like folding, structure and most importantly function. Similarity 
between distantly related proteins can be effectively established using profile-based 
searches of databases of proteins families. In order to elucidate a possible function of 
the CTD of NS4b, we generated a multiple sequence alignment (profile) of the NS4b-
CTD including all genotypes of HCV, Hepatitis GB virus A, B and C (Supplemental 
figure 1), which we manually refined. Programs for profile-profile comparisons 
have been developed and are available as web-based tools. We used three different 
tools for profile-profile comparison with our HCV NS4b-CTD query profile, namely 
PRC 38, HHpred 39 and COMPASS 40 because each is sensitive to a different set 
of algorithms and the combination of the three tools reinforces independently 
detected relationships. This allows us to construct a consensus result with hits 
found by all tools. Using similar search parameters (see Materials and Methods) 
twelve, eight and five hits were found by PRC, HHpred and COMPASS respectively. 
Interestingly, only one protein family Lact-deh-memb (PF09330) was found by all 
three methods. This was the highest scoring profile for the three methods, next to the 
NS4b profile (E-values 0.057, 0.086 and 0.35 for the respective searches). According 
to HHpred the probability (which also includes the contribution from the secondary 
structure score) that Lact-deh-memb is significant similar to NS4-CTD is 44.8%. 
Members of this Lact-deh-memb family are predominantly found in prokaryotic 
D-lactate dehydrogenase (d-LDH), which is a peripheral-membrane respiratory 
enzyme located on the cytosolic site of the inner membrane 41. Comparison of the 
sequence similarity between HCV NS4b-CTD and d-LDH from E. coli, of which the 
crystal structure has been resolved 41, revealed that the common region lies in the 
membrane-binding domain (MBD) of d-LDH (Fig.3A and Supplemental figure 1) 
42. Thus besides apparent sequence similarity, both domains seem to perform similar 




functions, that is, they allow for membrane association. The MBD of d-LDH was 
suggested to bind non-specifically to the membrane through (the positively charged) 
basic residues (Lys, Arg), interacting with the negatively charged phospholipids of 
the membrane, rather than penetrating the lipid bilayer 41-43. Part of the d-LDH MBD 
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Figure 3  -  Sequence similarity between NS4b carboxy-terminal domain and the membrane-
binding domain of D-lactate dehydrogenase
A. Multiple sequence alignment of the carboxy-terminal domain of four genotypes of HCV NS4b 
proteins and the membrane-binding domain of four d-LDH family members (referenced by their 
accession numbers). Bold residues highlight amino acids present in both families. Basic residues 
(R, K, H) making up the potential electropositive surface are indicated (+). Dotted line indicates 
disordered region in the d-LDH crystal structure. Arrowheads point to mutations made in the CTD 
of NS4b.
B. Ribbon representation of the membrane-anchored side of d-LDH (PDB code 1F0X). Stick resi-
dues indicate the surface exposed amino acids of the ordered membrane-binding helix.
                                             LPPRMKNWRDK     4B-CT  Helix-swap     
                                               EE E      4B-CTD TripleE  
                                                 S   S   4B-CTD sub-Cys  
                                               ▲▲ ▲     ▲   ▲     
GAVQWMNRLIAFASRGNHVSPRHYVPESEPAARVTQILSSLTITQLLKRLHQWINEDCSTPCS  AAA52748 (1b) 
GAVQWMNRLIAFASRGNHVAPTHYVAESDASQRVMQMLSSLTITSLLRRLHTWITEDCPVPCS  AAP55698 (2b) 
GAVQWMNRLIAFASRGNHVSPTHYVPESDAAARVTQILSSLTITHLLKRLHKWINDDCSTPCA  CAH64686 (4a) 
GANQWMNRLIAFASRGNHVSPTHYVPETDASKNVTQILSSLTITSLLRRLHQWVNEDASTPAS  ABE98160 (6a)              
       +      +  +   ++         +           +  ++ + 
                                             L KR HQ INE  putative membrane interface (GT1b)  
 
                                             L PR KN RDK  d-LDH membrane interface (1FOX)
   +   +    + +  +   +          +      +    +  ++ +  + +  ++ 
DK-MPFFFNLKGRTDAMLEKVKFFRPHFTDRAMQKFGHL PSHLPPRMKNWRDKYEHHL L  1FOX E.coli 
GTDK-MPTYFTLKGRMDAIFNRVPFLPVNLIDRIMQGLSRLLPSHLPKRLKEYRNRFEHHLIL  NP_930082 
GTHR-LPKLFALKAKVDRIAKKVSFLPNDFSDKFMQILSKAMPEHLPKSLWQYRDQFEHHLIV  YP_718994  












corresponding to the CTD of NS4b is disordered in the crystal structure and is thought 
to form a defined structure upon binding to the membrane 41. The central alpha-helix 
of the d-LDH MBD (Fig.3B) corresponds to the extreme carboxy-terminal end of 
NS4b-CTD. The amino acids on the membrane interface of this alpha-helix and the 
corresponding residues of NS4b-CTD are indicated in Figure 3A.
Membrane targeting of NS4b carboxy-terminal domain and d-LDH is 
comparable
Profile-profile comparison E-values in the range of 0.1-0.001 can indicate a true 
relationship, but require additional evidence to conclude that there is a functional 
parallel between NS4b-CTD and d-LDH-MBD in membrane binding 44. Mutational 
studies could reveal functional similarity and were accordingly performed. D-LDH 
is a general membrane-binding protein in E. coli located on the cytosolic side of 
the inner membrane. The position of such a protein in eukaryotic cells is unknown. 
Therefore, we first investigated localisation of d-LDH MBD in Huh7 cells. As shown 
in Figure 4A d-LDH MBD (aa 319 to 390) mainly overlaps with COX-IV illustrating 
that when the d-LDH MBD is expressed separate from the enzyme part of the d-LDH 
protein, functionality of membrane binding is maintained. Moreover, co-transfection 
of NS4b-CTD and d-LDH MBD showed nearly complete overlap of the two patterns 
(Fig.4B). Furthermore these immunofluorescence assays indicate that d-LDH MBD, 
a general membrane-binding domain, has a preference for mitochondrial membranes 
in eukaryotic cells, which is comparable to the localisation of NS4b-CTD (Fig.4A), 
implying analogous membrane targeting of the two domains.
To test the hypothesis that the CTD of NS4b associates with the membranes in a 
way similar to the d-LDH MBD, we introduced mutations designed to disrupt the 
positive residues postulated to interact with the negative headgroups of lipids 41, 42 
(Fig.3A). The side chains of the d-LDH MBD pointing away from the protein, facing 
the membrane surface are indicated in Figure 3B. Three positively charged amino 
acids (Lys 247, Arg 248 and His 250) in NS4b corresponding to the structured alpha-
helix in d-LDH were simultaneously replaced with a negatively charged glutamic 
acid (K247E/ R248E/ H250E; NS4b-CTD tripleE), which should not be able to 
bind to phospholipid heads. The NS4b-CTD tripleE mutant was expressed in Huh7 
cells and membrane association was investigated using immunofluorescence and a 
membrane-floatation assay. Mutation of all three positively charged residues results 




in a dramatic change of localisation of the NS4b-CTD, from punctate structures in 
the perinuclear region to a diffuse distribution throughout the cell, possibly cytosolic 
(Fig.4A, compare NS4b-CTD to NS4b-CTD tripleE). Loss of membrane association 
was also shown in a continuous-density gradient, in which NS4b-CTD tripleE was 
detected in the same fractions as the cytosolic marker GAPDH (Fig.2). 
A functional parallel can also be examined by swapping part of the membrane-binding 
domains of two proteins. A mutant was constructed, in which we exchanged the 
putative membrane-contacting helix of NS4b-CTD for the corresponding membrane-
contacting helix of the d-LDH MBD (NS4b-CTD helix-swap) (Fig.4A). Huh7 cells 
expressing NS4b-CTD helix-swap display punctate structures in immunofluorescence, 
though the staining has a slightly more diffuse localisation compared to NS4b-CTD 
(Fig.4A). Similarity in patterns with COX-IV also indicated that the NS4b-CTD 
helix-swap is targeted to membranes while the NS4b-CTD tripleE mutant has lost 
membrane binding. Furthermore, a membrane-floatation assay showed that NS4b-
CTD helix-swap is membrane associated (Fig.2), although compared to NS4b-CTD 
more was observed in the non-floating fractions. Altogether, these results illustrate 
that the CTD of NS4b can interact with membranes via the positively charged 
residues, comparable to d-LDH MBD.
Positively charged residues of NS4b carboxy-terminal domain are 
essential for replication
To examine the importance of the NS4b-CTD positively charged residues for RNA 
replication, we exchanged these amino acids involved in membrane association for 
negatively charged glutamic acids in selectable subgenomic replicons 9. Huh7 cells 
transfected with replicon RNA that carry the three negatively charged residues (tripleE) 
did not yield any viable colonies (Fig.5). Moreover, the single mutations K247E and 
R248E were replication defective and gave no colonies (Fig.5). Thus the positive residues 
are clearly indispensable for viral RNA replication in cell culture, suggesting that loss 
in membrane association leads to a replication defect. These results, together with the 
possible functional parallel between d-LDH MBD and the NS4b-CTD, prompted us to 
swap the membrane-binding helix from d-LDH MBD (PPRMKNWRDK) into replicons 
(helix-swap, Fig.3A) and determine colony formation. These replicons, in which eight 
amino acids are exchanged, indeed formed several viable colonies (40 colony-forming 






































Figure 4  -  Cellular distribution of NS4b carboxy-terminal domain mutants and D-lactate 
dehydrogenase membrane-binding domain in Huh7 cells
A. The panels on the right show Huh7 cells expressing different NS4b-CTD mutants or d-LDH 
membrane-binding domain (d-LDH MBD) after 24 h. Expression constructs are shown in red. Us-
ing COX-IV as a marker protein, mitochondria are shown in middle panels and in merged picture 
in green. On the right a schematic view of the different NS4b-CTD mutants is drawn; in red the 
sequence of NS4b-CTD-wt, in black the mutations made and in green the exchanged amino acids 




formed relative to wild type (~10.000 CFU), but the replication defect from the helix 
swap is less than the negative charged mutations, where no colonies were formed. Two 
separate replicon colonies derived from the NS4b-CTD helix-swap were expanded, RNA 
isolated and sequenced to analyse whether they still contained the original mutations. 
Interestingly, the complete introduced helix was retained, confirming the importance of 
this membrane-contacting helix.
Discussion 
Compared to other HCV proteins NS4b is the least characterised. Besides 
involvement in replication and induction of membrane rearrangements little is 
known about the function(s) of the protein. A well-conserved part of NS4b is the 
carboxy-terminal domain (CTD) (Supplemental figure 1), which is predicted to 
contain two alpha-helixes and expected to localise cytosolically 20, 23. Surprisingly, 
we found using different approaches that the NS4b-CTD is membrane associated. 
Immunofluorescence analysis of Huh7 cells expressing NS4b-CTD shows punctated 
Figure 5  -  Effect of NS4b carboxy-
terminal mutations on colony for-
mation using selectable replicons
Colony-formation assay in which 
Huh7 cells are transfected with in vitro 
transcribed replicon RNA that contain 
NS4b-CTD mutations. Colonies were 
stained using Coomassie blue. Wild-
type is pFK5.1. Mock transfected cells 
as the control. The NS4b-CTD muta-
tions TripleE, E247, E248 and helix-
swap in pFK5.1 are explained in Fig-
ure 4.
from the membrane-contacting helix of the d-LDH-MBD.
B. Huh7 cells were co-transfected with NS4b-CTD-HA and d-LDH MBD-Myc and analysed by im-
munofluorescence after 24 h of expression. The first panel shows d-LDH MBD, which is presented 
as red in the merged picture. NS4b-CTD is displayed in the second panel and is shown in the 
merged picture as green.
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structures (Fig.1). Furthermore, in a membrane-floatation gradient, we could 
demonstrate that fractions containing floating membranes also have NS4b-CTD 
(Fig.2). Using profile-profile searches, we found similarity between the CTD of NS4b 
and the membrane-binding domain (MBD) of D-lactate dehydrogenase (d-LDH) 
(Fig.3A). D-LDH is a prokaryotic respiratory enzyme that is located on the cytosolic 
side of the inner membrane 41. When we expressed the MBD of d-LDH from E.coli 
in mammalian Huh7 cells and performed immunofluorescence, we observe a pattern 
similar to NS4b-CTD (Fig.4A). Nearly complete overlap of both signals was shown 
in a co-transfection experiment of NS4b-CTD and the MBD of d-LDH (Fig.4B), 
indicating a functional parallel of both domains in membrane association. D-LDH 
is suggested to anchor to the membrane via interactions of positively charged amino 
acids with the negative heads of membrane phospholipids 41-43. Substitution of 
three positive residues in the NS4b-CTD resulted in complete loss of membrane 
association (Fig.4A). Together these experiments strongly suggest association of the 
NS4b-CTD to membranes. 
The localisation of NS4b-CTD to mitochondria is the most prominent (Fig.1B and 
4A). However, there is no complete co-localisation as a fraction is targeted to the ER 
(Fig.1A) and the plasma membrane (Fig.1B, Inset). In addition, the d-LDH MBD, 
a general membrane-binding domain that normally targets the enzyme towards the 
cytosolic side of the inner membrane of E. coli through electrostatic interactions, is 
largely located on mitochondrial membranes when expressed in human Huh-7 cells 
(Fig.4A) 41. The apparent preference for mitochondria might be caused by the slow 
turnover rate of mitochondrial membranes compared to the rapid turnover of ER 
and Golgi membranes 45. A more general membrane-association characteristic of the 
NS4b-CTD is implied by these results.
Given the similarity between the CTD of NS4b and the d-LDH membrane-binding 
domain, the mode of general association to the membrane, through electrostatic 
interactions 41-43, might be comparable as well. When we substituted three positive 
residues in the NS4b-CTD region corresponding to the MBD of d-LDH into negative 
residues, to create repulsion towards the negative headgroups of lipids, membrane 
association is lost (Fig.2 and Fig.4A, NS4b-CTD tripleE), as well as the ability to form 
subgenomic replicon colonies (Fig.5). Single substitution of each positive residue in 
the NS4b-CTD resulted in a mild loss of membrane targeting (Data not shown), though 
a complete loss of replicon colony formation (Fig.5). It was previously shown that the 




integrity of NS4b is important for HCV replication; changes of only one amino acid 
can already influence replication 46, 47. Mutants in which we exchanged the complete 
membrane-contacting helix of NS4b-CTD with the d-LDH membrane-interface helix, 
retained membrane targeting (Fig.2 and Fig.4A, NS4b-CTD helix-swap) and selectable 
replicon colonies were obtained (Fig.5). Nonetheless, in this NS4b-CTD helix-swap 
fewer replicon colonies were formed compared to wild type. Moreover, the introduced 
sequence was unchanged in these colonies. In the NS4b-CTD helix-swap, mutant 
eight amino acids are substituted and it gains in total one positively charged residue 
compared to NS4b-CTD, though this charge is distributed differently along the helix. 
Both the immunofluorescence assay and the colony-formation assay illustrate that these 
mutations are allowed and indicate similar function of the two domains, NS4b-CTD 
and d-LDH MBD. Our experiments give an indication that the CTD of NS4b targets 
to membranes via electrostatic interactions of the positive residues in the NS4b-CTD 
with the negative phosphates of the phospholipids (Model in Fig.6), moreover that this 
protein-membrane interaction is important for HCV RNA replication.
The NS4b protein is associated with membranes in various ways. Four to five 
transmembrane domains in the central region 20, 23 and an amphipathic helix at the 
N-terminus of the protein 22 were described previously. In addition, we now show 
that the CTD of NS4b is a membrane-binding domain. This stresses the importance 
Figure 6  -  Model of NS4b membrane association
Schematic of the proposed topology of NS4b relative to the ER membrane and reported functional 
properties (see introduction). Model for NS4b-CTD membrane association is discussed in this pa-
per. Here we propose that positive residues (amino acids are indicated) are important for mem-
brane targeting through the interaction with the negative headgroups of phospholipids. 




of protein-membrane interaction throughout the protein. For the NS4b-CTD, we can 
envisage several possible functions. One possibility might be to position this domain 
of NS4b in a correct orientation. Recently, a membrane-binding amphipathic helix in 
NS3, together with the transmembrane domain of NS4a, were suggested to properly 
position the NS3-4a protease on the membrane 11. Positive residues in a MBD can also 
stabilize the orientation on the membrane surface 48. In analogy, membrane contacts 
of NS4b-CTD might position the domain on the membrane surface or facing towards 
the cytosol.
NS4b is involved in the formation of membranous web structures 18. Therefore, a 
function of the NS4b protein might be the induction of membrane curvature. The 
N-terminal amphipathic helix could act as a wedge inserted into one leaflet of the 
lipid bilayer leading to membrane curvature 49, 50. Also transmembrane domains can 
influence membrane curvature, depending on their conical shape 49. The CTD of NS4b 
might induce or stabilize curvature by bracing the membrane like a scaffold 49, 50. 
An interesting question for both the N-terminal amphipathic helix and the CTD 
membrane-binding domain of NS4b is whether these bind to the same membrane 
(cis) as the central transmembrane helices or that these can bind to other cellular 
membranes in close proximity (trans). In the latter situation it is conceivable that 
such a membrane-protein-membrane interaction would bring different membrane 
surfaces into close proximity, resulting in convoluted membranes 19. 
Recently, the positively charged amino acids that we propose to interact with the 
lipid headgroups, were also indicated in RNA-binding with an apparent preference 
for minus strand 3’NTR 25. When we co-transfected NS4b-CTD together with an 
excess of minus strand 3’NTR RNA, no change in localisation of the NS4b-CTD 
could be observed (data not shown). This indicates that membrane association is not 
affected by the suggested RNA-binding characteristics of the domain in the presence 
of RNA. 
Clearly, the HCV life cycle is achieved by the interchange between membranes, 
protein membrane anchors and proteins. The membranous web formation for 
replication, possibly lipid droplet associated membranes are involved in virus particle 
assembly 16, 35. The switch between active replication and assembly of infectious 




virus particles requires further levels of interactions between the membranous web 
and other associated membranes both in time and space 35, 51, 52. The modular domain 
architecture and association to membranes of NS4b suggests various functions 
throughout these processes. 
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Supplemental figure 1  -  Multiple sequence alignment of NS4b carboxy-terminal domain and 
Lact-deh-memb 
Top panel contains a multiple sequence alignment of Lact-deh-memb (PF09330). A multiple se-
quence alignment of the NS4b-CTD, which includes all genotypes of HCV, Hepatitis GB virus A, B 
and C is shown in the bottom panel.
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Post-translational modifications of viral proteins regulate various stages 
of infection and can even control cellular processes. With only 10 proteins 
Hepatitis C virus (HCV) can orchestrate its complete viral life cycle. The HCV 
non-structural protein 3 (NS3) has many functions. It has protease and helicase 
activity, interacts with several host cell proteins and plays a role in translation, 
replication and virus particle formation. Organisation of all these functions 
seems necessary and could be regulated by post-translational modifications. 
We therefore searched for modifications of the NS3 protein in the subgenomic 
HCV replicon. When performing a tag-capture approach coupled with two-
dimensional gel electrophoresis analyses, we observed that isolated His6-NS3 
yielded multiple spots. Individual protein spots were in-gel digested with 
trypsin and analysed by mass spectrometry. Differences observed between 
the individual peptide mass fingerprints suggested the presence of modified 
peptides and allowed us to identify N-terminal acetylation and an adaptive 
mutation of NS3 (Q1067R). Further analysis of other NS3 variants revealed 
phosphorylation of NS3.





Post-translational modifications (PTMs) like phosphorylation, prenylation, 
methylation and acetylation play an important role in protein activity, localisation 
and protein-protein interactions 1, 2. Not only eukaryotes use this mechanism to 
modulate the function(s) of their proteins. Especially viruses require PTMs because 
their genome is small and events like translation, replication, virus assembly and 
release all need to be well orchestrated 3, 4. The small 9,6 kb genome of Hepatitis C 
virus (HCV), a positive-stranded RNA virus, yields a single polyprotein, which after 
processing results in three structural proteins Core, E1 and E2, a peptide p7 and six 
non-structural proteins NS2, NS3, NS4a, NS4b, NS5a and NS5b. Together these 10 
proteins coordinate the complete life cycle of HCV 5. For some of these proteins it is 
known that they have a dual function involved in more than one process of the virus 
life cycle, requiring precise regulation 6-9.
An apparent example of a multifunctional protein within the HCV genome is NS3, 
which contains protease and helicase activity 10, 11. The serine protease domain of 
NS3 is in the N-terminal one third of the protein. Together with NS4a it forms a 
stable complex, which cleaves the non-structural proteins, downstream of NS3 12-
14. Besides these cleavages, the NS3-4a protease is known to cleave MAVS/IPS-1/
VISA/Cardif and TRIF, which affect signalling of the RIG-I and Toll-like receptor 3 
pathways respectively, thereby abrogating the interferon response 15. 
Upon binding to NS4a the localisation of NS3 changes from cytosolic to endoplasmic 
reticulum (ER) membrane-associated, indicating that protein-protein interactions 
modulate its localisation 16. 
In addition to the protease activity of NS3 in the N-terminus, the C-terminus of NS3 
can unwind RNA through ATP-ase and helicase activity 11, 17. RNA-unwinding activity 
seems to be modulated by other viral proteins like NS5b, the RNA-dependent RNA 
polymerase 18, 19 and NS4a 20. A fine balance between the concentration of NS5b, NS3 
and RNA has been indicated to influence activity 18. The helicase domain of NS3 
can be post-translationally methylated at Arg1493 (polyprotein) by Protein Arginine 
Methyltransferase 1 (PMRT1) 21. Non-methylated NS3 helicase can unwind dsDNA, 
however when the helicase domain of NS3 is methylated unwinding of dsDNA is 
inhibited 22. This shows that methylation of the NS3 helicase domain can change its 
activity. The mechanism resulting in inhibition and the conditions for methylation 
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are still unclear, though proteins in the alpha interferon-induced signalling pathway 
have been implicated 22. 
Besides the interaction of NS3 with PMRT1, several other host-protein interactions 
with NS3 have been described, including PKA, PKC, TBK1 and p53, which are all 
proteins involved in cell signalling 23-26. Recently a role in virus particle production 
has been suggested for NS3, by the identification of adaptation and compensatory 
mutations in NS3 using the infectious virus system 27, 28.
Taken together, the NS3 protein has various interaction partners and many functions 
which need to be regulated. Post-translational modifications could direct these 
processes. A first step towards understanding regulation is the identification of 
NS3 modifications. Besides methylation, which seems to regulate helicase activity 
and has been identified using over-expression of NS3, no other modifications are 
known. We therefore set up an assay to search for other NS3 modifications in the 
context of functional replication. In order to purify NS3 from the replicon, we 
introduced a His6-tag at the N-terminus of NS3 in the replicon RNA genome. After 
two-dimensional poly-acrylamide gel electrophoresis separation of purified NS3, at 
least 6 major protein spots corresponding to NS3 were observed. These spots point 
to several post-translational modifications of NS3. To identify post-translational 
modifications, we analysed spots by MALDI-ToF-ToF and LC-iontrap MS/MS and 
could reveal an N-terminal acetylation. In addition, an amino acid change in NS3, 
reported to enhance replication, was discovered. We furthermore show, by phosphate 
specific staining and phosphatase treatment, phosphorylation of NS3. 
Methods
Plasmid Construction
To construct His6-tagged NS3-replicons, the sequence was amplified by PCR 
from pFK5.1Neo 29 using the specific primers GTTCGGACCGTCTAGACAT-
CATCACCATCACCATGCGCCTATTACGGCCTACTCC and GAAGTCGACT-
GTCTGGGTGACAATG. The PCR product was digested with RsrII and BsrGI 
and ligated into pFK5.1Neo similarly digested with RsrII and BsrGI. Start codon 
and plasmid were restored by introducing PCR product derived from specific prim-
ers GCTAAGCTTCGTAATACGACTC and ATTCTAGACATGGTATTATCGT-




GTTTTTC, digested with RsrII - XbaI back into the construct. This resulted in the 
construction of a replicon containing a His6-tag at the N-terminus of NS3.
Cell culture
Human hepatoma cell line Huh7 containing HCV replicons was grown in 
Dulbecco’s Modified Eagle’s Medium supplemented with Non-essential amino 
acids, L-glutamate, Penicillin, Streptavidin and Geneticin. Cells were subcultured 
using Trypsin.
Purification of His6-NS3
Huh7 cells containing His6-tagged NS3 replicons were sub-cultured at least two days 
before cell lysis with Ureum buffer (8 M ureum, 300 mM NaCl, 1% NP40, 50 mM 
Tris pH 7.0 and 10 mM imidazole pH 7.0). Total lysate volume of each 15 cm culture 
dish was 2 ml. To get ride of cell debris, mainly genomic DNA, total cell lysates 
were subjected to centrifugation at 14.000 ×g for 15 min at 4°C and supernatant was 
collected. Eighty µl of 50% Cobalt2+-beads (Clontech) in Ureum buffer was added to 
the supernatant of one dish and incubated for 2 h at 4°C under continuous rotation. 
Subsequently the beads were washed three times with Ureum buffer. His6-NS3 was 
eluted from the beads using Ureum buffer containing 190 mM imidazole. Proteins 
in the eluate were precipitated overnight at –20°C by adding 9 volumes of ethanol, 
followed by centrifugation at 14.000 ×g for 1 h at 4°C. The protein pellet was either 
dissolved in Laemmli buffer or 2D-PAGE buffer (8 M ureum, 4% CHAPS, 15 mM 
Tris pH 8.5, 1% DTT, Brome phenol Blue (BPB) and 0.5% IPG-buffer (pH 3-10, 
GE-Healthcare).
Two-dimensional poly-acrylamide gel ectrophoresis (2D-PAGE)
Immobiline DryStrips pH 3-10, 13 cm (GE-Healthcare) were incubated for at least 
6 h with 0.5% IPG-buffer in De-streak rehydration solution (GE-Healthcare), before 
starting isoelectric focusing of the sample. To apply the His6-NS3 samples (in 
2D-PAGE buffer) onto the strip we used cup-loading at the basic end of the strip. 
Isoelectric focusing was performed on an Ettan IPGphor™ 3 Isoelectric Focusing 
System running the following program: 3 h at 150 V, 3 h at 300 V, gradually to 
1000 V in 6 h, gradually to 8000 V in 1 h and 8000 V for 2 h. After first dimension 
separation the strip was equilibrated to SDS-PAGE conditions with two consecutive 
15 min incubation steps with Equilibration buffer (6 M ureum, 50 mM Tris (pH 8.8), 
30% glycerol and 4% SDS), which contained in the first step 2% DTT and in the 
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second 2.5% iodoacetamide and BPB. Subsequently the strips were applied to SDS-
PAGE gels and covered with agarose. Following second dimension separation, gels 
were subjected to western blotting, silver staining, or ProQ diamond staining.
Western blotting
After separation on SDS-PAGE gels, proteins were transferred to PVDF membranes 
(Hybond P, GE-Healthcare) using a Semi-Dry blot apparatus (Biorad). Membrane 
blocking and antibody incubations were performed using 0.5% Tween-20, 5% non-fat, 
dry milk (Campina) in PBS. Monoclonal anti-NS3 was obtained from Novo Castra. 
Goat-anti-mouse (DAKO) conjugated to horseradish peroxidase together with enzyme-
catalysed chemoluminescence (ECL+, GE-Healthcare) and Fuji Super RX medical 
X-ray film or Typhoon imager (GE-Healthcare) were used to visualise the signal.
Silver staining
SDS-PAGE gels were incubated in 50% ethanol, 12% acetic acid and washed 
with 50% ethanol. Sensitisation was performed using sensitise solution (1.5 
mM sodiumthiosulfate) for 30 min, which was followed by washing with H2O. 
Subsequently Silver solution (12 mM silvernitrate, 0.075% formaldehyde) was added 
for 30 min. After rinsing the SDS-PAGE gel in H2O, it was stained with Develop 
solution (2.5% sensitise solution, 0.57 M sodiumcarbonate, 0.05% formaldehyde) 
until desired staining was reached. The staining reaction was stopped with 50% 
methanol, 12% acetic acid. 
Phosphatase treatment
Purified His6-NS3 eluted from the Cobalt2+-beads was diluted to 1 M Urea using 
PBS (154 mM NaCl, 1.4 mM Phosphate, pH 7.5). Subsequently the phosphatase 
treatment was performed in the presence of 5 mM Tris pH 8.0 and 1 mM MgCl2 with 
1 unit Shrimp Alkaline Phosphatase (SAP) (USB) per 64 µl. Both the phosphatase-
treated and the control sample, to which no SAP was added, were incubated at 37°C 
for 1h. After that, the samples were concentrated using ethanol precipitation as 
described above and the protein pellets were dissolved in 2D-PAGE buffer.
ProQ diamond staining
SDS-PAGE gels were fixed in 50% methanol, 10% acetic acid, washed with H2O 
and stained for 1.5 h with Pro-Q Diamond phosphoprotein gel stain (Invitrogen). 
Then destaining was performed using 20% acetonitrile, 50 mM sodium acetate, pH 




4.0 for a total time of 1.5 h. Until imaging, the gel was stored in H2O. To visualise 
the ProQ diamond signal we used the Typhoon imager (excitation 532nm; emission 
filter 560nm; GE Healthcare). 
In-gel tryptic digestion
Protein spots were excised, cut into small pieces and washed with 25 mM NH4HCO3 
followed by dehydration with 100% acetonitrile (ACN) for 10 min. For reduction 
and alkylation, dried gel particles were first incubated with 10 mM dithiothreitol for 
30 min at 56 °C. Following dehydration with ACN, gel plugs were subsequently 
incubated in 55 mM iodoacetamide for 20 min at room temperature. After washing 
with 25 mM NH4HCO3 and dehydration with 100% ACN, the gel particles were 
completely dried in a centrifugal vacuum concentrator (Eppendorf, Hamburg, 
Germany). Dried gel particles were re-swollen for 15 min on ice by addition of 10-15 
µl of a trypsin solution (12.5 ng/µl in 25 mM NH4HCO3, sequencing grade modified 
trypsin, Promega, Madison, WI). Following this, 25-35 µl of 25 mM NH4HCO3 was 
added and samples were kept on ice for an additional 30 min. Tryptic digestion 
was subsequently performed overnight at 37 °C. Following tryptic digestion, the 
overlaying digestion-solution was collected (extract 1). Two additional rounds of 
extraction with 20 µl 0.1% TFA were used to extract peptides from the gel plugs and 
these were pooled with extract 1.
MALDI-ToF MS
For MALDI-ToF, tryptic digestions were desalted using C18 ZipTips (Millipore) 
according to the manufacturer’s instructions. Peptides were eluted using approx. 1 µl 
of 0.33 mg/ml alpha-cyano-4-hydroxycinnamic in acetone:ethanol 1:3 and spotted 
directly on a 600 µm AnchorChip MALDI target plate (Bruker Daltonics, Bremen, 
Germany) and allowed to dry. MALDI-ToF(-ToF) analyses were performed on an 
Ultraflex II time-of-flight mass spectrometer (Bruker Daltonics, Bremen, Germany) 
controlled by the Flexcontrol 2.0 software package. Spectra were recorded in the 
positive ion reflectron mode at a laser frequency of 50 Hz. For MS/MS analysis, 
precursors were accelerated and selected in a time ion gate after which laser-
decomposed fragments were further accelerated in the LIFT cell and their m/z were 
analysed after passing the ion reflectron. 
Nano-LC-iontrap MS
Tryptic digests were separated on a C18 pepmap100 column (75 µm I.D., 15 cm 
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long; Dionex, Amsterdam, The Netherlands) coupled to an electrospray ionisation 
(ESI)-iontrap mass spectrometer (HCTultra, Bruker Daltonics, Bremen, Germany). 
The gradient profile started with 100% solvent A (20% ACN/0.1% formic acid) for 
10 min. This was followed by a 20 min linear gradient from 20% solvent B (95% 
ACN/0.1% formic acid) up to 60% solvent B. The system remained at 60% solvent B 
for 25 min followed by a second linear gradient up to 90% solvent B in 10 min. After 
30 min at 90%, solvent B the gradient was changed to 0% solvent B. The flow rate 
was maintained at 200 nL/min during the entire run. Eluting peptides were analysed 
in data dependent MS/MS mode over a 400–1600 m/z range. The five most abundant 
ions in each MS spectrum were selected for MS/MS analysis by collision-induced 
dissociation, using helium as collision gas. Mass spectra were evaluated using the 
DataAnalysis 3.1 software package (Bruker Daltonics, Bremen, Germany).
Results
Purification of NS3 from HCV selectable replicons
Besides methylation of the helicase domain of NS3 no other post-translational 
modifications (PTMs) of NS3 have been reported. Our objective was to identify 
novel NS3 PTMs in the context of actively replicating HCV RNA. For this purpose, 
we introduced a His6-tag to NS3 in the HCV replicon (Con1 genotype 1b containing 
NS3 to NS5b, see Methods), providing an unlimited source of HCV proteins actively 
replicating HCV RNA (Supplemental figure 1). Addition of the His6-tag did not 
influence replicon colony formation efficiency (Supplemental figure 1). RT-PCR 
sequencing of the replicon cell-line furthermore confirmed that the six histidines 
remained unchanged at passage 30 at which stage our experiments were conducted 
(Supplemental figure 1). In addition, lysates of the His6-NS3 replicon cell line show 
that the extra tag resulted in a slightly higher molecular weight compared to the 
control cell line (Fig.1A, lanes 1 and 2). Based on western blot, using NS3 antibody 
(NCL-HCV-NS3, Novagen) similar amounts of NS3 are expressed by both cell lines 
(Fig.1A).
An additional advantage of a His6-tag is that it allows for affinity purification under 
denaturing conditions. Hence, to maximise yields of purified NS3, an ureum/NP40-
based buffer was used to lyse the cells and, following centrifugation, the His6-NS3 
was purified from the supernatant using Cobalt2+ beads (See Methods). Figure 1 shows 
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Figure 1  -  Affinity purification and 2D-PAGE analysis of NS3 isoforms from Huh7 replicon 
cell line
A. Lysates of Huh7 replicon cells containing non-tagged NS3 (Control, lane 1) or His6-tagged NS3 
(His6-NS3, lane 2), standardised to protein concentration using Bradford reagent (Biorad), were 
separated by SDS-PAGE, followed by western blot analysis with anti-NS3. These lysates were sub-
jected to affinity purification under denaturing conditions, using Cobalt2+-beads (See Methods for 
further details). Lanes 3 and 4 represent (His6-)NS3 bound to the beads from control or His6-NS3 
cell lines, respectively. Lanes 5 to 8 contain increasing volumes of total cell lysate from His6-NS3 
cells, with 100% corresponding to the total amount of His6-NS3 used for pulldown.
Isolated His6-NS3 was separated on 2D-PAGE, followed by either silver staining (B) or western 
blotting using NS3-antibody (C). Each His6-NS3 spot is labelled with a number. Basic and acidic 































































































































     1 MSRHHHHHHA PITAYSQQTR GLLGCIITSL TGRDRNQVEG EVQVVSTATQ  
    51 SFLATCVNGV CWTVYHGAGS KTLAGPKGPI TQMYTNVDQD LVGWQAPPGA  
   101 RSLTPCTCGS SDLYLVTRHA DVIPVRRRGD SRGSLLSPRP VSYLKGSSGG  
   151 PLLCPSGHAV GIFRAAVCTR GVAKAVDFVP VESMGTTMRS PVFTDNSSPP  
   201 AVPQTFQVAH LHAPTGSGKS TKVPAAYAAQ GYKVLVLNPS VAATLGFGAY  
   251 MSKAHGIDPN IRIGVRTITT GAPITYSTYG KFLADGGCSG GAYDIIICDE  
   301 CHSTDSTTIL GIGTVLDQAE TAGARLVVLA TATPPGSVTV PHPNIEEVAL  
   351 SSTGEIPFYG KAIPIETIKG GRHLIFCHSK KKCDELAAKL SGLGLNAVAY  
   401 YRGLDVSVIP TSGDVIVVAT DALMTGFTGD FDSVIDCNTC VTQTVDFSLD  
   451 PTFTIETTTV PQDAVSRSQR RGRTGRGRMG IYRFVTPGER PSGMFDSSVL  
   501 CECYDAGCAW YELTPAETSV RLRAYLNTPG LPVCQDHLEF WESVFTGLTH  
   551 IDAHFLSQTK QAGDNFPYLV AYQATVCARA QAPPPSWDQM WKCLIRLKPT  
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hapter 3specific pulldown of NS3, only when it is His6-tagged (compare lane 3 (control) and 
lane 4 (His6-NS3)). When relating the amount of purified His6-NS3 (lane 4) to the 
total amount of His6-NS3 in the lysate (lane 8), it is apparent that almost all the NS3 
is pulled down under these purification conditions. This high yield makes it likely 
that all NS3 isoforms, if present, are isolated using this method.
2D-PAGE separation of NS3 isoforms
Protein isoforms may arise from PTMs, which introduce a variation in the molecular 
mass and/or charge of a protein. These isoforms can be efficiently separated on the 
basis of isoelectric point and molecular weight in 2D-PAGE (two-dimensional poly-
acrylamide gel electrophoresis). To examine possible isoforms of NS3, we analysed 
purified His6-NS3 using this approach. His6-NS3 was visualised by means of silver 
staining (Fig.1B) or western blot using NS3 specific antibodies (Fig.1C). With both 
techniques, at least 11 NS3 protein spots were resolved, with a pI ranging from 
approximately 7 to 9 and with an apparent molecular mass around 70 kDa. Lower 
molecular weight products were considered to be NS3 breakdown products. The 
split of NS3 into multiple pI variants indicate several NS3 protein modifications in 
the context of replication. 
Tryptic digestion and MALDI-ToF analysis of individual NS3 spots
To unravel possible PTMs, responsible for the appearance of multiple spots of His6-
NS3 after 2D-PAGE separation, tryptic digestion followed by mass spectrometric 
analysis was performed on spots 3 to 8. As an example, the MALDI-ToF spectrum 
of spot 5 is shown in Figure 2A. Additionally, samples were measured in a higher 
mass range (between m/z 3000-6000, data not shown). In total, peptides assigned to 
HCV NS3 add up to 60% coverage (Fig.2B, bold sequence). Although the sequence 
coverage was much lower in the digests of spots 7 and 8, NS3 specific peptides were 
also observed in these spectra (Fig.2C), confirming the results from the western blot 
Figure 2  -  MALDI-ToF analysis of affinity purified and 2D-PAGE separated NS3-isoforms
His6-tagged NS3 was affinity purified and separated using 2D-PAGE. Six individual proteins spots 
(3-8, Fig.1B) were digested with trypsin and analysed by MALDI-ToF MS. A. MALDI-ToF spectrum 
showing individual tryptic peptides from NS3. B. Primary sequence of His6-tagged NS3 with the 
sequence coverage obtained with MALDI-ToF MS in bold. C. Comparison of MALDI-ToF spectra 
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(Fig.1C). Since we observed similar intensities and comparable sequence coverages 
for the spots 3-6 (Fig.2C), these spectra were used for side-by-side comparison.
Identification of a Gln to Arg mutation in NS3 
In the MALDI-ToF MS spectrum of spot 3, a peptide at m/z 2314.2 was observed, 
which was absent in the other spectra (Fig.3A). This mass could not be matched to 
an in silico tryptic peptide of NS3. MALDI-ToF-ToF analysis revealed that this ion 
corresponds to the peptide SFLATCVNGVCWTVYHGAGSK (aa 51-71, Fig.3B). 
This was unexpected because at position 50 within NS3 there is no tryptic cleavage 
site (Arg or Lys). We therefore speculated that NS3 corresponding to this spot was 
mutated at position 50. Indeed, using LC-MS, a peptide was observed with an Arg at 
position 50 (NQVEGVQVVSTATR (Fig.3C). Altogether, this revealed a Gln to Arg 
mutation in NS3 at position 50, corresponding to position 1067 of the polyprotein 
(HCV type 1b genome Con-1, AJ238799), which is likely to alter the isoelectric 
point of NS3.
Molecular mass based identification of HCV NS3 N-terminal 
acetylation.
During further analysis of the spots by MALDI-ToF a unique peptide at m/z 2343.3 
was observed in spots 3, 4 and 5, which was absent in spot 6 (Fig.3A). This mass 
could not be assigned to any in silico tryptic peptide belonging to NS3. MALDI-
ToF-ToF and manual inspection of the spectrum revealed a series of His residues 
in this peptide (data not shown). This indicates that the peptide corresponds to 
the N-terminus of NS3 and suggests that an N-terminal modification can explain 
these results. Indeed N-terminal acetylation (including removal of the Met) would 
Figure 3  -  Mass spectrometric characterization of NS3 mutation and post-translational 
modification
A. Comparison of MALDI-ToF spectra from NS3 isoforms in spots 3-6 (Fig.1B) The unique pres-
ence of a peptide at m/z 2314.2 in the tryptic digest of spot 3 and absence of the tryptic peptide 
at m/z 2343.3 in spot 6 are shown. MALDI-ToF-ToF revealed that the peptide at m/z 2343.3 corre-
sponds to the acetylated N-terminal tryptic peptide of NS3, Ac-SRHHHHHHAPITAYSQQTR (data 
not shown) 
B. MALDI-ToF-ToF analysis of the peptide at m/z 2314.2 showing that it matches with the peptide 
SFLATCVNGVCWTVYHGAGSK, corresponding to amino acid 51-71 in NS3 (Fig.2B). C. Identifica-
tion of a peptide in the LC-MS run from the digest of protein spot 3, confirming Gln to Arg substitu-
tion at position 50 within NS3.
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generate a m/z of 2343.3 (Acetyl-SRHHHHHHAPITAYSQQTR) corresponding 
to the observed mass and also would explain the MALDI-ToF-ToF fragmentation 
pattern (data not shown). This modification, which occurs on approximately 85% 
of all eukaryotic proteins 30, could therefore at least explain some of the different 
spots we observed. It should be noted that normally the N-terminal end of NS3 
is generated by (auto-) proteolytic cleavage of the HCV polyprotein and that the 
initiator methionine is added for construction in the HCV replicon 31. 
Additional comparison of the MALDI-ToF spectra derived from the separate 
spots yielded no qualitative differences that could be explained by modifications. 
In conclusion, using this mass spectrometry based approach, we elucidated one 
modification and a mutation, but still lack an explanation for the other different 
isoforms observed.
HCV NS3 is phosphorylated
One of the most common post-translational modifications of proteins is phosphorylation 
(estimated one third of all cellular proteins 32), which leads to a change of the net 
charge of proteins and thus the migration behaviour during 2D-PAGE. Consequently, 
comparison of 2D-gel spot patterns before and after treatment of the sample with a 
A)  Without phosphatase
B)  With phosphatase
basic (pH10) acidic (pH6.5)











Figure 4  -  NS3 phosphorylation
Purified His6-NS3 from Huh7 repli-
cons was incubated without (A, C) or 
with alkaline phosphatase (B) at 37°C 
for 1 h. The samples were then con-
centrated, followed by separation on 
isoelectric point and molecular weight. 
Subsequently western blot detection 
was performed using anti-NS3 (A, 
B). Alternatively, the gel was directly 
stained with a phospho-specific stain 
(See Methods) (C). The negative and 
positive pole position are indicated 
with basic and acidic, respectively.




phosphatase can be utilised to assess the phosphorylation state of a protein 33. 
Therefore, phosphatase treated and untreated His6-NS3 samples were analysed by 
2D-PAGE and stained with NS3 antiserum. In the untreated sample, we detected 
several spots in a similar pattern as shown before (Fig.4A). Upon treatment with 
phosphatase, the two most acidic spots disappeared and one extra spot appeared 
at the alkaline (basic) side of the gel (compare Fig.4A and B). This shift of spots 
towards the basic pole, after removing negatively charged phosphate group, clearly 
indicates phosphorylation of His6-NS3. Distinct spots resembling spots 9, 10 and 11 
in Figure 1C were not detected in these experiments. This might be due to the long 
phosphatase procedure before separation in the two-dimensional gel electrophoresis 
(see Methods). 
To further corroborate these results, we stained the 2D-PAGE gels directly with proQ 
diamond, a dye that selectively stains phosphorylated proteins in polyacrylamide 
gels (Fig.4C). The phospho-specific stain mainly coloured the acidic spots, which are 
the low abundant isoforms of NS3. Conversely, highly abundant NS3 isoforms were 
hardly stained. This is in accordance with the phosphatase treatment experiment, as 
the most acidic spots are lost after addition of phosphatase. 
Taken together, the phosphospecific staining and the de-phosphorylation assay 
strongly suggest phosphorylation of NS3.
Discussion
Identification of NS3 modifications in the context of self-replicating HCV RNA is 
complicated, given that only low amounts of protein are available and a combination 
of processes can influence the modification states of NS3. For that reason we 
designed an isolation method to purify NS3 from replicon cells. A His6-tag was 
added to the N-terminus of NS3 in this system that comprises HCV proteins NS3 
to NS5b. With this approach, high amounts of NS3 can be isolated (Fig.1A) and 
is thus likely to include all NS3 isoforms. Since modifications can induce changes 
in the isoelectric point (pI) and molecular weight of proteins, NS3 variants were 
visualised by two-dimensional gel electrophoresis (2D-PAGE). Purified NS3 was 
found to show multiple pI variants (Fig.1B and C), indicating several NS3 protein 
modifications in the context of replication. We uncovered protein modifications for 
some NS3 isoforms using various approaches.
Chapter 3
84
Using mass spectrometry, we analysed four NS3 spots (spots 3-6) for modifications. 
Comparison of MALDI-ToF spectra from spots 3, 4 and 5 with spot 6 resulted in 
the identification of N-terminal acetylation of His6-NS3 (Fig.3A, m/z 2343.3). 
N-terminal acetylation is the most common covalent modification of eukaryotic 
proteins 30 and can affect protein-protein interactions, activity or stability of proteins 
34-36. Viral proteins can also be acetylated at their N-terminus, such as mature Core 
protein from HCV and Gag protein from L-A double-stranded RNA virus 37, 38. In 
the latter virus acetylation affects viral assembly 38. Since we use the HCV replicon 
system acetylation might be the result of the introduced starting methionine used in 
this construct. However, we cannot exclude N-terminal acetylation on proteolytically 
processed NS3 derived from the polyprotein. 
Another change we observed was a Gln to Arg mutation at position 50 (corresponding 
to 1067 in the polyprotein), which would add a significant charge difference to 
the NS3 protein (pI 7.5 versus 7.8). This mutated arginine residue introduced an 
extra trypsin cleavage site resulting in two peptides (NQVEGVQVVSTATR at m/z 
808.9 [M+2H]2+ and SFLATCVNGVCWTVYHGAGSK at m/z 2314.2 [M+H+], 
respectively) in spot 3 of NS3 (Fig.3). This Q1067R is located close to the active site 
of the NS3 protease 39. An identical mutation at this position was described for a HCV 
genotype 1a replicon 40. Interestingly, this mutation was shown to compensate for a 
negative effect located in the proximal NS3 protease region of the HCV genotype 
1a and found to enhance the replication capacity of the viral RNA 40. Surprisingly, 
we now observe this compensating mutation at the protein level in the Con1 HCV 
genotype 1b, which is normally not down modulated and does not accumulate 
mutations at this position. 
Protein phosphorylation is an important regulator of diverse intracellular processes. 
HCV NS5a is a phosphoprotein, involved in replication and virus particle formation. 
In both processes the phosphorylation status of NS5a was shown to be critical 8, 41-
43. The multifunctional protein NS3 might be regulated in a similar way. Since we 
observed a train of spots, which might indicate phosphorylation, we investigated 
this possibility for NS3. Both treatment with phosphatase and specific staining 
of phosphate groups by ProQ diamond illustrate phosphorylation of NS3 (Fig.4). 
Multiple phosphorylation sites are suggested within NS3 using the phosphorylation 
prediction program NetPhos 2.0, i.e. 17 serine-, 13 threonine- and 4 tyrosine-




phosphorylation sites. As illustrated in Figure 4 phosphorylated NS3 protein is low 
abundant, therefore concentration of phosphorylated peptides was necessary to try to 
identify the phosphorylated amino acid in NS3. Phosphorylated peptides, generated 
from a pool of NS3 isoforms, were enriched using TiO2-beads prior to analysis by 
mass spectrometry. However, using this approach no phosphorylated peptides could 
be identified. As illustrated in Figure 3 phosphorylated NS3 protein is low abundant. 
Additionally lower signal intensities are often observed for phosphopeptides, 
possibly due to low ionisation efficiency 44. Moreover, the phosphorylation site 
might be located within a tryptic peptide that is not well suited for our standard 
mass spectrometric analysis (Fig.2B). Usually tryptic digestions are measured in the 
mass range of 500 to 3500 Da. When only peptides between 500 and 3500 Da from 
the in-silico digest of His6-NS3 were taken into account, we observed coverage 
around 92%. Altogether, this might explain the difficulty to identify the site of 
phosphorylation. 
pI heterogeneity of a protein can be generated by PTMs, chemical reactions like 
deamination 45, or it could be due to conformational isomers of a protein 46. All 
result in multiple isoforms observed in 2D-PAGE. In contrast a PTM that does not 
affect the pI of proteins is methylation 47. Methylation was described to take place on 
amino acid 1493 and/or 1490 of NS3 (Fig.2B, aa 473 and 475) 21. In our experiment, 
we were not able to detect specific peaks in this region, since digestion with trypsin 
in the area of NS3 methylation generates very small peptides (5 amino acids), which 
are difficult to assign specifically to NS3. 
Taken together we identified modifications of His6-NS3 in the context of self-
replicating HCV RNA, such as N-terminal acetylation, a Q1067R point mutation and 
phosphorylation. Resolving the precise sites of phosphorylation and determining their 
function will be the next challenging step. Generation of replicons with mutations in 
the predicted phosphorylation sites, in total around 34 sites, followed by 2D-PAGE 
analysis could result in identification of specific phosphorylation sites, which might 
help our understanding of the orchestration of the HCV life cycle.
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Supplemental figure 1  -  Analysis of the His6-NS3 replicon cell line.
A. [3H] uridine labeling of total RNA isolated from 1x106 cells incubated for 12 hours in the presence 
of 50 µCi of [3H] uridine and 5mg/ml Actinomycin D. 
B. Isolated RNA from the His6-NS3 replicon was subjected to sequence analysis after reverse 
transciptase and PCR amplification of the 5’ region of NS3. 
C. Coomassie stained culture dish 3-weeks after electroporation of Huh-7 cells with no (top) or 10 
ng of in vitro transcribed His6-NS3 tagged replicon RNA (middle) or untagged control replicon RNA 
in the presence of 500 µg/ml G418 (bottom). 
D. MALDI-ToF and MALDI-ToF-ToF of 2058 [M+H]+ corresponding to N-terminal tryptic peptide of 
NS3 showing the presence of the consecutive histidines.
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The life cycle of a virus greatly depends on interactions with the host cell. This 
is not different for the Hepatitis C virus, which is a positive single-stranded 
RNA virus and a major cause of chronic liver disease. An important Hepatitis 
C viral protein is non-structural protein 3 (NS3), because it participates in viral 
translation, replication and virus assembly. Moreover, it can modulate several 
cellular pathways by association with host cell proteins. Therefore, an assay 
was set-up to investigate virus-host protein interactions of this multifunctional 
protein. A His6-tag was introduced in the subgenomic replicon genome at 
the amino-terminus of NS3. This enabled us to isolate NS3 from Huh7 cells 
containing this subgenomic replicon, accordingly in the context of active rep-
lication. Several methods were explored to purify NS3 and interacting pro-
teins, including pulldown under native conditions, NS3 isolation after in vivo 
crosslinking and purification with mild detergent Nonidet P-40 (NP40). In this 
chapter we describe, that in vivo crosslinking with paraformaldehyde resulted 
in co-purification of NS5a with NS3. Furthermore, we demonstrate that NS3 
can be isolated using only 0.05% NP40. Additionally, we show by density 
gradient studies that, at this detergent concentration, endoplasmic reticulum 
membranes are disrupted. By means of mass spectrometry protein identifica-
tion in combination with one-dimensional as well as two-dimensional poly-
acrylamide gel electrophoresis, two NS3 interacting proteins were identified 
i.e. Glycosyl transferase 25 containing domain 1 and lysyl hydroxylase 3. 
Both proteins are involved in lysine glycosylation of collagenous proteins.





Hepatitis C virus (HCV) is a major healthcare problem, about 2.2–3% of the world’s 
population is chronically infected 1. The virus is transmitted by infected blood and 
blood products, therefore the widespread increase of iatrogenic procedures and intra-
venous drug use coincided with the global spread of HCV genotypes 1b and 1a in the 
1940s and 1960s respectively 2. Nowadays blood and blood products are screened 
for HCV, still yearly around 2.3–4.7 million people become newly infected 1. The 
current treatment, a combination of ribavirin and pegylated interferon alpha, is ef-
fective in only 55% of the patients 3. Most drugs under development target the viral 
enzymes, though other strategies could be directed at affecting virus-host interac-
tions. To design these new drugs more knowledge of the virus life cycle is required 
and especially of the virus-host interactions.
The genome of the positive single-stranded RNA virus encodes one large polyprotein, 
which is cleaved into 10 viral proteins 4, 5. The two main viral enzymes produced are 
the RNA-dependent RNA polymerase, NS5b and the multifunctional protein NS3 6. 
NS3 contains ATPase, helicase and protease activities, which point out why it is es-
sential during viral replication and translation 7-9. In addition, mutational studies show 
that virus assembly also requires NS3 10, 11. Furthermore, NS3 is suggested to modu-
late the innate immune response (reviewed in 12), to adjust intracellular transport 13, 14 
and to alter various signal transduction pathways 15. These pathways are often affected 
by NS3 as a result of association with host proteins. For example, the TBK1-NS3 
interaction abolishes downstream signalling of the interferon-alpha pathway by pro-
hibiting TBK1 to bind to IRF-3 16. TRIF and Cardif (also known as IPS-1, MAVS or 
VISA) are protease substrates of NS3 and are inactivated by cleavage; consequently, 
the interferon-alpha signalling is abrogated 17-19. Additionally, NS3 might have onco-
genic properties as well, due to association with p53, protein arginine methyltrans-
ferase 5 (PMRT5) and Ataxia telangiectasia mutated (ATM) 20-23.
The interaction between NS3 and some of the host proteins have been identified us-
ing yeast-two-hybrid screens (Y2H) 13, 20, 23-25. However there are certain drawbacks of 
this technique, since only binary interactions and not complexes can be investigated. 
Additionally, classical (or conventional) Y2H systems suffer from false negative and 
false positive protein-protein interactions. These are attributable to improper fold-
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ing of the fusion protein, failure in nuclear localisation, dependence of interactions 
on protein modification or non-relevant interaction imposed by overexpression (Re-
viewed in 26). Similar disadvantages have to be considered in immunoprecipitation of 
overexpressed epitope-tagged proteins (Reviewed in 27, 28). Therefore, an alternative 
method to identify NS3 associating proteins was chosen here.
To investigate host cell interactions of NS3, we took the approach of protein purifica-
tion by tag-affinity in the context of active replication. Therefore, a small His6-tag 
was introduced at the N-terminus of NS3 in the HCV subgenomic replicon genome. 
This tag was used to affinity purify NS3 from the human hepatoma cell line, Huh7, 
harbouring this replicon expressing NS3 to NS5b and actively replicating the HCV 
subgenome. Using this system, we could explore several possible methods to iden-
tify NS3 interacting proteins. First, native conditions were tried for NS3 purification. 
Secondly, in vivo protein crosslinking experiments were carried out, to stabilize NS3 
interactions with host-proteins in their native environment, followed by purification 
of NS3 under denaturing conditions. Thirdly, low concentrations of detergent were 
used to isolate NS3 and interacting proteins. With this approach we could identify 
two new interacting proteins, both involved in lysyl-glycosylation of collagenous 
proteins.
Methods
Culturing Huh7 replicon cells
Human hepatoma cell lines, Huh7, harboring the HCV replicons were grown in Dul-
becco’s Modified Eagle’s Medium without NaPyruvate, supplemented with non-es-
sential amino acids, L-glutamate, Penicillin, Streptavadin and Geneticin. Cells were 
subcultured using trypsin.
Lysis of cells under native conditions and addition of 0.05% NP40 
Huh7 replicon containing cells were washed three times with PBS (154 mM NaCl, 
1.4 mM Phosphate, pH 7.5), after which the cells were scraped in an isotonic buffer, 
containing 50mM Tris pH 7.0, 15 mM NaCl, 1 mM MgCl2, 240 mM sucrose and 20 
mM imidazole. Subsequently, the cells were lysed with a ball-bearing homogeniser 
(Isobiotec, Heidelberg Germany), which has a clearance of 18 micron. Total lysate 




volume of a 15 cm dish (~1.5 x107 cells) was 2 ml. Whole cells and cell debris was 
spun down at 800 ×g for 10 min and supernatant was collected. Supernatants of the 
two cell lines with and without His6-tag at NS3 were standardised to protein con-
centration using Bradford reagent (Biorad). When NS3 isolation was performed in 
the presence of 0,05% NP40, detergent was added prior to beads incubation and left 
on ice for 30 min. 
Lysis of cells with Triple detergent buffer 
Huh7 cells harbouring the HCV replicon were lysed directly after washing with PBS 
in Triple detergent buffer, which is the isotonic buffer supplemented with 0.1% SDS, 
0.5% DOC and 1% NP40. Cell lysates were subjected to centrifugation at 800 ×g for 
10 min and the supernatants were used for NS3 isolation.
Crosslinking and lysis of the cells
After washing with PBS, Huh7 replicon cells (15 cm dish) were incubated with 3ml 
0.5% paraformaldehyde (PFA) in PBS for 10 min. The crosslinking reaction was 
stopped with 5ml 1 M glycine, 1 M Tris  buffer (pH 7.0) for at least 30 min. Subse-
quently the cells were washed with PBS and lysed with denaturing buffer (8 M Urea, 
50 mM Tris pH 7.0, 300 mM NaCl, 1% NP40, 10 mM imidazole). Lysates were 
subjected to NS3 isolation after centrifugation at 14,000 ×g for 15 min.  
NS3 isolation and elution from the beads
Cell lysate from one 15 cm dish (~1.5 x107 cells) was incubated with 80 µl of 50% 
Cobalt2+ bound-beads (Clontech) for 2 h under continuous rotation. The beads were 
washed three times with the appropriate lysis buffer. After washing, Laemmli was 
added to the beads and heated to 95°C for 10 min. Except for the PFA crosslinked 
samples, these were either heated to 65°C for 10 min or to 95°C for 20 min.
To elute associated proteins from the beads, the beads were incubated in lysis buffer 
containing 190 mM imidazole, under continuous rotation for 10 min. The superna-
tant was taken off the beads and pooled with other eluates.
Protein concentration using Trichloricacetic acid or ethanol
Eluate was adjusted to 25% trichloroacetic acid (-20°C) and incubated overnight at 
-20°C. After centrifugation at 14,000 ×g for 30 min, 0.05 N HCl Acetone was added 
to the pellet and subjected to identical centrifugation. This was followed by addition 
of Acetone to the pellet and another round of centrifugation. The pellet was taken up 
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in Laemmli-buffer and if required pH was corrected.
Another method applied to concentrate proteins is by the addition of at least 6 vol-
umes of -20°C ethanol to the eluate. After overnight incubation the proteins were 
spun down at 14,000 ×g for 1 h. Pellets were taken up in 2D-PAGE buffer (see 2D-
PAGE for composition of the buffer).
Membrane floatation assay
In total 15 x107 Huh7 cells containing HCV replicon were scraped in isotonic buffer 
and spun down at 500 ×g for 5 min. The pellet was solved in 1 ml isotonic buffer, 
which was followed by mechanical lyses using the ball-bearing homogeniser. After 
centrifugation at 800 ×g for 10 min, the supernatant was split in two. To one part 
0.05% NP40 and sucrose with a final density around 1.26 g/ml was added, the other 
part was only mixed with sucrose. These samples were loaded underneath a sucrose 
gradient ranging from densities 1.09 to 1.23 g/ml (20%–70% w/v sucrose, 50 mM 
Tris pH 7, 1 mM MgCl2, 15 mM NaCl) and subjected to centrifugation in a SW41 
tube at 100,000 ×g for 14 h (Beckmann ultracentrifuge). Subsequently 500 µl sam-
ples were collected from the top to the bottom and the even fractions were analyzed 
by SDS-PAGE and western blotting. 
SDS-PAGE and western blotting
After heating in Laemmli-buffer, proteins were separate on SDS-PAGE gels (sodi-
umdodecylsulfate polyacrylamide gel electrophoreses). Subsequently, proteins were 
transferred to PVDF-membranes (Hybond-P, GE-Healthcare) using a Semi-Dry blot 
apparatus (Biorad). Blocking of the membranes and the following antibody incu-
bations were performed in PBS containing 0.5% Tween-20, 5% non-fat, dry milk 
(Campina). Since the secondary antibodies are conjugated to horseradish peroxidase 
(HRP), enzyme-catalyzed chemoluminescence (ECL+, GE-Healthcare) was used 
for detection. The signal was captured on Fuji Super RX medical X-ray film or visu-
alised using a Typhoon Imager 9410 (GE-Healthcare). 
Antibodies
Primary antibodies used in this study are anti-His6 (mouse, Abcam), anti-NS3 
(mouse, Nova castra), anti-NS5a (mouse, Virostat), anti-NS5b (mouse, Virostat), 
anti-calnexin (mouse, BD Biosciences), anti-GAPDH (goat, Santa Cruz), anti-PDI 
(rabbit, Stressgen), anti-LH3 (Mouse, Abnova). The primary antibodies against 
GLT25D1 and NS4b were raised against a specific protein peptide in rabbits, CKT-




DWDRAKSQKMRE (Biogenes) and CRGNHVSPTHYVPES (Innovagen), respec-
tively. The serum from GLT25D1 peptide immunised rabbits was peptide purified 
to increase specificity. Secondary antibodies goat-anti-mouse-HRP, rabbit-anti-goat-
HRP and swine-anti-rabbit-HRP were all purchased from Dako.
Two-dimensional poly-acrylamide gel electrophoresis (2D-PAGE)
Protein pellets were solved in 2D-PAGE buffer, which contains 8 M ureum, 
4% CHAPS (3-[(3-Cholamidopropyl)dimethylammonio]-2-hydroxy-1-propanesul-
fonate), 15 mM Tris pH 8.5, 1% dithiothreitol, 0,5% immobilised pH gradient (IPG) 
buffer pH 3-10 (GE Healthcare). Before starting isoelectric focusing of the sample, 
Immobiline DryStrips pH 3-10, 13 cm (GE-Healthcare) were incubated for at least 6 
h with 0.5% IPG-buffer in De-streak rehydration solution (GE-Healthcare). Samples 
were applied to the strips at the basic end via cup-loading. Isoelectric focusing was 
performed on an Ettan IPGphor™ 3 Isoelectric Focusing System using the following 
program: 3 h at 150 V, 3 h at 300 V, gradually to 1000 V in 6 h, gradually to 8000 V 
in 1 h and 8000 V for 2 h. Thereafter the strips were equilibrated in two consecutive 
15 min incubation steps with Equilibration buffer (6 M ureum, 50 mM Tris (pH 8.8), 
30% Glycerol and 4% SDS), containing in the first step 2% DTT and in the second 
2.5% iodoacetamide and brome phenol blue (BPB). Before starting second dimen-
sion separation, the strips, on top of the SDS-PAGE gel, were covered with BPB 
coloured agarose. Following SDS-PAGE, the gels were subjected to silverstaining.
Silverstaining
SDS-PAGE gels were fixed in 50% ethanol, 12% acetic acid, washed with 50% etha-
nol and sensitised for 30 min using sensitise solution (1.5 mM sodiumthiosulfate). 
After washing with H 2O, Silver solution (12 mM silvernitrate, 0.075% formalde-
hyde) was added for 30 min. Subsequently, the SDS-PAGE gels were rinsed with 
H 2O and stained with Develop solution (2.5% sensitise solution, 0.57 M sodium-
carbonate, 0.05% formaldehyde) until desired staining was reached. 50% methanol, 
12% acetic acid was used to stop the staining reaction.
In-gel digestion of proteins
The desired gel bands, isolated from gel, were digested with the Proteineer DP di-
gestion robot (Bruker, Bremen, Germany), following the protocol supplied by the 
manufacturer, which is based on the protocol by Shevchenko et al 29. The plate holder 
was modified in house to accommodate a Millipore solvinert hydrophilic filter plate, 
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type MSRLN04. After overnight digestion the peptide fragments were extracted with 
water/acetonitril/formic acid 1/1/1 v/v/v.
Mass spectrometry and database searching
The extracts were freeze dried and dissolved in 95/3/0.1 v/v/v/ water/acetonitril/for-
mic acid and subsequently sequenced by tandem mass spectrometry. Peptides were 
analysed by nanoflow liquid chromatography using an Agilent 1100 HPLC system 
(Agilent Technologies) coupled on line to a 7-tesla LTQ-FT Ultra mass spectrometer 
(Thermo Electron, Bremen, Germany). 
The chromatographic system consisted of the following components. ReproSil-Pur 
C18-AQ, 3 µm (Dr. Maisch GmbH, Ammerbuch, Germany) was used as a resin for 
the analytical nano column and AQUA-C18 5 µm was used as a resin for the trap-
ping column. Peptides were trapped at 5 µl/min on a 1 cm column (100 µm internal 
diameter, packed in house) and eluted to a 15 cm column (50 µm internal diameter, 
packed in house) at 150 nl/min in a 60 min. gradient from 0 to 50% acetonitrile in 
0.1% formic acid.
The eluent was sprayed via emitter tips (made in house) butt-connected to the ana-
lytical column. The mass spectrometer was operated in data-dependent mode, au-
tomatically switching between MS and MS/MS acquisition. Full scan MS spectra 
were acquired in FT-ICR with a resolution of 25,000 at a target value of 5,000,000. 
The two most intense ions were then isolated for accurate mass measurements by a 
selected ion-monitoring scan in FT-ICR with a resolution of 50,000 at a target ac-
cumulation value of 50,000. These ions were then fragmented in the linear ion trap 
using collision-induced dissociation at a target value of 10,000. In a post analysis 
process, raw data were converted to peak lists using Bioworks Browser software, 
Version 3.1. For protein identification, MS/MS data were submitted to the SwissProt 
database using Mascot Version 2.1 (Matrix Science) with the following settings: 2 
ppm and 0.8 Da deviation for precursor and fragment masses, respectively; trypsin 
was specified as the enzyme. All reported hits were assessed manually, and peptides 
with MASCOT scores lower than 40 were usually discarded.
RNA isolation and RT-PCR
RNA was isolated using High Pure Viral RNA Kit (Roche). In brief, 35 µl eluate was 
mixed with 400 µl binding buffer containing carrier RNA (10 µl/ml) and applied to 
the filter. After centrifugation at 8000 ×g, the filter was rinsed with 500 µl  Inhibitor 




Removal Buffer and washed two times with 450 µl Wash Buffer. Subsequently the 
RNA was eluted from the filter with 14µl Elution Buffer and used for cDNA syn-
thesis. 5x buffer, reverse transcriptase (Thermoscript), dNTP’s, RNaseOUT and the 
primer GGCCTGGAGTGKTTAGCTCCCCRTTCA (HCV genome 9372-9398) 
were added to the isolated RNA and incubated for 1.5 h at 50°C. The cDNA synthe-
sis reaction was terminated for 5 min at 85°C and RNA was degraded by RNaseH. 
PCR was performed using the RT-primer and CACAACATCCCTCAGCGCAAG 
(HCV genome 7717-7735), in the presence of dNTP’s, DMSO, buffer 3, Expand 
enzyme Taq/T90 + proofreading and 2 or 4 µl of cDNA. After 40 cycles of PCR 
(15 sec 94°C, 30 sec 57.3 °C and 3 min 68 °C), the PCR products were analysed by 
electrophoresis on a 1% agarose gel.
Results and Discussion
Introduction of His6-tag into HCV replicon cell line
In order to identify NS3 interaction partners in the context of active replication, 
we introduced a His6-tag at the N-terminus of NS3 in the replicon RNA genome 
(genotype 1b expressing NS3 to NS5b) (pFK5.1Neo 30). This tag can be used for 
purification of NS3 from lysates of the human hepatoma 7 (Huh7) cell line contain-
ing this subgenomic HCV replicon. In addition, a tagged replicon cell line provides 
an unlimited source of functional (His6-tagged) NS3 protein. Our group previously 
showed that replicon colony formation efficiency of this N-terminally His6-tagged 
NS3 replicon cell line was not influenced by the addition of the His6-tag, compared 
to the control cell line 31. In addition to that, we examined whether both cell lines 
express similar amounts of NS3 protein, which has a molecular weight of about 70 
kDa (Fig.1). Cell lysates from the N-terminally His6-tagged NS3 (+) and the con-
trol Huh7 replicon cell lines (–, without His6-tag) were separated on SDS-PAGE. 
Subsequently western blot analysis was performed with an antibody against NS3. 
Figure 1 shows expression of NS3 at comparable protein levels in both replicon cell 
lines (compare lanes 1 and 2). Furthermore, demonstrated by RT-PCR sequencing of 
the replicon RNA, the His6-tag remained unchanged in the tagged NS3 cell line for 
at least 30 passages 31. Before or at this stage our experiments were conducted. The 
presence of the His6-tag was also confirmed at protein level using SDS-PAGE and 
western blot analysis with an antibody against His6 (Fig.1). This antibody  recognises 
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a  specific band in the NS3 His6-tagged replicon cell line (+) at 70 kDa (Fig.1; lane 4), 
corresponding to NS3 (Fig.1; lane 2). Given that the His6-tag is the only difference 
between the two replicon cell lines, these results clearly show that an N-terminally 
His6-tagged NS3 protein is present in the replicon cell line. 
Purification of His6-NS3 from the HCV replicon cell line under native 
conditions
A first step towards identification of NS3 interacting proteins is the isolation of His6-
NS3 from this replicon cell line, showing that the His-tag is available for purifica-
tion. A pulldown experiment was performed using a buffer containing a mixture of 
three detergents, sodium dodecyl sulfate (SDS), sodium deoxycholate (DOC) and 
Nonidet P-40 (NP40) (Fig.2). Huh7 replicon containing cells with (+) or without 
(–) an N-terminal His6-tag at NS3 were lysed in this Triple detergent buffer. After 
centrifugation, removing nuclei and large cell debris at 800 ×g , Cobalt-beads were 
added to the supernatant (Lysates) for affinity purification of His6-NS3. The lysates 
and the proteins associated to beads (Bound) were separated on SDS-PAGE, fol-
lowed by western blotting using an antibody against NS3. As shown in Figure 2, 
similar amounts of NS3 were present in the lysates of the His6-NS3 cell line (+) and 
the control cell line without the His6-tag (–) (Fig.2; top panel, lanes 1 and 2). In the 
lanes loaded with proteins associating to the beads, we observe that NS3 only binds 
to the Cobalt-beads when tagged with His6 (+) (Fig.2; bottom panel, lanes 1 versus 
2). This clearly demonstrates that NS3 can be specifically purified from the replicon 
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Figure 1  -  Presence of His6-tag at amino-
terminus of NS3 within replicon containing 
cells
Lysates of Huh7 cells, containing subgenomic 
replicons with (+) (lanes 2 and 4) or without (–) 
(lanes 1 and 3) a His6-tag at the amino-terminus 
of NS3, were loaded on SDS-PAGE gels. This 
was followed by western blotting using either an-
ti-NS3 (left panel) or anti-His6 antibodies (right 
panel). Arrow indicates the NS3 protein.




To preserve protein-protein interactions as much as possible, native conditions dur-
ing isolation are essential. We therefore used an isotonic buffer, to harvest the cells 
in, in combination with a ball-bearing homogeniser for mechanical lysis of the cells 
(Iso), which keeps intracellular membranes intact. Compared to the Triple detergent 
lysed cells, less NS3 was observed in the 800g supernatant from cells lysed with 
the ball bearing homogeniser (Fig.2; top panel, lanes 3 and 4). Most NS3 is in the 
800 g pellet, which is likely due to membrane structures, to which NS3 associates, 
 ending up in this pellet fraction (data not shown). When focused on NS3 purification, 
we observe no to minimal binding of His6-NS3 to the beads (Fig.2; bottom panel, 
lanes 3 and 4), indicating that isolation of high amounts of NS3 under completely 
native conditions is not achievable. According to these results the His6-tag at the 
N-terminus of NS3 does not seem accessible during a native pulldown, whilst is 
available when detergents are present. Detergents dissolve cellular membranes and 
can solubilise proteins and protein-complexes, possibly resulting in the accessibility 
of the His6-tag for isolation. 
Purification of His6-NS3 and complexes from the HCV replicon cell 
line after in vivo crosslinking with paraformaldehyde
Apparently, more stringent conditions are required to make the His-tag available. 
Therefore chemical cross-linking followed by purification under denaturing condi-
tions was performed. This is an alternative method to study protein-protein  interactions 
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Figure 2  -  Isolation of His6-tagged NS3 from 
replicon containing cells
Huh7 cells, harbouring replicons with (+) or with-
out (–) a His6-tag at NS3, were lysed in a triple 
detergent buffer (Triple), containing sodium do-
decyl sulfate, sodium deoxycholate and Nonidet 
P-40. Otherwise, the cells were lysed with a ball-
bearing homogeniser in isotonic buffer (Iso). Fol-
lowing an 800 хg spin, the supernatant (Lysate) 
was subjected to NS3 purification using Cobalt-
bound beads (for more details see Methods). 
The 800g supernatant (Lysate, top panel) and 
the proteins associated to the beads (Bound, 
bottom panel) were analysed by SDS-PAGE and 
western blotting with an antibody against NS3. 
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Paraformaldehyde (PFA) is a cross-linker that can be used for such purposes 32, 33 
because it can quickly permeate the cell membranes, it has a short distance crosslink 
arm of 2.3 to 2.7 Å and the formed crosslinks can be disrupted by heating, which 
makes subsequent analysis possible. Furthermore, the crosslinks stay intact at non-
physiological conditions and for that reason can be subjected to stringent purification 
buffers for the removal of contaminants and non-specifically bound proteins 34. The 
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Figure 3  -  Purification of NS3 and co-purification of NS5a from replicon containing cells 
after in vivo crosslinking
With increasing concentrations of PFA (0% - 1%), in vivo crosslinking was performed on replicon 
containing Huh7 cells with (+) and without (–) a His6-tag at NS3. The cells were lysed in an ureum-
based buffer, which was followed by centrifugation at 14,000 хg (for more details see Methods). The 
supernatant (lysate) was used for metal-affinity purification of NS3. Subsequently, the lysates (top 
panel) and the proteins associated to the beads (Bound, middle and bottom panel) were examined 
by western blotting. Before separation on SDS-PAGE gels, the samples were heated to 65°C (odd 
lanes) or 95°C (even lanes), to preserve or break the crosslinks, respectively. In the top and middle 
panel, NS3 was detected using an antibody against NS3. The bottom panel was incubated with 
anti-NS3 and anti-NS5a antibodies. The middle panel is a short exposure of the long exposure bot-
tom panel. The blocks in the top panel are from the same film.




Hence, we set up an assay to crosslink NS3 to interacting proteins and to isolate 
these complexes (Fig.3). Replicon containing cells with (+) and without (–) a His6-
tag at NS3 were incubated with increasing concentrations of PFA during crosslink-
ing. In a denaturing buffer, the cells were harvested and after centrifugation of the 
cell lysates at 14.000 ×g, the supernatants (Lysates) were incubated with Cobalt-
bound beads (See Methods for more details). Prior to separation on SDS-PAGE, 
proteins associated to the beads (Bound) were heated in Laemmli-buffer to 65°C or 
95°C. Heating to 95°C will disrupt the crosslinks, while they remain intact at 65°C. 
After protein transfer, the western blot membranes were incubated with anti-NS3. 
Figure 3 shows that NS3 can be isolated after crosslinking, because NS3 signal is 
observed in the panel representing beads associated proteins (Fig.3; middle panel). 
However, binding of His6-NS3 to the beads decreased at a concentration of 1% PFA 
(Fig.3; middle panel, lanes 19 and 20). It seems that large complexes, formed by 
(extensive) crosslinking, are lost in the pellet during preparation of the cell lysates 
(Fig.3; top panel, compare lanes 1 and 2 with 17 and 18). Furthermore, crosslinking 
of NS3 might interfere with the availability of the His6-tag to bind to the beads. 
Since NS3 can be isolated in the presence of PFA, this method might allow isola-
tion of interacting proteins crosslinked to NS3. Long exposure of the western blot 
membrane with proteins bound to the beads reveals that, after incubation with PFA, 
crosslinks are formed and purified (high molecular weight complexes) (Fig.3; bot-
tom panel), indicating NS3 forms complexes. Comparison of samples heated at 
65°C or 95°C confirms that heating disrupts crosslinks, causing high molecular 
weight complexes to dissociate (Fig.3; bottom panel even versus odd lanes). We 
furthermore tested whether NS5a, another HCV non-structural protein reported to 
bind to NS3 35, 36, can be co-purified with His6-NS3 in this crosslinking experi-
ment. The western blot membranes were incubated with NS5a antibodies, in ad-
dition to the NS3 antibodies, to observe crosslinking as well as co-purification of 
NS5a (Fig.3; bottom panel). The apparent molecular weight of NS5a is 56 kDa 
and 58 kDa 37. If NS5a is crosslinked and co-purified with His6-NS3, we expect an 
increased signal at this molecular weight after disruption of the crosslinks. When 
comparing the lanes 65°C to 95°C from cells incubated with 0.5% or 1% PFA, a 
band corresponding to a molecular weight around 58 kDa is observed and intensi-
fied at 95°C (Fig.3; bottom panel, lanes 15 and 20). It should be mentioned that this 
58 kDa band was also observed when western blot analysis was performed in the 
presence of only anti-NS5a antibody, showing co-purification of NS5a and NS3. 
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Together these results  substantiate that this assay could be useful for the capture of 
NS3 interacting proteins. 
With the aim of identifying the crosslinked proteins, we carried out an experi-
ment to discover these unknown proteins by using mass spectrometry (MS). Rep-
licon cells (– or + His6-tag) were incubated with 0.5% PFA and lysates were sub-
jected to metal-affinity purification. After heating to 95°C, proteins associated to 
the beads were separated on SDS-PAGE. This was followed by silverstaining to 
visualise these proteins. NS3 and interacting proteins will appear as variation in 
the protein band patterns from the control (–) and the His6-tagged NS3 replicon 
(+) cell lines. Figure 4 shows the results, arrows indicate differences and the ex-
pected band of NS3 is specified. To identify these proteins (including NS3), the 
bands were excised and in-gel digested with 
trypsin. The extracted peptides were separated 
on a nano-HPLC system and introduced into a 
LTQ-FT ultra mass spectrometer equipped with 
an electrospray ionisation interface (ESI MS). 
MS/MS analysis was performed for peptide 
identification (See for more detail Methods). 
Unexpectedly, despite assaying ample amounts 
of proteins after silverstaining, no proteins were 
identified, because peptide sequences could not 
be recovered from the MS. Given that we can 
identify NS3 by western blotting, there seems 












Figure 4  -  Isolated NS3 and associated proteins after 
in vivo crosslinking of replicon containing cells
Huh7 cells, harbouring a replicon with (+) and without (–) 
a His6-tag at NS3, were in vivo crosslinked using 0.5% 
PFA. NS3 was purified from the 14,000 хg supernatant 
and the proteins associated to the Cobalt-bound beads 
were subjected to SDS-PAGE. Subsequently, the pro-
teins in the SDS-polyacrylamide gel were visualised by 
silverstaining. Arrows point to differences between the two 
lanes and NS3 is indicated specifically.




procedure. A  possible  explanation could be hindrance of PFA crosslinking with 
trypsin digestion, because formaldehyde is highly reactive with lysines, which are 
cleaved by trypsin used to generate peptides for MS 34. Therefore, chymotrypsin, 
which cleaves after aromatic amino acids tyrosine, tryptophan and phenylalanine, 
was applied to the putative NS3 band avoiding lysines. Again, no NS3 peptides 
were recovered. Another possibility could be that peptide modifications by PFA 
hamper subsequent MS analysis. Since PFA crosslinking is not protein-specific, 
PFA can crosslink proteins to DNA, RNA and other macromolecules. NS3, an 
RNA binding protein 38, could be crosslinked to RNA. Furthermore, two-dimen-
sional PAGE (2D-PAGE) analysis already failed at the stage of isoelectric focusing 
of the crosslinked proteins, which suggests insolubility of the proteins or a change 
of protein charge. Together this could point to protein modifications that hinder 
further analysis. Although we thoroughly showed that PFA crosslinking intervenes 
with subsequent MS analysis, work by Tagwerker et al. showed identification of 
ubiquitinated proteins using a similar approach 32. 
His6-NS3 purification from HCV replicon cell line using NP40
An alternative strategy to isolate NS3 and interacting proteins is by the usage of de-
tergents. Depending on the chemical properties and the concentration of detergents, 
proteins and protein complexes can be solubilised and purified. The triple detergent 
buffer, containing SDS, DOC and NP40, was shown to be useful for NS3 pulldown 
(Fig. 2). To investigate whether one of the three detergents alone is effective in NS3 
isolation, three buffers were prepared with a single detergent (Fig.5A). His6-tagged 
NS3 replicon cells (+) were lysed with a ball bearing homogeniser and after an 800 
×g-centrifugation step detergents were added to the supernatant. Similar amounts of 
NS3 were present in the lysates (Fig.5A; top panel). Subsequent to affinity purifica-
tion, NS3 bound to the beads was analysed by western blotting, using an anti-NS3 
antibody. NS3 could be purified with buffers containing all detergents (triple), 1% 
DOC or 0.5% NP40, but not in the presence of 0.1% SDS or without detergents (Iso.) 
(Fig.5A; bottom panel). The concentration of SDS in the lysis buffer was below the 
critical micelle concentration (0.23% w/v) of the detergent, which might explain 
the failure to purify NS3. Since NP40 is effective in NS3 isolation, we decided to 
continue with this detergent. Especially for NP40 is a non-ionic detergent and less 
denaturing to proteins compared to the ionic detergents SDS and DOC. Additionally, 
non-ionic detergents do not interfere with isoelectric focusing of proteins used in two 
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dimensional poly acrylamide gel electrophoresis (2D-PAGE), a technique later used 
for analysis of complexes.
Besides chemical properties, the concentration of detergents during purification of 
proteins and protein complexes can be critical. On one hand a too low detergent 
concentration will not solubilise proteins and therefore not succeed in isolation of 
proteins. On the other hand a too high concentration of detergents might disrupt 
protein-protein interactions, consequently loosing associated proteins during purifi-
cation. We therefore determined the lowest effective concentration of NP40 for NS3 
isolation (Fig.5B). NS3 was purified from replicon cells with (+) and without (–) a 
His6-tag at NS3 in the presence of different concentrations of NP40, ranging from 
no detergents to 1% NP40. Pulldown of NS3 was examined by western blot analysis 
(Fig.5B). There was no isolation of NS3 from the control cell line (–, no His6-tag). 
Some NS3 was purified without any detergents (0%), but a large increase in the 
amounts of NS3 was observed in the presence of NP40. The minimal concentration 
of NP40 required for NS3 isolation was determined at 0.05% NP40 (Fig.5B) and was 
used in the following experiments to purify NS3 and interacting proteins. 
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NP40Figure 5  -  Purification of NS3 using detergents
A. Huh7 cells, containing HCV subgenomic replicon with a His6-tag at NS3, were lysed in isotonic 
buffer using a ball-bearing homogeniser. To the lysate of an 800 хg centrifugation step none (Iso.), 
sodium dodecyl sulfate (SDS), sodium desoxycholate (DOC), Nonidet P-40 (NP40) or all these 
three detergents (Triple) were added. NS3 was affinity purified from each condition and detected 
with anti-NS3 during western blot analysis (Bound, bottom panel). Also the lysate was subjected to 
western blotting (lysate, top panel). 
B. A similar experiment as in A was carried out. This time NS3 isolation was performed in the pres-
ence of increasing concentrations of NP40 (0% - 1%) (bound, bottom panel). NS3 was purified 
from 800g supernatant of Huh7 cells containing replicons with (+) and without (–) a His6-tag at the 
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Characterisation of His6-NS3 purified material by fractionation
All HCV proteins are associated to membranes, including NS3 6. NS3 is associated 
indirectly to the membranes via the small HCV non-structural protein 4a. Through 
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Figure 6  -  Membrane floatation gradient of replicon containing Huh7 cell lysates
A. Plot showing densities of sucrose gradient fractions from replicon containing Huh7 cell lysates 
without detergent (black triangles) or in the presence of 0.05% NP40 (open squares). 
B. Huh7 cells harbouring HCV replicon were lysed in isotonic buffer using a ball-bearing homog-
eniser. Lysates were subjected to 800 хg centrifugation and the supernatant was adjusted to a 
sucrose density concentration of ~1.26 g/ml and loaded underneath a sucrose gradient with densi-
ties ranging from 1.23 to 1.09 g/ml. After overnight centrifugation, samples were taken from the top. 
The fractions were analysed by SDS-PAGE and western blotting using antibodies against calnexin, 
NS3, NS5a and NS5b. The loaded fractions are in lanes 11, 12 and 13 and the lanes 1 to 10 repre-
sent the membrane floatation fractions. 
C. Experiment as in B, but differs in that the cell lysate, which was loaded underneath the sucrose 
density gradient, contained 0.05% NP40.
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Together, NS3 and NS4a are anchored to membranes by the N-terminal transmem-
brane domain of NS4a 42, 43. More recently, a direct interaction with membranes was 
identified within NS3, that is a hydrophobic helix at the N-terminus of NS3 42. 
To examine some properties of the NS3 purified material several experiments were 
carried out. First a membrane floatation gradient assay on replicon lysates was per-
formed to determine membrane association of NS3 in the presence or absence of 
NP40 (Fig.6) 44. Replicon cells were lysed in isotonic buffer using a ball bearing 
homogeniser. Following centrifugation either no detergents or NP40, with a final 
concentration of 0.05%, were added to the 800g supernatant. These two samples 
were then adjusted to a sucrose density concentration of ~1.26 g/ml and loaded un-
derneath a sucrose gradient with densities ranging from 1.23 to 1.09 g/ml (Fig.6A). 
After centrifugation, subsequent samples were taken from the top of the gradient 
and analysed by western blotting (Fig.6B and C). Fractions 1 to 10 represent floating 
membranes and their associated proteins. The last three samples (11 to 13) corre-
spond to the loaded fractions; where all material resides that does not float. When no 
detergent is added to the lysate, Calnexin, an ER transmembrane protein, is mainly 
observed in fractions 6 to 10 (Fig.6B). Similarly, we predominantly find the HCV 
non-structural proteins, NS3, NS5a and NS5b, in the floating fractions 7 to 10. Yet 
addition of 0.05% NP40 relocates Calnexin, as well as the HCV NS proteins, towards 
the three bottom fractions corresponding to non-floating material (Fig.6C). Together 
this indicates that at a concentration of 0.05% NP40 most membranes are disrupted. 
Moreover, it suggests that the majority of non-structural proteins no longer reside on 
floating membranes. 
Supplementary, a centrifugation assay of replicon cell lysates (800g Sup) containing 
NP40 illustrates that NS3 is present in the supernatant (100kg Sup) and in the pellet 
fraction (100kg Pellet) after 100,000 ×g centrifugation of these lysates (Fig.7A; mid-
dle and bottom panel); indicating NS3 could still be associated to non-floating large 
structures, which might be protein complexes and/ or membrane sheets. We therefore 
investigated the composition of the isolated NS3 during affinity purification (Fig.7B). 
Replicon cells with (+) and without (–) a His6-tag at NS3 were lysed in an isotonic 
buffer and following centrifugation at 800 ×g NP40 was added to the supernatant. 
After affinity purification, proteins associated to these beads were eluted and the eluate 
was subjected to centrifugation at 100,000 ×g. Figure 7B shows that some of the NS3 
that is bound to the beads can be pelleted at 100,000 ×g (bottom panel) and suggests 
that a very small portion of NS3 might be in a complex or associated to membrane 




sheets. Both the density gradient and the differential centrifugation assay results sug-
gest that a part of purified NS3 is soluble and that a small portion might be in a large 
complex or membrane associated. 
Co-purification of HCV RNA with His6-NS3, though lack of other HCV 
proteins
As NS3 contains helicase activity and can bind to RNA 45, HCV RNA might still be 
associated to NS3. Therefore, affinity-purified material was examined on the pres-
ence of HCV RNA (Fig.8). Eluates from beads incubated with lysates of replicon 
cells with (+) or without (–) a His6-tag at NS3 were subjected to RNA isolation, 
followed by reverse transcriptase using a primer at the end of NS5b and PCR with 
an additional primer at the beginning of NS5b. The resulting PCR products were 
analysed on an agarose gel (Fig.8). The PCR product from HCV RNA is 1683 bp. 
At this size, bands are only visible in the lanes containing PCR products ampli-





























Figure 7  -  Differential centrifugation of 
purified NS3
A. Using the ball-bearing homogeniser Huh7 
cells containing replicon were lysed in isoton-
ic buffer. The supernatant of an 800 хg spin 
was split and one part was supplemented 
with 0.05% NP40 (0.05% NP40), the other 
part was not (Iso.). Next, both lysates were 
subjected to 100,000 хg centrifugation. The 
800g supernatant (top panel), the 100,000 g 
pellet (1/3 of total amount) (middle panel) and 
the 100,000g supernatant (1/60 of total vol-
ume) (bottom panel) were examined for NS3 
using SDS-PAGE and western blot with an 
anti-NS3 antibody. 
B. In the presence of 0.05% NP40, NS3 was 
isolated from the 800g supernatant of Huh7 
cells harbouring replicons with (+) and with-
out (–) a His6-tag at NS3. NS3 eluated from 
the beads was used for 100,000 хg centrifu-
gation. The total eluate (top panel) and the 
100,000g pellet of the eluate (bottom panel) 
were analysed by western blotting using an 
antibody against NS3. 
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 Conversely, there are no PCR products observed in the cDNA from eluate of the 
control cell line (–, no His6-tag), nor in the PCR control (Fig.8; lanes 1, 5 and 6). 
This clearly shows HCV RNA is co-purified together with NS3 isolated from repli-
con cells, implying a putative protein-RNA complex.
The replicon cells contain the non-structural proteins 3 to 5b and interactions be-
tween NS3 and other NS proteins have been shown previously 36. For that reason we 
examined the presence of NS4b, NS5a and NS5b, three other HCV proteins, in NS3 
purified material using western blot analysis. NS3 was purified from Huh7 replicon 
containing cells with (+) or without (–) a His6-tag at NS3. Proteins associated to 
the beads (AB) were separated by SDS-PAGE and HCV proteins were detected by 
western blotting. Figure 9 shows that His6-tagged NS3 is specifically associated 
to the beads (Fig. 9; NS3, lane 3 versus lane 4). To check for residual cellular pro-
teins present in the beads fraction, GAPDH a cytosolic protein was used. Clearly, 
GAPDH wasn’t found in the beads fraction, indicating that no remainder of the 800g 
supernatant was left (Fig.9; GAPDH, lanes 3 and 4). 
The three bottom panels in Figure 9 show the co-purification results of the three 
other HCV proteins, NS4b, NS5a and NS5b. The proteins are present at a similar 
expression level in both cell lines, with and without a His6-tag at NS3 (Fig.9; lanes 
1 and 2), confirming that there is no interference of the tag in these replicon cells. 
Some non-specific background binding to the beads is observed for NS5a and NS5b, 
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Figure 8  -  Co-purification of HCV-RNA to-
gether with NS3
Huh7 cells harbouring replicons with (+) (lanes 3 
and 4) and without (–) (lanes 5 and6) a His6-tag 
at NS3 were subjected to NS3 purification using 
0.05% NP40. This was followed by elution of the 
material from the beads. RNA was isolated from 
this eluate and subsequently reverse transcrip-
tion was performed with a primer at the end of 
NS5b. With 2 or 4 µl cDNA a PCR was carried 
out, using primers resulting in a 1683 bp product 
(lanes 3 to 6). A negative PCR control was taken 
along, which is shown in lane 1. A marker was 
loaded on the agarose gel (lane 2) and its band 
sizes are indicated on the right.




(Fig.9; NS4b/NS5a/NS5b, lanes 3 and 4), indicating that the HCV replicon proteins 
NS4b, NS5a and NS5b were not co-purified together with NS3. 
This could, on one hand, demonstrate dissociation of NS3 from the other NS pro-
teins during the procedure. On the other hand, a specific sub-population of NS3, 
not containing other NS proteins, might have been isolated. In literature, different 
pools of NS3 are suggested. Only less than 5% of the non-structural proteins are 
protease resistant. In fact this small pool is accountable for all the RNA synthesis 
activity 46. Additionally, immunofluorescence assays indicate slight differences in 
ER distribution of the NS proteins 47, 48. NS3 seems to also localise at ER mem-
branes more closely to mitochondria 38, 47, 49, implying different pools of NS3. Both 
possibilities could explain why we do find an interaction between NS3-NS5a, us-
ing our crosslinking strategy. In that approach any transient interactions are fixed 
and possibly all pools of NS3 are captured due to the harsh denaturing conditions 
we used after crosslinking.
Reducing non-specific binding of proteins to Cobalt bound-beads
To identify NS3 interacting proteins, reduction of background binding proteins to 
beads is required. Non-specific protein binding to positively charged metal-affinity 
beads can be reduced by low concentrations of imidazole, an organic compound 
competing for binding with histidine due to similar ring structures. Conversely, too 
high concentrations of imidazole will prevent specific binding of His6-tagged pro-
teins to the Cobalt bound-beads. We therefore optimised imidazole concentrations 
during isolation (Fig.10). Replicon cells with (+) and without (–) a His6-tag at NS3 
Figure 9  -  Lack of co-purification of other 
HCV proteins together with NS3
The 800g supernatant (Lysate, lanes 1 and 2), 
from ball-bearing homogeniser lysed Huh7 cells 
that contain replicons with (+) and without (–) a 
His6-tag at NS3, was supplemented with 0.05% 
NP40. Subsequently, NS3 and associated pro-
teins (Bound, lanes 3 and 4) were isolated and 
analysed by SDS-PAGE and western blotting 
using antibodies against NS3, Glyceraldehyde 
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were used for NS3 purification. Binding of proteins to the beads was performed in 
presence of increasing concentrations of imidazole, ranging from 0mM to 40mM. 
Proteins associated to the beads were subjected to SDS-PAGE, followed by western 
blot analysis with an antibody against NS3 (Fig.10; middle panel) or the gel was 
directly silver stained (Fig.10; bottom panel). Figure 10, bottom panel shows that 
increasing the concentration of imidazole decreases the binding of non-specific pro-
teins to the beads. Without imidazole, some NS3 binds non-specifically to the metal-
affinity beads (Fig.10. middle panel, lanes 1 and 2). Together this indicates that imida-
zole is necessary for background reduction and increased specificity of the assay. At 
this point, it should be noted that previous experiments shown here were performed 
with optimised imidazole concentrations. High concentrations of imidazole reduce 
association of NS3, which is observed at concentrations of 30 and 40 mM imidazole 
(Fig.10; middle panel, lanes 7 to 10). Therefore, the optimum in NS3 binding to the 
beads seems to be at 20mM imidazole (Fig.10; middle panel, lanes 5 and 6). 
For specificity of the assay and maximum association of NS3 to the beads, other 
steps of the purification protocol, including pH during purification, elution of the 
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Figure 10  -  Background reduction of NS3 
isolation using Imidazole
Huh7 cells containing replicons with (+) and with-
out (–) a His6-tag at NS3 were lysed. To the 800g 
supernatant (Lysate, top panel) 0.05% NP40 and 
increasing concentrations of imidazole (0mM – 
40mM) were added. Under these conditions 
NS3 was purified. NS3 binding to the beads 
was examined by SDS-PAGE and western blot 
using anti-NS3 (Bound WB, middle panel). Pro-
teins associated to the beads were separated 
on SDS-PAGE and visualised by silverstaining 
(Bound Silver, bottom panel).




timal conditions were used for the experiments to identify NS3 interacting proteins 
(see Methods for conditions). 
Isolation of His6-NS3 interacting proteins in SDS-PAGE
In order to identify NS3 interacting proteins by mass spectrometry (MS) analysis 
a sufficient amount of associated proteins needs to be purified, typically a mini-
mum amount of 5-10 ng. This would correspond to about 100 femtomol of NS3 
(70kDa). In order to reach these requirements the purification was scaled up to 1.5 
x108 cells, proteins in the eluate from the Cobalt coated beads were concentrated us-
ing tri-chloroacetic acid (TCA). Subsequently, the proteins were separated on SDS-
PAGE and visualised by silverstaining (Fig.11). Comparison of the lanes from the 
two cell lines uncovered several differences, which are indicated by arrows in Figure 
11. These bands were excised and analysed by MS as described before, which re-
sulted in the identification of NS3 with 8 peptides 
in band 3. In the other bands either no proteins 
could be identified or proteins with only one cor-
responding peptide. Within band 1, two peptides 
of collagen XVIII, a precursor of endostatin, were 
obtained. In band 2 two peptides of lysyl hydrox-
ylase 3 (LH3) were found. These were good leads 
to start additional experiments. However, we 
sometimes identified more than one protein in a 














Figure 11  -  Isolated NS3 and associated proteins after 
0,05% NP40 detergent extraction in 1D SDS-PAGE
In an isotonic buffer and with the ball-bearing homog-
eniser Huh7 cells harbouring replicons with (+) (lane 2) 
and without (–) (lane 1) a His6-tag at NS3 were lysed. 
Following 800 хg centrifugation, 0.05% NP40 was added 
to the supernatant. Subsequently, NS3 was metal-affinity 
purified and after separation on 10% SDS-PAGE, proteins 
associated to the beads were coloured by silverstaining. 
Arrows point to band differences between the two lanes. 




stained bands at identical molecular weight were sometimes more intense in the NS3 
His6-tagged cell line compared to the non-His-tagged cell line, which could imply 
that associated proteins are underneath the non-specific background band. Therefore, 
more resolution was required for protein separation to unambiguously identify in-
teracting proteins. This was accomplished by two-dimensional PAGE (2D-PAGE), 
which separates proteins on isoelectric point, as well as on molecular weight. Con-
sequently, several proteins found within one band of SDS-PAGE can be observed in 
distinct spots with 2D-PAGE.
Isolation of His6-NS3 interacting proteins in 2D-PAGE
This time NS3 isolation was performed followed by 2D-PAGE (Fig.12). Again, like 
for the 1D SDS-PAGE experiments, the purification was scaled up to 2 x108 cells. 
Pooled eluates were concentrated with ethanol, because this matches better with 
isoelectric focusing and yields a higher amount of proteins compared to TCA pre-
cipitation, which was assessed by silverstaining and western blot analysis of NS3 
(data not shown). The concentrated protein samples were applied to isoelectric fo-
cusing, followed by SDS-PAGE and silver staining (see Methods for more detail) 
(Fig.12). The non-specific binding proteins are observed in the gel from the control 
cell line (Fig.12; left panel, no His-tag). Some spots in the 2D-PAGE gel from the 
NS3 His6-tagged replicon cell line (+) were clearly distinct from the control cell 
line (–, no His6-tag) and indicated by arrows (Fig.12; right panel, arrows). These 
spots could represent NS3 and NS3 interacting proteins. Hence, the indicated spots 
were excised and analysed by MS (see Methods). From spots 1 and spot 2, in total 
12 NS3 peptides were obtained. In spot 3, which has a molecular weight of about 72 
kDa, Glycosyl transferase 25 containing domain 1 (GLT25D1) was identified with 
about 10 peptides. No significant protein match could be found in spot 4 and only 
two peptides of eukaryotic initiation factor 4A-I (eIF4A-I) were observed in spot 5. 
Both NS3 and GLT25D1 could be reproduced in repeated experiments. In addition, 
LH3, a protein previously identified in 1D SDS-PAGE, was observed in repeated 
2D-PAGE experiments. 
Conversely, eIF4A-I and other RNA binding proteins, like DDX19A, DDX42 and 
polyRC-binding protein 50, 51, were observed in a single experiment. This could in-
dicate some non-specific background of RNA binding proteins, possibly associating 
to HCV RNA, which we showed to co-purify with NS3 earlier (Fig.8). Further-
more, some spot differences seem to be at other molecular weights than observed 




in the previous 1D SDS-PAGE experiment (Fig.11). One of the reasons might be 
the solubilisation of proteins that is important in the first step of 2D-PAGE, which 
is sometimes difficult to achieve especially for hydrophobic proteins like membrane 
proteins. The next step was to substantiate the proteins GLT25D1 and LH3, which 
were reproducibly found.
Specific co-purification of GLT25D1 and LH3 together with His6-NS3
To confirm the interaction of GLT25D1 and LH3 with His6-NS3 and verify their 
identification by mass spectrometry, samples with purified NS3 were investigated 





Figure 12  -  Isolated NS3 and associated proteins in two-dimensional PAGE
From Huh7 cells, containing replicons with (+) (right panel) and without (–) (left panel) a His6-tag at 
NS3, NS3 and associated proteins were isolated in the presence of 0.05% NP40. Proteins associ-
ated to the beads were eluted, concentrated and applied to two-dimensional PAGE. The proteins 
were first focused on their isoelectric point in an immobilised pH gradient strip ranging from pH 3 to 
pH 10 and subsequently separated on a 9% SDS-PAGE gel. Proteins in the SDS-PAGE gel were 
visualised by silverstaining. Arrows indicate protein spots that differ from the other gel.
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by western blotting using specific antibodies against GLT25D1 and LH3 (Fig.13). 
Since an antibody against GLT25D1 was not available, we raised one against a se-
lected peptide of GLT25D1 (See Methods). This antibody recognises in western blot 
 analysis a protein at 72 kDa, the expected molecular weight of GLT25D1. Addition-
ally, this antibody recognised GLT25D1 expressed from a CMV driven construct 
that was overexpressed in Huh7 cells (data not shown) 52.
NS3 was isolated from replicon cells with (+) and without (–) His6-tag at NS3 and 
subjected to western blot analysis. As shown in Figure 13, NS3 is specifically iso-
lated (Fig.13; NS3, lanes 3 and 4) (same as Fig.9). Similar amounts of GLT25D1 and 
LH3 are present in the 800g supernatant (Fig.13; GLT25D1 and LH3, lanes 1 and 2). 
In the lanes loaded with proteins associated to the beads, a clear increase in signal 
for both GLT25D1 and LH3 is observed in the lanes representing isolated proteins 
from replicons containing His6-tagged NS3 (Fig.13; GLT25D1 and LH3, compare 
lanes 3 and 4). This suggests there is specific co-purification of these two proteins 
with NS3. 
To exclude non-specific binding of ER, especially since LH3 localises to the ER 53 
and GLT25D1 is predicted to localise there 54, we incubated the western blot mem-
branes with antibodies specific for the ER resident proteins, calnexin and protein 
disulfide isomerase (PDI). Although some non-specific association of calnexin to 
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Figure 13  -  Co-purification of GLT25D1 and 
LH3 together with NS3
Huh7 cells, containing replicons with (+) and 
without (–) a His6-tag at NS3, were lysed and 
subjected to 800 хg centrifugation. NP40 was 
added to the 800g supernatant, to a final concen-
tration of 0.05%. Subsequently, NS3 was affinity 
purified from these lysates. The proteins associ-
ated to the beads (Bound, lanes 3 and 4) and 
800g supernatant (Lysate, lanes 1 and 2) were 
analysed by SDS-PAGE and western blot using 
antibodies against NS3, glycosyltransferase 25 
containing domain 1 (GLT25D1), lysylhydroxy-
lase 3 (LH3), protein disulfide isomerase (PDI) 
and calnexin.




the presence of NS3 (Fig.13; PDI and calnexin, lanes 3 and 4). Together these data 
clearly indicate specific association of LH3 and GLT25D1 with NS3.
After confirming the interaction of NS3 with GLT25D1 and LH3 in western blot 
analysis, further validation is necessary. For instance, in order to interact, two pro-
teins need to be targeted to the same organelle. Since the cellular localisation of 
GLT25D1 is predicted, we first investigated this. The findings of that study are de-
scribed in the next chapter. 
Both LH3 and GLT25D1 are suggested to play a role in glycosylation of collagens 
and certain immune defence molecules (collectins) 53, 54. New data is becoming avail-
able on the role of collectins in antiviral defence and it will be interesting to know 
how HCV affects these molecules. More specifically, GLT25D1 was shown to be 
able to galactosylate mannose binding lectin, a collectin capable of binding to viral 
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The human collagen beta 
(1-O)galactosyltransferase, 
GLT25D1, is a soluble 
endoplasmic reticulum-
localised protein









Glycosyl transferases transfer glycosyl groups onto their substrate. Localisation 
partially defines their function. Glycosyl transferase 25 domain 1 (GLT25D1) 
was recently shown to have galactosyltransferase activity towards collagens 
and another well known substrate, mannose binding lectin (MBL). To gain 
more insight in the role of galactosylation of lysines in the Gly-X-Lys 
repeats of collagenous proteins, we investigated the subcellular localisation 
of GLT25D1. Immunofluorescence analysis of GLT25D1 expressed in the 
human hepatoma cell line (Huh7), revealed a perinuclear lattice-like staining, 
resembling localisation to the endoplasmic reticulum (ER). Possible targeting 
signals, an N-terminal signal sequence and a C-terminal ER-retention signal, 
were identified using prediction programs. These signals were then investigated 
by constructing a series of epitope-tagged forms of GLT25D1 that were 
analysed by immunofluorescence and western blotting. In agreement with the 
predictions, our results show that GLT25D1 is directed to the ER lumen as 
a soluble protein and retained there. Moreover, using two endoglycosidase 
enzymes EndoH and EndoF, we demonstrate that the putative bi-functional 
glycosyl transferase itself is a glycoprotein. Additionally we examined co-
localisation of GLT25D1 with MBL and lysyl hydroxylase 3 (LH3, PLOD3), 
which is a protein able to catalyse hydroxylation of lysine residues before 
they can be glycosylated. We demonstrate overlapping localisation patterns of 
GLT25D1, MBL and LH3. Taken together our data indicate that galactosylation 
of collagenous proteins by the soluble GLT25D1 occurs in the early secretory 
pathway.





Hydroxylation and subsequent glycosylation of lysine residues is a characteristic 
of collagens and proteins containing a collagen-like region (collectins) 1-3. These 
proteins contain repeats of Gly-X-Y motifs, where lysines present at the Y-position 
can be galactosylated 4, 5. 
Collagens and collectins are built up of three polypeptide chains, which wind together 
to form a triple helix. The Gly-X-Y repeats, where X is often a proline, allow tight 
coiling of the chains as the small glycines fit into sterically restricted spaces where 
the three chains come together 6.
The function of the lysine linked sugars is not fully understood, but this 
posttranslational event occurs before triple helix formation 7 and mutations in these 
residues clearly affect the oligomerisation state resulting in aberrant secretion 8. 
Mutation of two lysines to arginines in the Gly-X-Lys repeat of mannose binding 
lectin (MBL), which is involved in neutralisation of invading micro-organisms by 
triggering the complement cascade, resulted in inefficient complement activation 
8. At the protein level glycosylated lysines are suggested to play a role in folding, 
stability and prevention of inter-chain cross-linking 4, 8, 9.
Lysyl hydroxylase enzymes catalyse the hydroxylation reaction on lysines, after 
which the residue can by glycosylated 10. Recently, two new genes responsible for the 
galactosylation of Gly-X-Y repeats were described. Using affinity chromatography 
and tandem mass spectrometry, Schegg et al. identified two glycosyltransferase 
GT25 family members, GLT25D1 and GLT25D2, to encode galactosyltransferases 
involved in transfer of galactose to hydroxylysine residues in MBL and collagen 11. 
Attachment of galactose occurs via the β (1-O) bond to the hydoxylated lysine (Cδ), 
assigning these proteins to β (1-O) galactosyltransferases.
Most members of glycosyltransferases (GT) are localised to the Golgi, but GTs 
can also be observed in the cytosol, nucleus, mitochondria, endoplasmic reticulum 
(ER), on cellular membranes, secreted from the cell or widely distributed between 
all these 12. Their distinct subcellular localisation most likely reflects their role in 
glycosylation pathways. For example, the subsequent arrangement in which glycan 
synthesis takes place in the Golgi apparatus can often be related to the location of the 
glycosyltransferases in the cisternae 13. Here we examined the cellular localisation 
of GLT25D1 relative to one of its reported substrates, MBL, which is produced in 
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liver cells 14. We also identified ER-targeting signals within GLT25D1 causing it to 
localise to the early secretory pathway.
Methods
Signal predictions
Prediction of signal peptides: http://www.cbs.dtu.dk/services/SignalP/ 15. Prediction 
of N-glycosylation sites: http://www.cbs.dtu.dk/services/NetNGlyc/.
Plasmid construction
To construct epitope-tagged GLT25D1 expression plasmids; the sequence was ampli-
fied by PCR from GLT25D1 full-length clone, IRAKp961P01217Q (imaGenes, Berlin, 
Germany), using specific primers, see Table 1. The PCR products were digested with 
KpnI and XbaI and ligated into pCDNA3.1mychisB (Invitrogen) similarly digested 
with KpnI and XbaI. This resulted in the construction of expression vectors containing 
a 10-residue Myc-epitope-tag at its C-terminus. In order to construct C-terminal HA-
epitope-tagged GLT25D1 expression constructs (GLT25D1-HA, ∆signal sequence-
GLT25D1-HA), the Myc-epitope sequence was XbaI – PmeI cut and replaced with 
an XbaI – PmeI fragment coding for the HA-epitope. For construction of the RDEL 
at the extreme C-terminus (GLT25D1-MycRDEL, HA-GLT25D1-MycRDEL), the 
constructs were AgeI - PmeI cut and replaced with a fragment coding for RDEL.  For 
construction of GLT25D1 with an internal Myc-epitope-tag (GLT25D1 FL Myc-int.) 
after the signal sequence, two annealed oligos with protruding TGCA nucleotides 
(see Table 1) were ligated into the GLT25D1 gene cut with restriction enzyme Sbf-I, 
which generates complementary ends (CCTGCA|GG).
Cell culture and transfection 
Human hepatoma cell line Huh7 was grown in Dulbecco’s Modified Eagle’s 
Medium supplemented with non-essential amino acids, L-glutamate, Penicillin and 
Streptavadin. Trypsin was used to subculture the cells. Cells were transfected using 
Amaxa Cell line Nucleofactor kit T (Lonza), program T016 and 4µg of DNA.
Antibodies
The following antibodies were used: anti-PDI (Stressgen), anti-Giantin (Alexis 
Biochemicals), anti-ERGIC53 (Alexis Biochemicals), anti-LH3 (Abnova), anti-Myc 




(mouse, immunofluorescence) (Invitrogen), anti-Myc (rabbit, immunofluorescence) 
(Abcam), anti-Myc (mouse, western blotting) (Roche) and anti-HA (mouse) (Abcam), 
Donkey-anti-mouse-cy3 (Jackson), Donkey-anti-rabbit-cy3 (Jackson), Goat-anti-
mouse-Alexa488 (Invitrogen), Goat-anti-rabbit-Alexa488 (Invitrogen), Goat-anti-
mouse-Alexa633 (Invitrogen) and Goat-anti-mouse-HRP (Dako).







Reverse primer as for HA-GLT25D1-Myc
∆ signal sequence -GLT25D1-Myc (construct 3)
Forward primer, GTGGGTACCATGGGCGCCGACGCCTACTTC
Reverse primer as for HA-GLT25D1-Myc
HA-GLT25D1 (construct 8)
Forward primer as for HA-GLT25D1-Myc
Reverse primer, TAGTCTAGATCAGAGTTCATCCCGGGCAGCAC
HA-GLT25D1-∆RDEL (construct 9)
Forward primer as for HA-GLT25D1-Myc
Reverse primer, TAGTCTAGATCAGGCAGCACTGTCCAGTGG




Cells were fixed with 3% paraformaldehyde in PBS (154 mM NaCl, 1.4 mM 
phosphate, pH 7.5) 24 h post transfection. PFA was quenched using 50 mM NH4Cl 
in blockbuffer, which contained 5% fetal calf serum (FCS) in PBS. The cells were 
permeabilised with 0.1% TritonX-100 in blockbuffer and stained with primary 
antibodies diluted in blockbuffer for 1 h. Next the coverslips were washed with 
blockbuffer and incubated with secondary antibody diluted in blockbuffer for 1 
h. After washing with glycinebuffer (10 mM glycine in PBS), PBS and water, the 
coverslips were mounted with Prolong mounting medium (Invitrogen). Fluorescence 
images were captured using Leica TCS SL confocal microscope, 63x Plan Apo oil 
immersion objective (zoom approximately three times), appropriate filter settings 
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and sequential scan modes. Images were optimised with Adobe Photoshop CS2. 
Profile plots were generated using ImageJ (NIH).
SDS-PAGE and western blotting
After separation on SDS-PAGE gels, proteins were transferred to PVDF membranes 
(Hybond P, GE-Healthcare) using a Semi-Dry blot apparatus (Biorad). Membrane 
blocking and antibody incubations were performed using 0.5% Tween-20, 5% non-
fat, dry milk (Campina) in PBS. Since all secondary antibodies were conjugated 
to horseradish peroxidase, the proteins were visualised using enzyme-catalysed 
chemiluminescence (ECL+, GE-Healthcare) and Typhoon Imager (GE-Healthcare).
De-glycosylation assay
Cells transfected with GLT25D1-FL-MycHis6 or GLT25D1-∆SS-MycHis6 were 
lysed after 16 h in isotonic buffer, which contains 20 mM Tris pH 7, 1 mM MgCl2, 15 
mM NaCl, 240 mM sucrose and 10 mM imidazole, using a ball bearing homogeniser 
(Isobiotec, Heidelberg Germany). Following centrifugation of the cell lysates at 
800 хg for 10 minutes, supernatants were incubated with cobalt-beads (Talon) for 
2 h under continuous rotation. Proteins binding to the beads were eluted using the 
isotonic buffer now containing 190 mM imidazole. Eluates were split into three 
portions to de-glycosylate or not. One sample was boiled for 10 min in Laemmli 
buffer and subsequently treated with Endoglycosidase H (New England Biolabs) in 
50 mM sodium citrate for 3.5 h or overnight at 37°C. Another sample was adjusted 
to 1% NP40, followed by boiling for 10 min. N-Glycosidase F (EndoF) (Roche) was 
added to this sample and incubated for 3.5 h or overnight at 37°C. The third sample 
was directly examined by SDS-PAGE.
Modular structures of GLT25D1
A multiple sequence alignment of the strongly similar sequences corresponding to 
GLT25D1 (Swiss-Prot:Q8NBJ5), GLT25D2 (Swiss-Prot:Q8IYK4) and GLT25D3 
(Swiss-Prot: Q5T4B2) was created using AlignX (VectorNTI, invitrogen) with the 
ClustalW algorithm (default settings). This sequence alignment was used as input for 
the HHpred comparison tool (http://toolkit.tuebingen.mpg.de/hhpred 16). Selected: 
database pdb70, Max. PSI-BLAST iterations: 0, other settings default.
The region corresponding to aa 48 - 299 of GLT25D1 produced a hit with the 
structure of pp-GalNAc-T10 (PDB ID: 2D7I 17, belonging to the CAZY family GT-2/
PF00535), probability 92.6, E-value-0.006, P-value 3E-7. The region corresponding 




to aa 331 - 525 of GLT25D1 produced a hit with the structure of the catalytic Domain 
Of Mouse Manic Fringe (PDB ID: 2J0A 18, belonging to the CAZY family GT-31 19, 
probability 43, E-value-0.15, P-value 0.00076.
The indicated sequences of GLT25D1, including gaps and insertions created by the 
HHpred, were structurally modelled onto the backbone of these structures, 2D7I and 
2J0A, using Protein Homology/analogY Recognition Engine 20.
Results
GLT25D1 localises mainly to the ER
To elucidate to which particular compartment (tagged-) GLT25D1 was targeted, we 
compared the localisation with subcellular markers by immunofluorescence in human 
hepatoma cell line Huh7 (Fig.1). Dual staining of the internally Myc-tagged GLT25D1 
transfected cells using antibody to the endoplasmic reticulum (ER)-resident protein, 
protein disulphide isomerase  (PDI) together with the Myc-antibody demonstrated 
virtually complete overlap (yellow colouring), showing clear ER localisation of 
GLT25D1 (Fig.1). Co-localisation can be quantified using Pearsons correlation, 
where -1 means no overlap and 1 complete co-localisation. The Pearsons correlation 
calculated for PDI compared to GLT25D1 was 0.58, meaning considerable overlapping 
patterns. We furthermore examined the ER-Golgi intermediate compartment (ERGIC) 
and Golgi, using ERGIC53 and giantin respectively. Figure 1, however shows only 
minor overlap between GLT25D1 and ERGIC/ Golgi with Pearsons correlations of 
0.13 and 0.04 respectively. Detailed inspection of many transfected cells showed no 
altered ER or Golgi distribution in GLT25D1 transfected compared to non-transfected 
cells (Fig. 1 and data not shown). Together these data indicate GLT25D1 mainly 
localises to the early secretory pathway; particularly ER.
Predictions of GLT25D1
A first step towards identifying the mechanisms responsible for directing GLT25D1 
to the ER is defining subcellular localisation signals by using prediction algorithms 
(See Methods). Consistent with our observed ER localisation, we noted that the 
N-terminal 40 amino acids encompass a potential ER signal sequence, including 
a hydrophobic core region (h-region), a positively charged N-terminus (n-region) 
and a potential cleavage site between position 36 and 37 (Fig.2). Furthermore, upon 
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examining the C-terminus of the protein we noticed that the four extreme C-terminal 
residues Arg-Asp-Glu-Leu (RDEL) strongly resemble the tetrapeptide sequence 
KDEL, which causes retention in the ER 21. Both predictions point to possible insertion 
of GLT25D1 into the ER and, if cleavage occurs, release from the ER membrane into 
the ER lumen. In order to investigate these potential targeting signals a series of 
deletions from the N-terminus as well as the C-terminus, including epitope tags on 
the opposite side, were made to observe their effect on localisation (Fig.3A).
N-terminal signal sequence targets GLT25D1 to the ER
We first studied the localisation of GLT25D1 with the putative signal sequence 
deleted (GLT25D1-∆SS-Myc-tagged) compared to full-length GLT25D1 (GLT25D1 
FL-HA-tagged). As shown in Figure 3B little overlap was evident with the full-
length protein and the ∆SS protein, the latter displaying a diffuse cytosolic staining. 
This strongly suggests that the extreme N-terminus is a genuine signal sequence and 
targets the protein to the ER. Furthermore, when the N-terminal signal sequence of 
GLT25D1 was fused to GFP (SS-GFP), a reticular expression pattern was observed 
in a few cells (data not shown).  
Cleavage of the GLT25D1 signal sequence
Next to the signal sequence a potential cleavage site is predicted (c-region, Fig.2). 
Cleavage of this N-terminal signal of GLT25D1 was analysed by blotting total 
cell lysate of cells transfected with N-terminally HA-tagged GLT25D1 construct 
(Fig.3A: HA-FL-Myc, construct 1). As shown in Figure 3C, the N-terminal HA-
tagged GLT25D1 protein (Fig.3C: lane1, Total, anti-HA) was not visible with an 
anti-HA antibody, suggesting that the N-terminus was cleaved off. This construct 
is also tagged at the C-terminus with a Myc-tag that was detected in the total cell 
lysate, showing that the protein was indeed correctly expressed (Fig.3C: lane1, Total, 
anti-Myc). When Huh7 cells were transfected with GLT25D1 only Myc-tagged at 
the C-terminus (Fig.3A: FL-Myc, construct 2) identical protein size was detected 
compared to GLT25D1 tagged on both sides (Fig.3C: lane1 and 2, Total, anti-Myc). 
This furthermore indicates that the N-terminal signal sequence must be cleaved, since 
both proteins have a distinct N-terminus, which should have resulted in a different 
size in the absence of cleavage. Note the size difference between the full-length 
GLT25D1 construct and the GLT25D1 construct with a deleted signal sequence 
(Fig.3C: compare lanes 2 and 3, Total, anti-Myc), which is caused by protein 


















Figure 1  -  Subcellular localization of Glycosyltransferase 25 domain 1 protein
Huh7 cells were transfected with full-length Glycosyltransferase 25 domain 1 containing an internal 
Myc-tag (GLT25D1) (See Methods for more details). After 24 h of expression, cells were fixed and 
subjected to immunofluorescence analysis. Cells were double labelled for GLT25D1 by anti-Myc 
(shown in red) and for the cellular markers (shown in green). ER is visualised by anti-protein di-
sulfide isomerase (PDI) (top panels), ER-Golgi intermediate compartment by anti-ERGIC53 (middle 
panels) or Golgi by anti-giantin (bottom panels). Yellow observed in the overlay indicates overlap of 
red and green signal. Pearsons correlation of PDI and GLT25D1 is 0.58, ERGIC53 and GLT25D1 
is 0.13, and giantin and GLT25D1 is 0.04.
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glycosylation and will be explained below. Our findings are furthermore confirmed 
with other constructs, FL-MycRDEL, HA-FL-MycRDEL, HA-FL and HA-∆RDEL 
(Fig.3C: lanes 6, 7, 8 and 9, Total, anti-Myc and anti-HA). The N-terminal HA-tag is 
not detected in lanes 7, 8 and 9 and a similar molecular weight of the constructs HA-
FL-MycRDEL and FL-MycRDEL is observed. Hence, apparent by these results, the 
signal sequence of GLT25D1 is cleaved. 
Carboxy terminal RDEL retains GLT25D1 in the ER
Proteins targeted to the ER that lack a specific retention signal are secreted or 
transported to the plasma membrane. Since the hydrophobic signal sequence of 
GLT25D1 is clearly cleaved off and its potential hydrophobic membrane anchor 
lost, the protein could be secreted in the cell culture medium. In contrast, if the 
C-terminal residues RDEL represent an ER retrieval signal, GLT25D1 would be 
SS RD
ELGT2 GT25
10                20                 30                  40
|          |          |           |
MAAAPRAGRR RGQPLLALLL LLLAPLPPGA PPGADA|YFPE.. 
n-region          h-region               c-region
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610               620     
|          |
..VL QSPLDSAARDEL 
ER retention sequence
Predicted N-Glycosylation sitePredicted signal sequence cleavage site
Figure 2
Figure 2  -  Schematic representation of Glycosyltransferase 25 domain 1, including various 
predicted motifs 
Top: Homology based structural models of the tandem glycosyltransferase domains. Bottom:  Linear 
representation of GLT25D1 with possible signal sequence, ER retention signal and N-linked glyco-
sylation sites indicated. Verification and discussion of these predictions are described in this article.




retained. We therefore examined the presence of the tagged GLT25D1 constructs 
in the cell culture medium. The constructs HA-FL and HA-FL with RDEL deleted 
(HA-FL-∆RDEL) could not be shown to be present in the medium (Fig.3C: lanes 
8 and 9, Medium, anti-HA), because the HA recognition epitope tag is cleaved off 
together with the signal sequence. Transfected HA-FL-Myc, FL-Myc and FL-HA 
could be detected with a C-terminal tag in the medium of Huh7 cells (Fig.3C: lanes 
1, 2, and 4, Medium, anti-Myc and anti-HA). However, addition of an epitope tag 
(either Myc or HA) at the C-terminus of GLT25D1 could interfere with the RDEL 
retention function, resulting in (partial) secretion. When we compare localisation of 
GLT25D1-HA tagged and GLT25D1 internally Myc-tagged (GLT25D1 FL Myc-
int.), we observe large overlapping patterns (Supplemental figure 1). Assuming that 
the internal tag reflects endogenous proteins best, the tagging seems to influence 
localisation only slightly.
In order to preserve the RDEL at the extreme C-terminus, we constructed RDEL at the 
end of two constructs, HA-FL-MycRDEL and FL-MycRDEL. In contrast to HA-FL-
Myc and FL-Myc, both these constructs could not be detected in the medium (Fig.3C: 
lanes 6 and 7, Medium, anti-Myc), indicating that the RDEL is an ER-retention signal 
for GLT25D1. Additionally, as anticipated protein without the signal sequence ∆SS-
Myc and ∆SS-HA, which are located in the cytosol, were not observed in the hepatocyte 
cell culture medium (Fig.3C: lanes 3 and 5, Medium, anti-Myc and anti-HA). Taken 
together these data clearly indicate that RDEL retrieves GLT25D1 to the ER.
Cleavage and retrieval of GLT25D1 could indicate that the protein is soluble. To 
confirm this we performed a membrane-floatation gradient experiment (Supplemental 
figure 2). As marker for integral membrane proteins we used calnexin and PDI was used 
as a type of ER soluble protein. As anticipated, calnexin is observed in the membrane-
floating fractions with a peak signal present in fraction 7, while PDI is mainly found 
in the non-floating, bottom fractions. The bulk of GLT25D1 is observed in the bottom 
fractions of the gradient, indicating the protein is not an integral membrane protein.
GLT25D1 is N-linked glycosylated
Unexpectedly there is a substantial size difference between full-length GLT25D1 
proteins, which are cleaved in the ER, and proteins with a deleted ER signal sequence 
(∆SS) (Fig.4A: compare lane 1 with 2 and Fig.3C: compare lanes 1, 2 and 4 with 

































































were made starting at the predicted signal cleavage site and should therefore be of 
equal size. The higher molecular weight of the processed full-length proteins might 
be explained by posttranslational modifications occurring in the ER, which cannot 
take place on proteins with a deleted signal sequence contained in the cytosol. A 
potential modification increasing the molecular weight of a protein occurring in the 
ER is Asn-linked glycosylation. To assess glycosylation, we employed digestion with 
Endoglycosidase H and F (EndoH, EndoF), which cleave high mannose-containing 
oligosaccharides. GLT25D1 was purified from Huh7 cells transfected with FL-Myc 
(Fig.3A: construct 2) or ∆SS-Myc (Fig3A: construct 3), then treated with EndoH/ 
EndoF, separated by SDS-PAGE and subjected to western blot analysis (Fig.4A) 
(See for more details Methods). Figure 4A shows that after de-glycosylation the full-
length protein decreases in molecular weight similar to the delta-signal sequence 
protein. This illustrates that the size difference is caused by glycosylation. When 
the full-length protein was only shortly incubated with EndoH or EndoF, we could 
discern, besides the full-length protein, three additional products (Fig.4B). These 
four bands likely correspond to three glycosylations of GLT25D1. 
GLT25D1 co-localises with mannose binding lectin and lysyl hydroxylase
The report by Schegg et al., which elegantly demonstrated that GLT25D1 shows 
a strong galactosyltransferase activity towards mannose binding lectin (MBL), 
prompted us to compare the intracellular location of GLT25D1 and its substrate MBL 
11. To correlate the expression of GLT25D1 with MBL in liver cells, where MBL is 
synthesised, we transfected GFP-tagged MBL and internal Myc-tagged GLT25D1 
into Huh7 cells and performed immunofluorescence analysis. In Figure 5A GLT25D1 
is shown in red and MBL in green (Fig.5A: top, first two panels), they both have a 
Figure 3  -  Characterisation of signals in Glycosyl transferase 25 domain 1, suggesting ER 
residence
A. Summary of GLT25D1 expression constructs. HA indicates Hemagglutinin epitope tag; Myc refers 
to Myc epitope tag; FL denotes a full-length protein; RDEL represents carboxy-terminal Arg-Asp-Glu-
Leu sequence; SS stands for signal sequence and ∆ is followed by deleted part of the protein. 
B. Co-transfected Huh7 cells with constructs GLT25D1 FL-HA and GLT25D1 ∆SS-Myc were sub-
jected to immunofluorescence analysis. Signal of FL-HA is shown in green and of ∆SS-Myc in red. 
C. Constructs 1 to 9, shown in A, were transfected into Huh7 cells. Total cell lysates (Total) and 
culture medium (Medium) from these cells were analysed by SDS-PAGE and western blot. Using 




perinuclear and reticular staining. MBL localises intracellular predominantly to the 
ER, though also accumulates in foci (Fig.5A: top, first panel) that were previously 
shown by Nonaka et al. to be ER exit sites 22. In accordance with ER localisation, 
substantial co-localisation of GLT25D1 with MBL is illustrated by yellow colouring 
in the overlay (Fig.5A: bottom, first panel). 
Hydroxylation of lysines, to which galactosyltransferases transfer galactose, 
is carried out by lysyl hydroxylases (LH). These enzymes act upstream of 
glycosyltransferases. We therefore triple labelled the cells with LH3, which is one 
of the three LH isoforms in humans 10, depicted in blue (Fig.5A: top, third panel). 
The reticular and perinuclear staining of LH3 is similar to GLT25D1, which is also 
shown in the overlay of Figure 5A in purple (Pearson correlation: 0.42) (Fig.5A: 
bottom, second panel). In summary, there seem to be partially overlapping patterns 
of GLT25D1, MBL and LH3 (Fig.5A: bottom, third panel, white staining). To further 
substantiate co-localisation, we generated an intensity graph of the signals from each 
of these three proteins (Figure 5B). In the plot we observe similar profiles, indicating 
comparable sub-cellular localisation of GLT25D1, MBL and LH3, with exception of 






































Figure 4: N-linked glycosylation of Glycosyl transferase 25 domain 1 
A. Full-length GLT25D1 (FL) or GLT25D1 with the signal sequence deleted (∆SS) constructs were 
transfected into Huh7 cells. Both constructs were carboxy terminal tagged with MycHis6, to purify 
proteins using Co2+-beads and to detect in western blotting. Cell lysates are shown in the first two 
lanes after separation on SDS-PAGE and western blotting using an antibody against Myc. The 
purified proteins were subjected to either none (-) or Endoglycosidase H (EndoH) or F (EndoF) 
treatment (See for more details Methods). Results for FL protein are shown in lanes 3 to 5 and for 
∆SS protein in lanes 6 to 8. 
B. Partial de-glycosylation treatment of GLT25D1 full-length (FL).
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Figure 5: Co-localisation of Glycosyl transferase 25 domain 1 with Mannose binding lectin 
and Lysyl hydroxylase 3
A. Huh7 cells were co-transfected with Mannose binding lectin fused to GFP (MBL-GFP) and full-
length GLT25D1 tagged with Myc internally (GLT25D1), and analysed by immunofluorescence after 
24 h of expression. MBL was detected directly due to GFP and is shown in green. GLT25D1 and 
lysyl hydroxylase 3 (LH3) were visualised using antibodies against Myc or LH3 and are presented 
in red and blue respectively. When red and green signals overlap this is observed as yellow, red 
and blue as purple and red, blue and green as white. Pearson correlation of GLT25D1 and MBL is 
0.53, GLT25D1 and LH3 is 0.42, and LH3 and MBL is 0.45.
B. A profile plot with signal intensities from MBL (green), GLT25D1 (red) and LH3 (blue) along the 




The human protein GLT25D1 was reported to have galactosyltransferase activity 
towards mannose binding lectin (MBL), transferring galactose to hydroxylysine 
residues in the Gly-X-Lys repeats 11. In this report, we examined the GLT25D1 
localisation by immunofluorescence and made deletion mutants of GLT25D1 to 
ascertain whether the predicted subcellular targeting signal sequences were functional 
(Fig.2 and Fig.3A). It should be noted that exogenous over-expression might influence 
localisation due to saturation of the transport machinery. We performed our studies 
with a human hepatoma cell line, Huh7, because MBL is produced mainly by liver 
cells 14. Additionally, we confirmed by mass spectrometry analysis that GLT25D1 
is normally expressed in these cells (Observed peptides are shown in Supplemental 
figure 3). Moreover, identical results were obtained in an additional cell line VERO, 
derived from monkey kidney epithelial cells. We found that GLT25D1, after being 
targeted to and cleaved in the ER (Fig.1 and Fig.3C), appears primarily in the ER most 
likely due to a functional ER retention signal, RDEL (Fig.3C). Although GLT25D1 
gets secreted when a C-terminal tag is present, no secretion was found when the 
extreme four amino acids are RDEL, showing that these represent a functional ER 
retention signal (Fig.3C). This modified but related to KDEL carboxyl-terminal 
tetrapeptide has been shown to direct intracellular retention for several other proteins 
21. Moreover GLT25D1 is highly sensitive to Endoglycosidase H, which is able to 
cleave non-complex N-linked oligosaccharides present in the ER 23. This not only 
shows targeting to the ER lumen, but also ER-retention of the soluble GLT25D1 
(Fig.4A).
We furthermore demonstrate by partial digestion with Endoglycosidase H or F that 
at least three asparagine residues become N-glycosylated (Fig.4B). In accordance 
with the number of glycosylated forms we distinguish, the NetNglyc server exactly 
predicted three asparagines to be N-glycosylated (residues 96, 184, 404) (Fig.2), 
suggesting that all these three residues are modified. 
GLT25D1 is able to galactosylate MBL and other collagens 11. Interestingly, we 
observe co-localisation between GLT25D1 and MBL. Intracellularly, MBL forms 
oligomers before it moves from the ER to the Golgi apparatus 8 and is secreted 
to serve as an activator of the lectin complement pathway. Binding of MBL to 




carbohydrates on pathogens not only can mediate an innate immune response towards 
microbes, but more and more data indicate a potential defence against viruses 24, 25. 
The envelope glycoproteins of human immunodeficiency virus (HIV), Ebola and 
Influenza A virus were demonstrated to attach to serum MBL 26-28. Additionally a 
subcellular interaction between HIV glycoprotein gp120 and MBL was shown 22. 
The presence of GLT25D1 mainly in the ER, where it co-localises with MBL and 
LH3, suggests that galactosylation by GLT25D1 occurs early in biosynthesis before 
being transported to the Golgi. This would be in line with the results of Heise et al., 
which demonstrate that glycosylation of MBL continues while transport to the Golgi 
complex is blocked by Brefeldin A treatment 8. 
Before galactosylation of the lysine in the Gly-X-Lys repeat, the lysine is 
hydoxylated. LH3 has hydroxylase, galactosyltransferase and glucosyltransferase 
activity (Reviewed in 10). When performing domain prediction analysis of GLT25D1 
(see Methods), we noticed that GLT25D1 is a modular glycosyltransferase 
(GT) composed of two GT family members, with the C-terminal one related to 
glycosyltransferase of family 25 (hence its name) and an additional N-terminal 
domain which displays distant relation to family GT2 transferases (Fig.2 and 
Supplemental figure 4). In both domains the conserved DxD motif, which binds 
one of the ribose hydroxyl groups, could be observed (See Supplemental figure 4; 
Bernard Henrissat personal communications). Other examples of modular GTs are 
Heparin synthase, Chondroitin synthase and hyaluronan synthase, each involved 
in addition of alternating sugars, and each containing an N-terminal GT2 domain 
29. Part of this GT2 domain of GLT25D1 surprisingly shows sequence homology 
to LH3, which suggests that they might function similarly either in substrate 
recognition or in glucosyltransferase activity.
It is interesting to note that in a search for tumor-specific markers both GLT25D1 
and LH3 genes were up regulated in a large majority of human malignancies 30, 
but the biological pathway involved is unknown. The location of a particular 
glycosyltransferase in the cell clearly defines its function and biological importance. 
Most glycosyltransferases reside in the Golgi, where glycan synthesis takes place 
in a sequential order 12, 13. The presence of GLT25D1 early in the secretory pathway 
indicates its enzyme activity is displayed there, confirming that collagens and 
collectins are likely to be glycosylated in the ER before they move to the Golgi 
apparatus and are secreted. Yet, the exact role of glycosylated hydroxylysine residues 
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in collagenous proteins is still poorly understood. Nonetheless, our results strengthen 
the hypothesis that glycosylation of collagens and collectins occurs early in their 
biosynthesis. 
Conclusions
Our experiments show that GLT25D1 is a soluble protein present in the lumen of 
the ER, is cleaved after its signal sequence and is N-glycosylated at three positions. 
The occurrence of GLT25D1 early in the secretory pathway, mainly ER, suggests 
that collagens and collectins are likely to be galactosylated before trafficking to the 
Golgi and are secreted.
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GLT25D1 FL Myc-int. OverlayGLT25D1 FL-HA
Supplemental figure 1  -  Localisation of GLT25D1-HA compared to internally Myc-tagged 
GLT25D1
Huh7 cells were co-transfected with full-length GLT25D1-HA (GLT25D1 FL-HA) and internally Myc-
tagged full-length GLT25D1 (GLT25D1 FL Myc-int.). 24 h after transfection the cells were subjected 
to immunofluorescence analysis. GLT25D1 FL-HA and GLT25D1 FL Myc-int. were detected by 
antibodies against HA (green) and Myc (red), respectively. Pearson correlation of GLT25D1 FL-HA 
and GLT25D1 FL Myc-int. is 0.83.
Calnexin





Supplemental figure 2  -  GLT25D1 is a luminal ER protein
After 24 h, Huh7 cells transfected with GLT25D1 FL-HA were subjected to sucrose density gradient 
centrifugation. Cell lysates were loaded under a sucrose gradient from 10-80% w/v. Fractions were 
taken from top (fraction 1) to bottom (fraction 12) and separated by SDS-PAGE, followed by immu-
noblot analysis for calnexin and PDI (protein disulfide isomerase ). GLT25D1 FL-HA was visualised 














Supplemental figure 3 
Supplemental figure 3  -  GLT25D1 peptide coverage
Huh7 cell lysates were subjected to two-dimensional PAGE, followed by silverstaining. Spots, cor-
responding to Mw 72 kDa and isoelectric point ~7 were digested with trypsin and analysed by ESI 
tandem MS. The obtained peptide sequences from GLT25D1 are shown in bold in the primary 
sequence of the protein.
LH3
25 240 564











Supplemental figure 4  -  Sequence alignment of human GLT25D1, LH3(PLOD3) and close 
homologues
Alignment was generated using the ClustalX program. DXD motif is indicated (red box). Yellow 
indicates putative glycosyltransferase folds. FeII_Oxy indicates a predicted Fe(II)-dependent oxy-
genase superfamily. Numbers indicate amino acid position.
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The interplay between a virus and its host is important for the replication of the virus. 
Hepatitis C virus, a positive single-stranded RNA virus, infects human hepatocytes, 
in which the virus life cycle depends on many cellular processes. In Chapter 4, we 
investigated protein-protein interactions between the HCV multifunctional non-
structural protein 3 (NS3) and host-proteins. In that study we identified glycosyl-
transferase 25 containing domain 1 (GLT25D1) as a novel NS3 associated protein. 
Since the cellular localisation of GLT25D1 was unknown, we determined in Chapter 
5 that the protein is targeted to the lumen of the endoplasmic reticulum (ER). NS3, 
on the other hand, is localised on the cytocolic side of the ER-membrane 1, pointing 
out a membrane barrier hampering a direct interaction. Therefore, additional char-
acterisation of the association mode of NS3 with GLT25D1 is required. This was 
achieved by performing experiments to determine domains within the protein im-
portant for association. In addition, the site of interaction was established at the ER, 
using co-localisation analysis. These characterisation studies of the NS3 interaction 
with GLT25D1 are shown here and discussed using interaction models.
Methods
Cell culture and transfection
Human hepatoma cell lines, Huh7, harbouring the HCV replicon were grown in 
Dulbecco’s Modified Eagle’s Medium without NaPyruvate, supplemented with non-
essential amino acids, L-glutamate, Penicillin, Streptavadin and Geneticin. Cells 
were subcultured using Trypsin.
Cells were transfected using Amaxa nucleofactor Kit (Lonza). In brief, cells were 
trypsinised and spun down at 100 ×g for 5 min. Subsequently cell pellets were solved 
in solution T (Lonza) and mixed with 4 µg of plasmid DNA. Cells were placed in the 
electroporation cuvet and pulsed with program T016. Subsequently, the cells were 
directly transferred to pre-warmed and humidified cell culture medium.
Plasmid construction
The plasmid expressing EGFP targeted to the ER is from Clontech. GLT25D1-
HA, deltaSS-GLT25D1-HA, GLT25D1-mycRDEL, HA-GLT25D1-mycRDEL 




were used previously 2. To construct GLT25D1 with the PDI signal sequence, 
the sequence was amplified by PCR from GLT25D1 full-length clone, IRAKp-
961P01217Q (imaGenes, Berlin, Germany), using forward primer: GCTTGTAC-
CATGCTGCGCCGCGCTCTGCTGTGCCTGGCCGTGGCCGCCCTGGT-
GCGCGCCGACGCCCCCGAGGAGCGCTGGAGCCCGGAGTCGC and reverse 
primer: CGCCAACAGCGCGATGAGCAC. The PCR product was digested with 
KpnI and SbfI-HF and ligated into GLT25D1-HA similarly digested with KpnI and 
SbfI-HF. 
NS3 isolation
36 h post-transfection, 1.5 x107 HCV replicon containing Huh7 cells were washed 
with PBS and scraped in isotonic buffer (50 mM Tris pH7.0, 15 mM NaCl, 1 mM 
MgCl2, 240 mM sucrose and 20 mM imidazole). Cells were mechanically lysed in a 
ball-bearing homogeniser (Isobiotec, Heidelberg Germany), with a clearance of 18 
micron. Following centrifugation at 800 ×g for 10 min, supernatant (volume around 
2 ml) was collected and the two replicon cell lines with and without a His6-tag at 
NS3 were equalised for protein concentration using Bradford reagent (Biorad). Sub-
sequently, NP40 was added to the cell lysate, to a final concentration of 0.05%. After 
30 min on ice, cell lysate was incubated with 80 µl 50% Cobalt2+ bound-beads (Clon-
tech) for 2 h under continuous rotation. Next the beads were washed three times with 
1 ml isotonic buffer containing 0.05% NP40, which was followed by heating the 
beads in Laemmli-buffer at 95°C for 10 min.
SDS-PAGE and western blotting
SDS-PAGE and western blotting was performed as described previously (e.g. Chap-
ter 4)
Immunofluorescence microscopy
Cells were fixed 12-16 h post transfection with 3% paraformaldehyde in PBS. PFA 
was quenched using 50 mM NH4Cl in blockbuffer, which contained 5% fetal calf 
serum (FCS) in PBS. After permeabilisation of the cell membranes in blockbuffer, 
supplemented with 0.1% Triton X-100, the cells were stained for 1 h with primary 
antibodies diluted in blockbuffer. The following washing steps were performed with 
blockbuffer or glycinebuffer (10 mM glycine in PBS). Next the coverslips were 
incubated with secondary antibodies diluted in blockbuffer for 1 h. Subsequent 
to washing with glycine buffer, PBS and H2O, the coverslips were mounted with 
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Prolong (Invitrogen) mounting medium. Fluorescence images were captured using 
Leica TCS SL confocal microscope, 63x Plan Apo oil immersion objective (zoom 
two or four times), appropriate filter settings and sequential scan modes. Images 
were optimised with Adobe Photoshop CS2. PDM images, Pearson’s correlation and 
Manders’ coefficient were generated using WCIF_ImageJ (NIH).
Antibodies 
The following antibodies were used: anti-NS3 (mouse) (NovaCastra), anti-Myc (rabbit, 
immunofluorescence) (Abcam), anti-Myc (mouse, western blotting) (Roche), anti-HA 
(mouse) (Abcam), Donkey-anti-mouse-cy3 (Jackson), Goat-anti-rabbit-Alexa488 (In-
vitrogen), Goat-anti-rabbit-Alexa633 (Invitrogen) and Goat-anti-mouse-HRP (Dako).
Results and discussion
Partial co-localisation of NS3 and GLT25D1
A first step required for protein-protein association is localisation to the same cel-
lular compartment. NS3 is present on endoplasmic reticulum (ER) membranes 1, 3 
and GLT25D1 resides within this compartment 2, suggesting that the ER must be the 
place of interaction. Therefore, an immunofluorescence assay was set up to deter-
mine co-localisation of the two proteins at the ER (Fig.1). HCV replicon containing 
cells (pFK5.1Neo 4) were co-transfected with an EGFP expression construct contain-
ing ER targeting signals (ER-EGFP), to visualise the ER, and a construct expressing 
GLT25D1 with a mycRDEL-tag at the C-terminus for detection 2. The cells were 
fixed 16 h post-transfection and subsequently analysed by immunofluorescence. 
Figure 1  -  Partial co-localisation of GLT25D1 and NS3 at the endoplasmic reticulum
Huh7 HCV subgenomic replicon containing cells were co-transfected with constructs expressing an 
endoplasmic reticulum localised enhanced-green-fluorescent protein (EGFP-ER) and a GLT25D1 
fused with a C-terminal mycRDEL-tag. After 16 h of expression the cells were fixed, using 3% PFA. 
In immunofluorescence NS3 and GLT25D1 were detected with antibodies against NS3 or the myc-
epitope. GLT25D1 (panel a), EGFP-ER (panel b) and NS3 (panel c) are labelled in blue, green and 
red, respectively. Panels d to f show merged images of two channels. Panel g illustrates all three 
signals together and the drawn square is the zoom of panels h to k. Panels l, m and n show pseu-
docolour PDM images of the panels above (h, i and k). High and low co-localisation is depicted in 
yellow and blue, respectively.















GLT25D1 was visualised with Alexa633 colouring blue and NS3 was labelled in red 
using Cy3 (Fig.1; panels a and c, respectively). Figure 1 shows a perinuclear stain-
ing for GLT25D1 (Fig.1; panel a). Apparent overlap of this pattern with ER-EGFP 
that is targeted to the ER (Fig.1; panel b) indicates ER localisation of GLT25D1 and 
confirms our previous results 2 (Fig.1; panels d and i). Examining NS3 localisation in 
the same cell shows a perinuclear staining (Fig.1; panel c). Overlay images illustrate 
that there is partial co-localisation between NS3 and GLT25D1 (Fig.1; panels e and 
j), similar for NS3 and the ER targeted EGFP (Fig.1; panels f and k). 
To corroborate these results, co-localisation was quantified by calculating Pearson’s 
correlation coefficient for NS3 compared to GLT25D1 or ER targeted EGFP. A value 
of 1 indicates perfect overlap of patterns, while a value of -1 suggests no relation 
between the two signals. Determined from an average of 6 pictures, NS3 related 
to GLT25D1 with a coefficient of 0.35. The correlation between NS3 and ER tar-
geted EGFP was 0.37. Both numbers verify our observation of partial co-localisation 
(Fig.1; panels e, f, j and k). Interestingly, the immunofluorescence images showing 
only partial co-localisation of NS3 with the ER (Fig.1; panel f and k), seem to sub-
stantiate our previous results on the presence of different pools of NS3 (Chapter 4). 
Likewise, other groups observed a wider distribution of HCV non-structural proteins 
compared to the ER or compared to HCV RNA 3, 5, 6. Together these data suggest the 
presence of diverse localisation of NS proteins, which are most likely involved in 
different functions during the virus life cycle.
Using PDM (Product of the Differences from the Mean) images, which illustrate 
where signals do or do not overlap, we investigated the site of co-localisation be-
tween NS3 and GLT25D1. In the panels l, m and n of Figure 1 the coincidence of 
the three proteins is shown, using pseudo-colouring of yellow and blue indicating 
co-localisation or no co-localisation respectively (GLT25D1 to ER-EGFP in panel 
l, GLT25D1 to NS3 in panel m and NS3 to ER-EGFP in panel n). It is evident that 
these patterns of co-localisation resemble each other, indicating that co-localisation 
of NS3 with GLT25D1 is mainly at the ER (Fig.1; compare panels l to n).
The signal sequence of GLT25D1 is important for association with NS3
To further characterise the interaction between NS3 and GLT25D1 at the ER, the do-
main important for association can be determined. This can be accomplished by con-
structing deletion mutants of GLT25D1, transfecting them into Huh7 cells  supporting 
a subgenomic RNA replicon and analyse their capability of binding to NS3. 
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Figure 2  -  Importance of the GLT25D1 signal sequence for association with NS3
A. Schematic drawing of the GLT25D1 constructs used in this figure. The constructs are full-length 
GLT25D1 (FL), GLT25D1 with a deleted signal sequence (deltaSS) and GLT25D1 with the signal 
sequence of protein disulfide isomerase (pdiSS) instead of its own signal sequence. These con-
structs are C-terminally tagged with HA for detection in western blot. The fourth construct is HA- and 
Myc-tagged at the N- and C-terminus, respectively (HA-FL-myc).
B. Huh7 cells, containing HCV replicon with (+) or without (–) a His6-tag at NS3, were transfected 
with the four different constructs of GLT25D1. After 36 h of expression cells were lysed and sub-
jected to metal affinity purification of NS3 (See for more detail Methods). Lysates and the proteins 
associated to the beads (Bound) were analysed by SDS-PAGE and western blotting using antibod-
ies against NS3 and the HA-tag.
C. Here the western blot results are shown from construct HA-FL-myc with anti-Myc antibody.
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In our preceding study, where we identified GLT25D1 as an interacting protein of 
NS3, we used a replicon cell line containing a His6-tag at NS3 7. This cell line is used 
in the assays described here. In the previous chapter we made a GLT25D1 construct 
lacking the signal sequence that localises to the cytosol (deltaSS) 2. Since NS3 is 
localised on the cytosolic side of membranes 1, we could envision binding of the two 
proteins NS3 and deltaSS. Replicon cells containing no tag (–) or a His6-tag (+) at 
NS3 were transfected with full-length GLT25D1 (FL) or with GLT25D1 lacking the 
signal sequence (deltaSS), both HA-tagged at the C-terminus (Fig.2A). After 36h, 
the cells were lysed and His6-NS3 was purified from these cells using Cobalt-coated 
beads. Proteins associated to the beads were separated on SDS-PAGE and subjected 
to western blot analysis. Figure 2B shows there is an equal amount of NS3 present in 
all the lysates (Fig.2B; top panel). After purification, NS3 is only present in the lanes 
representing the proteins bound to the beads isolated from lysates of the His6-tagged 
NS3 containing replicon cell line (Fig.2B; second panel, lanes 1 versus 2). 
In addition, full-length GLT25D1 (FL) was co-purified together with NS3 (Fig.2B; 
bottom panel, lanes 1 and 2). Surprisingly, GLT25D1 lacking the signal sequence 
(deltaSS) did not associate to NS3 (Fig.2B; bottom panel, lanes 3 and 4), suggest-
ing that the signal sequence is important for binding to NS3. There could be several 
explanations for this observation. First, there might be direct binding of the signal 
sequence to NS3. Secondly, a correct localisation of GLT25D1 to the ER might be 
required for the association, which is a result of targeting by the signal sequence. To 
discriminate between these two possibilities, we exchanged this region of GLT25D1 
with the signal sequence from the ER resident protein PDI (protein disulfide iso-
merase) (Fig.2A; pdiSS). This signal sequence differs substantially from the one of 
GLT25D1 and should exclude direct interaction with the signal sequence if binding 
is sequence specific (Table 1). Moreover, PDI was shown not to associate with NS3 
(Chapter 4). As shown in Figure 2B, there is co-purification of this protein (pdiSS) 
together with NS3 (Fig.2B; bottom panel, lanes 5 and 6), indicating that this signal 
sequence enables co-purification with NS3. However, when comparing the intensity 
Table 1
Protein Signal sequence 
GLT25D1 MAAAPRAGRRRGQPLLALLLLLLAPLPPGAPPGADA / YFPEERWSPE
LH3     MTSSGPGPRFLLLLPLLLPPAASA / SDRPRGRDPV
PDI            MLRRALLCLAVAALVRA / DAPEEEDHVL




of western blot signals from FL and pdiSS, isolation appears much less efficient 
(Fig.2B; bottom panel, lanes 2 and 6). This suggests that the signal sequence itself is 
needed for direct interaction. 
To investigate binding to this domain, a GLT25D1-construct was used with an N-
terminal HA-tag to detect the signal sequence. Since the signal sequence is cleaved 
off GLT25D1 2, a Myc-tag at the C-terminus was constructed to demonstrate protein 
expression (Fig.2A; HA-FL-myc). NS3 was specifically isolated (Fig.2B; second 
panel, lanes 7 and 8) and HA-FL-myc was co-purified with NS3, examined by west-
ern blotting using anti-Myc antibody (Fig.2C; lanes 3 versus 4). When looking at 
the results of the western blot incubated with anti-HA antibody, no HA signal is 
observed to co-purify with NS3, indicating that the signal sequence of NS3 associ-
ated GLT25D1 is cleaved off (Fig.2B; bottom panel, lanes 7 and 8). Additionally, 
uncleaved GLT25D1 runs slightly higher than the processed form (data not shown), 
yet the co-purified HA-FL-myc protein is detected at a similar molecular weight as 
the proteins in the lysate (Fig.2C). This points to association of processed GLT25D1 
to NS3. Together these data show that, in order to interact with NS3, the signal 
sequence is essential for the targeting of GLT25D1. Additionally, some signal se-
quence specificity might be needed for initial binding, though when associated to 
NS3 the signal sequence is cleaved.
Co-localisation of GLT25D1 and pdiSS
The difference in co-purification with NS3 between full-length GLT25D1 and the 
GLT25D1 containing the alternative PDI signal sequence (pdiSS) might be due to an 
altered targeting to the ER (Table 1). To verify the localisation of this protein compared 
to full-length GLT25D1, immunofluorescence was performed on Huh7 cells co-trans-
fected with these two constructs (Fig.3). For detection both constructs are C-terminally 
tagged, full-length GLT25D1 with a myc-RDEL (labelled in green, panel a and d) and 
an HA-tag on GLT25D1 with the PDI signal sequence (labelled in red, panel b and e). 
Figure 3 shows that the perinuclear staining of the two constructs substantially overlap 
(panel c and f). In addition, Pearson’s correlation coefficient was calculated at 0.66 
(average of 4 pictures), indicating considerable co-localisation. Moreover, the PDM 
images in Figure 3 illustrate in yellow that the staining pattern of the two proteins over-
lap (Fig.3; panel g and h). These data demonstrate that pdiSS and full-length GLT25D1 
are targeted in a similar way to the same compartment, indicating that the distinction in 








Figure 3  -  Co-localisation of GLT25D1 and PDI signal sequence-GLT25D1
GLT25D1-mycRDEL and PDI signal sequence-GLT25D1-HA (pdiSS) were co-transfected into 
Huh7 cells. After 16 h, the cells were fixed and subjected to immunofluorescence using antibodies 
against the Myc-epitope and the HA-tag. GLT25D1-mycRDEL is coloured in green (panel a, d), red 
represents pdiSS-GLT25D1-HA (panel b, e) and merged pictures are shown in the right panels c 
and f. Panels g and h show pseudocolour PDM images. High and low co-localisation is depicted in 
yellow and blue, respectively.





The experiments described above indicate the ER as the site of interaction (Fig.1 and 
3) and an essential role for the signal sequence of GLT25D1 for association to NS3 
(Fig.2). These results point out the membrane barrier between GLT25D1, which is 
in the ER lumen, and NS3 that associates via NS4a to the cytosolic side of the ER 
membranes (Fig.4; top image) 1, 2. In Figure 4 several models for association of NS3 
with GLT25D1 are shown that might overcome this membrane barrier. However, 
none of these models are completely in accordance with our experimental results as 
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Figure 4  -  Models for association of NS3 to GLT25D1
Top image indicates the localisation of NS3/NS4a relatively to GLT25D1. Three models are pro-
posed for interaction of NS3 with GLT25D1, these are discussed in the text.
Abbreviations: Non-structural protein (NS), Glycosyltransferase 25 containing domain 1 (GLT25D1), 
endoplasmic reticulum (ER), bridge factor (B), ribosome (Ribo).
Chapter 6
154
Model 1: Bridge factor
The first model proposes an additional protein, spanning the membrane and interact-
ing with both GLT25D1 and NS3 (Fig.4; model 1). In this model correct luminal 
localisation of GLT25D1 is important for interaction. Our data support that the tar-
geting to the ER by the signal sequence is essential. The failure of GLT25D1 without 
a signal sequence to co-purify with NS3, illustrates the requirement of the signal 
sequence (Fig.2B). In addition, the signal sequence of NS3 associated GLT25D1 
is cleaved off (Fig.2B and C). These data indicate that only the luminal localised 
GLT25D1 can interact with the bridge factor and form a complex with NS3. How-
ever, if the signal sequence itself is not important for binding, this model does not ex-
plain the results of GLT25D1 with the PDI signal sequence. That protein co-purifies 
to a much lower extend than full-length GLT25D1, while we would expect similar 
association efficiency of the same luminal protein (Fig.2B). This pdiSS construct 
implies that the signal sequence contains a specific function.
Besides GLT25D1, we have identified LH3 as an NS3 interacting protein. When 
performing sequence alignments, we observed a similar domain in both proteins, 
named GT2 domain (glycosyltransferase 2), implying a potential common associa-
tion domain (Chapter 5, Supplemental figure 4). This domain could be involved in 
attachment to the bridge factor. 
Initially NS4a was considered to be the bridge factor, since it binds directly to NS3 
and is membrane associated. Brass et al., however, have shown that NS4a does 
not traverse the lipid bilayer and thus cannot contact GLT25D1 directly 8 (Fig.5). 
In Chapter 4, we investigated co-purification of the other HCV NS proteins and 
observed no co-purification with NS3, indicating that the bridge factor must be a 
host-protein. However, in 2D-PAGE we do not co-isolate the bridge factor. Likely 
because hydrophobic proteins are difficult to analyze in 2D-PAGE, owing to protein 
solubility, hence a membrane-spanning bridge factor might not be observed.
Model 2: Post extraction
Another possibility might be binding of the two proteins after cell lysis, during isola-
tion of the NS3 protein. Two situations can be envisaged, the first is direct binding of 
GLT25D1 to NS3 and the second is via a bridge factor (Fig.4; model 2). In the latter 
condition, GLT25D1 should pre-form a complex with the bridge factor in the ER 
compartment in order to interact with NS3, later during isolation. This would explain 
why the ER targeting, due to the signal sequence, is essential for NS3 association 




(Fig.2B). For the same reason, a direct interaction between NS3 and GLT25D1 might 
be excluded, because GLT25D1 lacking the signal sequence does not co-purify to-
gether with NS3 (Fig.2B). On the other hand, NS3 may possibly contain a binding 
site for GLT25D1 and LH3. GLT25D1 and LH3 are involved in lysyl-galactosylation 
of collagenous proteins, containing Gly-X-Y repeats with X often being a proline 
and Y a lysine 9, 10. NS3 contains a small repeat, Gly-Pro-Lys-Gly-Pro-Ile (aa 1092 to 
1097 in HCV genome). If this is a binding site, the association could only take place 
after disruption of the ER membrane, during NS3 isolation. 
Figure 5  -  Model for the binding of NS3-4a with the membrane
The tertiary structure of NS3 is shown in yellow and red, and in blue NS4a is depicted. The NS3-4a 




Model 3: Two-step binding
In the third model, at first the signal sequence is required for targeting to the ER, 
subsequently a binding site of GLT25D1 is close enough to interact with NS3 (Fig.4; 
model 3). Here the signal sequence is only required initially. For that reason the 
signal sequence of NS3 co-purified GLT25D1 can be cleaved (Fig.2B and C). This 
model should occur during translation of GLT25D1, because only then the GLT25D1 
polypeptide is at the cytosolic side of the ER membrane. Since the molecular weight 
of associated GLT25D1 is identical to the mature form in the lysate (Fig.2C), this 
model furthermore includes that the protein is completely translated and fully glyco-
sylated when bound to NS3. 
The fact that each signal sequence has its own efficiency and specificity in translo-
cation (Reviewed in 11), might explain the difference in co-purification efficiency of 
the full-length protein and GLT25D1 with a PDI-signal sequence (Fig.2B). There-
fore, the PDI signal sequence might interfere with the first step of association and 
consequently reduce co-purification. Otherwise co-isolation might be decreased, 
because specific amino acid contacts are lost as a consequence of the alternative 
signal sequence.
It is difficult to discriminate experimentally between these three models. A GT2 do-
main deletion mutant could give a clue to the possible interaction domain. Another 
option could be an in vitro binding assay. In such an experiment, NS3 and GLT25D1 
are separately purified from cells, followed by analysis of their binding capabilities 
to each other in vitro. However, the bridge factor might be co-isolated and again one 
can only distinguish between the two-step binding mode (model 3) and the other two 
modes of interaction (model 1 and 2). It is very complicated to differentiate between 
the bridge factor (model 1) and the post extraction model (model 2), because a true 
protein-protein interaction occurs intracellularly as well as after cell lysis.
In the two-step binding model (model 3), GLT25D1 would change from a luminal 
protein to a membrane-associated protein. Consequently, a membrane-floatation as-
say could be used to reveal this difference, by showing a shift from the loaded frac-
tions towards the floating membrane fractions. This third model also postulates as-
sociation during translation and translocation. Therefore, an interaction competition 
experiment might be set up. In that assay, HCV replicon-containing cells are trans-
fected with a myc-tagged GLT25D1 and mixed with cells expressing GLT25D1 that 
is HA-tagged, this is followed by lysis of the cells. Subsequently, NS3 is isolated and 




co-purification of each GLT25D1 construct is examined. Competition could indicate 
complex formation after synthesis, whilst a lack of competition would indicate intra-
cellular protein association. Another experiment could be analysis of association of 
a GLT25D1 construct without an RDEL. This protein would be translocated into the 
ER lumen and secreted; the only opportunity for NS3 to associate to this GLT25D1 
would be during protein synthesis. In model 3 the absence of the RDEL should not 
result in a loss of association, whereas significantly less co-purification would be 
observed in models 1 and 2.
Taken together more experiments are required to examine the mode of interaction 
between GLT25D1 and NS3. It is clear from our experiments that the signal se-
quence of GLT25D1 is required for association, most likely for targeting to the ER. 
Additionally, there also seems to be some sequence specificity in the signal sequence 
for binding to NS3. Co-localisation is the first step towards an association and our 
experiments indicate that the ER is the main interaction compartment. The models 
proposed are testable and should enable us to elucidate the mode of interaction be-




 1.  Wolk B, Sansonno D, Krausslich HG, Dammacco F, Rice CM, Blum HE, Moradpour D 
Subcellular localisation, stability, and trans-cleavage competence of the hepatitis C virus NS3-
NS4A complex expressed in tetracycline-regulated cell lines. J Virol 2000;74:2293-304.
 2.  Liefhebber JM, Punt S, Spaan WJ, van Leeuwen HC The human collagen beta(1-O)
galactosyltransferase, GLT25D1, is a soluble endoplasmic reticulum localised protein. BMC Cell 
Biol 2010;11:33.
 3.  Mottola G, Cardinali G, Ceccacci A, Trozzi C, Bartholomew L, Torrisi MR, Pedrazzini E, Bonatti 
S, Migliaccio G Hepatitis C virus nonstructural proteins are localised in a modified endoplasmic 
reticulum of cells expressing viral subgenomic replicons. Virology 2002;293:31-43.
 4.  Krieger N, Lohmann V, Bartenschlager R Enhancement of hepatitis C virus RNA replication by 
cell culture-adaptive mutations. J Virol 2001;75:4614-24.
 5.  Shi ST, Lee KJ, Aizaki H, Hwang SB, Lai MM Hepatitis C virus RNA replication occurs on a 
detergent-resistant membrane that cofractionates with caveolin-2. J Virol 2003;77:4160-8.
 6.  Targett-Adams P, Boulant S, McLauchlan J Visualization of double-stranded RNA in cells 
supporting hepatitis C virus RNA replication. J Virol 2008;82:2182-95.
 7.  Liefhebber JM, Hensbergen PJ, Deelder AM, Spaan WJ, van Leeuwen HC Characterisation of 
hepatitis C virus NS3 modifications in the context of replication. J Gen Virol 2010;91:1013-8.
 8.  Brass V, Berke JM, Montserret R, Blum HE, Penin F, Moradpour D Structural determinants for 
membrane association and dynamic organization of the hepatitis C virus NS3-4A complex. Proc 
Natl Acad Sci U S A 2008;105:14545-50.
 9.  Schegg B, Hulsmeier AJ, Rutschmann C, Maag C, Hennet T Core glycosylation of collagen is 
initiated by two beta(1-O)galactosyltransferases. Mol Cell Biol 2009;29:943-52.
 10.  Wang C, Luosujarvi H, Heikkinen J, Risteli M, Uitto L, Myllyla R The third activity for 
lysyl hydroxylase 3: galactosylation of hydroxylysyl residues in collagens in vitro. Matrix Biol 
2002;21:559-66.





The studies described in this thesis concern virus-host interactions, at the level 
of protein-membrane association, protein-protein interactions and viral-protein 
modifications. In Chapter 2, we show that the membrane-altering protein NS4b 
associates with membranes through its C-terminal domain via electrostatic 
interactions. This additional membrane binding seems to emphasise that the protein 
plays an important role in ER membrane shaping. 
Using a replicon cell line, in which we His6-tagged the NS3 protein, we affinity 
purified NS3 from cell lysates in the context of active HCV RNA replication. With 
that cell system we determined in Chapter 3 that NS3 is modified by phosphorylation 
and in Chapter 4, we identified two new proteins associating with NS3, i.e. GLT25D1 
and LH3. The interaction of NS3 with GLT25D1 was further investigated in Chapters 
5 and 6. The results from those studies suggest that a specific pool of NS3 interacts 
with GLT25D1 at the ER. In this section, we place these observations in the broader 
perspective of the virus life cycle.
The interactions of NS4b with membranes
Full length NS4b localises to the ER 1, 2 and is capable of modifying ER membranes 
3. How exactly these membrane alterations are accomplished is still unknown. 
Therefore, it will be valuable to understand how the ER is shaped. In Chapter 2, 
we demonstrated membrane association of the C-terminal domain of NS4b. This 
membrane binding will be discussed in relation to the overall membrane-changing 
function of NS4b. Here new and more in-depth descriptions of membrane alteration 
models are given. 
Shaping the ER
The ER membrane system has different domains with distinct shapes, however the 
luminal space is continuous. Generally, these domains are: membranes surrounding 
the nucleus (nuclear envelope), the peripheral ER sheets (where translation takes 
place) and the tubular structured ER that associates with other organelles (Reviewed 
in 4). The structures of these ER domains are shaped by three main mechanisms. 
The first is by mechanical force of proteins on the membrane bilayer, via association 





partition the lipid bilayer thereby moulding its shape and thirdly, by formation of 
protein complexes connecting ER membranes with other membranes including 
different organelles (Reviewed in 4-6).
Microtubules and membranes
In fluorescence microscopy, one can observe that ER tubules align with microtubules 
of the cytoskeleton and ER tubules. Actually, the membrane tubules of the ER track 
along the microtubules in three different ways (7 and reviewed in 8). They can be 
statically attached to the microtubules via ER membrane proteins, which contain a 
microtubule binding domain associating the ER membranes to the cytoskeleton 9. 
Another possibility is movement along microtubules, which is mediated by motor 
proteins such as kinesin and dynein for transport from and to the cell nucleus, 
respectively 10. A different mechanism is that the ER tubules attach to the growing 
tip of a dynamic microtubule. Proteins bound to the microtubule’s positive tip 
connect with integral membrane proteins that reside in the ER 11. 
A cDNA microarray analysis using NS4b-expressing cells shows altered gene 
expression profiles of proteins involved in the cytoskeleton, e.g. a protein that 
stabilises and reorganises microtubules 12, 13, indicating that these are affected by 
NS4b. The participation of individual ER microtubule track mechanisms in HCV 
replication could be investigated by inhibiting each pathway separately using drugs 
or siRNA knockdown. 
Additionally, if NS4b and the cytoskeleton are localised close to each other, confocal 
microscopy might reveal a connection between the two. In fact, using electron and 
immunofluorescence microscopy, Lai et al. suggest a role for the cytoskeleton in 
the cytoplasmic localisation of replication complexes 14. Possibly NS4b associates 
with proteins involved in one of the ER microtubule track mechanisms, or NS4b 
attaches to microtubules itself. In view of that, it is noteworthy that NS3 and NS5a 
were shown to associate with the cytoskeleton proteins tubulin and actin 14. Both 
the N- and C-terminal parts of the NS4b protein are at the cytosolic side of the ER 
membrane; therefore, these domains might be able to bind the cytoskeleton or the 
associated proteins. This can be investigated by protein-protein interaction studies. 
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Proteins in the lipid bilayer
Proteins shape the ER by being part of the lipid bilayer. Figure 1 shows models 
on how the lipid membrane can be bent. First, transmembrane domains can have a 
cone shape, which induces curvature (Figure 1A). Secondly, an amphipathic helix 
can wedge into one half of the lipid bilayer, generating asymmetry between the two 
layers and resulting in bending of the membrane (Figure 1B). Another mechanism 
is scaffolding, where proteins impose upon the membrane the same shape of the 
protein by interacting with the lipid bilayer (Figure 1C). Scaffolding proteins usually 
interact with the negative headgroups of the lipid bilayer by positive amino acid 
residues (Reviewed in 6). An example of a scaffolding protein domain is the BAR-
domain, which is rigid and thereby forces membrane bending. Most of the BAR-
domains induce positive curvature, but recently a BAR-domain generating negative 
curvature was identified 15. There are also scaffolding proteins that do not curve the 
membrane, but support the membranes into flat sheets. Additionally, large protein 
complexes, like the polyribosome-bound translocation complexes, can also flatten 
the ER membranes 16, 17. A fourth mechanism to create membrane asymmetry is via 
oligomerisation of membrane proteins, which could bend the membrane depending 
on the shape of the protein (Reviewed in 5) (Figure 1D).
The last model is a combination of lipids and proteins (Figure 1E). Lipids themselves 
A. Shape TM-domains B. Wedge
C. Scaffold D. Oligomerisation
E. Lipid shape
Figure 1
Figure 1  -  Models for membrane curvature induced by proteins
Proteins (blue) can induce lipid bilayer asymmetry in various ways, which results in bending of the 
lipid bilayer (green). Several mechanisms are shown here. Red depicts specific lipids. See for more 
details the text. 
A. Shape TM-domains B. Wedge







can influence the curvature of membranes via acyl chain group composition or the 
size of the lipid headgroup. In this way lipids can have a cylindrical or cone-like shape 
(Reviewed in 5). There are protein domains that bind to specific lipids, such as the lipid-
binding domains C2, PH, FYVE, PX, ENTH 18. For example, the C2-domain binds to 
phosphatidylserine, whereas the ENTH-domain prefers certain phosphatidylinositols 
19-21. In NS5b a V3 loop domain is observed, through which the RdRp is able to interact 
with sphingomyelin, a lipid localised in membrane rafts 22. Although not specific to 
lipids, electrostatic interactions are also effective in lipid-protein binding. Not every 
protein, however, exposes positive or negative residues and not all membranes are 
charged, indicating specificity to a certain extent. Only about 10-20% of the lipids 
are negatively charged. Most of the lipids in the bilayer are zwitterionic and have no 
overall charge 23. The cytoplasmic side of the plasma membrane and the mitochondrial 
membranes are known to be more negatively charged 24, 25. The association of proteins 
to lipids suggests that asymmetry between two lipid layers of the membrane, thus 
possible curvature, can be stabilised by protein-lipid interactions. 
Several characteristics of NS4b indicate that the protein itself might bend 
membranes. Therefore NS4b seems the ideal protein candidate for the induction of 
Figure 2
90°
Figure 2  -  Model on the association of the NS4b C-terminal domain with the membrane
The putative tertiary structure of the NS4b C-terminal domain is positioned onto a lipid bilayer 
(green). The domain interacts via positive residues, here depicted in yellow, with the negative head-
groups of the lipids. Left panel shows a frontal view and right panel illustrates a side view. This 
model was kindly provided by Dr. H.C. van Leeuwen. 
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the membranous web, which consists of highly curved membranes 3. NS4b has four to 
five transmembrane domains 26, which possibly fold into a cone shape. Additionally, 
within these transmembrane domains a P-loop motif, common for NTPases, may be 
present 27, 28. P-loop NTPases often regulate cellular membrane alterations and vesicle 
trafficking 29. However, the role in the viral life cycle has not been determined yet. 
The transmembrane domains could also oligomerise and be involved in membrane 
curvature of larger surfaces. Unpublished data of Gouttenoire et al. indicate that the 
second alpha helix in the N-terminus, which can traverse the membrane, is necessary 
to form NS4b multimers 30, 31. 
Not only the transmembrane domains, but also the N- and C-terminal domains 
might be involved in inducing membrane curvature. The first N-terminal  alpha-
helix was suggested to be an amphipathic helix that wedges into the membrane 
32, though the membrane-binding capacity of this amphipathic alpha-helix was 
recently challenged. The dissimilarity in association was ascribed to differences in 
expression constructs 31.
Furthermore, mediated via an alpha helix formed by amino acids 229-253, others and 
we found that the C-terminal domain associates to membranes 33-36. Goutternoire et 
al. suggest this is a “twisted” amphipathic helix because two patches of hydrophobic 
residues are positioned on slightly different sides of the helix 34. We determined that 
the positive residues in the alpha-helix are responsible for membrane binding 36. 
These residues partially line up at the membrane surface with one of the hydrophobic 
patches, suggesting that in this helix both electrostatic and hydrophobic interactions 
are responsible for lipid bilayer association. As a result, the helix might wedge 
into the ER membrane and induce curvature. Figure 2 shows a possible model for 
membrane association of the C-terminal domain. The positive residues of the alpha-
helix are positioned at the interface region, close to the lipid head groups, because 
this will cost the least solvation energy 37. 
On the other hand, the C-terminus could act as a scaffold domain via the positive 
residues that can interact with the lipid head groups and thereby forcing the membrane 
into the shape of the domain. Alternatively, the domain might bind to specific lipids 
that by their shape mould the bilayer. Collectively, this strongly suggests that the 
NS4b protein itself can induce membrane curvature. Therefore membrane curvature 
by NS4b could be further investigated, either using the full-length protein or with 






The third way of shaping the ER membrane is via connecting two membranes to each 
other, either with membranes of the same compartment or from another organelle. A 
possible mechanism to form ER sheets is via intraluminal bridges, where a protein 
dimerises with its ER luminal domain to a protein in the opposite membrane. This 
could also explain why membrane sheets have the same width 6. It is well known that 
the ER is closely connected with other organelles in the cell. In fact, there seem to be 
special contact sites between the ER and each compartment, coordinated by proteins 
or protein complexes. For mitochondria the bridging protein to the ER might be 
mitofusin2 38 and the Golgi-ER contact sites are postulated to be stabilised by VAP-A 
and VAP-B 39. The latter are remarkable, because the HCV proteins NS5a and NS5b 
were shown to interact with VAP-A and -B 40, 41. Moreover the association of NS5a 
with VAP-A is affected by the phosphorylation state of the HCV protein, which 
is suggested to regulate replication 42. HCV possibly modulates the contact sites 
between the Golgi and the ER via this interaction.
NS4b is a transmembrane protein with two cytosolically localised domains. These 
might therefore associate with membranes in trans instead of in cis and pull two 
membranes together. If NS4b is connecting membranes of the ER, one can imagine 
several models (Fig.3A and B). The first is a paper-ball like folding of the ER 
compartment, where ER membranes are randomly connected (Fig.3A). The second 
model shows linking of separate vesicles to each other (Fig.3B). EM pictures in the 
paper of Aligo et al. might hint towards the second model. Huh7 cells transfected 
with full-length NS4b show membrane structures packed closely together, whereas 
in cells, expressing NS4b lacking the C-terminal domain, large vesicles are 
dispersed throughout the cytoplasm. This could indicate that the C-terminal domain 
is involved in keeping vesicles together 33. Yet, pictures of the actual membranous 
web in 2D cannot distinguish these types of structures from one another, or from 
multiple invaginations (Fig.3C) or from vesicles inside a larger membrane (Fig.3D). 
To discriminate between these models, 3D images of the membranous web are 
required to see the connections of the membranes.
Alternatively, NS4b could associate with other organelles. Actually, the isolated 
C-terminal domain of NS4b has a preference for mitochondrial membranes 34, 36 and 
also the N-terminal domain (aa 1-70) has been reported to occasionally localise to 
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mitochondria 1. This suggests a possible association of NS4b with mitochondria. 
Furthermore, HCV regulates several mitochondria related processes, for example 
NS3 cleaves IPS-1 and MAVS at mitochondria 43 and core partially localises to 
mitochondria to increase reactive oxygen species production 44, 45. However, in the 
immunofluorescence experiments performed for Chapter 2, we were not able to find a 
correlation between the localisation of full-length NS4b and mitochondria. However, 
these figures show whole cell images, which could mask partial co-localisation. 
Therefore, confocal microscopy through (Z-)sections of the cell might reveal NS4b 
at ER-mitochondrial contact sites.
Inducing membrane alterations
It is unknown whether the membranous webs are concave (negative) or convex (positive) 
curved membranes of the ER. From the publication by Quinkert et al., it could be derived 
that a membrane protects the replication complexes 46, whether this is for example via 
invaginations or a paper ball-like folding of the ER is not known (Fig.3). 
If HCV is along the lines of other Flaviviridae, concave curvature of the ER membrane 
is expected. The replication complexes of Dengue virus were recently shown to be 
invaginations into the ER membrane in which the Dengue viral proteins and dsRNA 
reside 47. Moreover electron tomography indicates a connection between the interior 
of the vesicles and the cytosol 47. This would be similar to model C in Figure 3. These 
structures are called vesicle packets and sometimes appear as double membrane 
vesicles, due to a double lipid bilayer 47, 48. In addition, the replication complexes of 
Kunjin virus, an Australian variant of the West Nile flavivirus, are localised in such 
A. Paper-ball B. Separate vesicles
C. Invaginations D. Vesicles inside
NS4b
Figure 3
Figure 3  -  Models for architecture of the membranous web
The hepatitis C virus induces a membranous web. Here several models on the structure of this 
membrane alteration are shown. See the text for more details.
A. Paper-ball B. Separate vesicles
C. Invaginations D. Vesicles inside
NS4b
Figure 3
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vesicle packets 49, 50. These membranes are derived from the ER as well 51. How these 
double membrane structures are formed is still under investigation. Given that the 
structures look as if ER membranes surround many invaginated membranes (Fig.3C 
and D) 51, 52, Kunjin virus seems to induce negative curvature. Taken together, these 
electron microscopy studies of other Flaviviridae indicate that the membranous web 
of HCV is formed by inducing negative membrane curvature. 
Unpublished data from the group of Ralf Bartenslager indicate that HCV infection 
generates multiple types of membrane alterations, which all seem to have a specific 
function in the virus life cycle 53. The membranous web is associated with replication 
and lipid droplets are related to virus particle assembly 54-56. Possibly different 
mechanisms are used to generate each type of membrane arrangement. For example 
the host proteins of the ESCRT complexes are involved in the late stages of the HCV 
life cycle, probably scission and/or secretion 57, 58. The ESCRT complexes in the 
host-cell are required for the formation of the inner vesicles of the multivesicular 
body, a late endosome (Reviewed in 59). In addition, more than one HCV protein 
might be involved in the modification of membranes. An example would be NS3-4a, 
which induces smooth-surfaced vesicles in the cytoplasm when overexpressed in 
U2OS cells 3. Furthermore, NS4b might have more than one-way to alter membranes, 
as described above. Additionally, the second N-terminal alpha helix of NS4b is 
suggested to translocate across the membrane 26, 31. This dual topology seems to be 
regulated by other HCV proteins, in particular NS5a 60. It is conceivable that these 
conformational changes of NS4b control different protein functions. Moreover, it 
would be interesting to know the difference between the ER-luminal and the cytosolic 
localisation of the N-terminus in relation to the function of NS4b. Perhaps one of the 
two topologies is required for replication. 
NS3 protein modifications
In Chapter 3, phosphorylation of NS3 was described, although the exact site of 
phos phorylation could not be identified. In this section, several strategies will be 
discussed, to identify the exact site of phosphorylation and the kinase responsible. 




Identifying the site of phosphorylation and the responsible kinase
Tryptic digestion and MALDI-ToF analysis of NS3 spots resulted in the identification 
of multiple NS3 peptides, which together add up to 60% sequence coverage of NS3. 
Since a phosphate acceptor site might be in a non-covered part of the protein, obtaining 
complete sequence coverage of NS3 is a challenge. Incomplete coverage is often caused 
by protein regions that lack or have too many tryptic cleavage sites. As a result, either 
large or very small peptides are generated which complicate standard mass spectrometric 
analysis. Additionally, some peptides are inefficiently ionised. NS3 also contains both 
poor and rich lysine and arginine regions and the use of a different proteolytic enzyme, 
e.g. chymotrypsin, could be a possibility to increase the overall sequence coverage of 
NS3. Low coverage was also experienced by Tellinghuisen et al., complicating the 
identification of the exact CKII phosphorylation site in domain III of NS5a 61.
The HCV phospho-protein NS5a has been extensively examined to determine the 
phosphate acceptor site. Deletion studies indicated two regions, aa 2200-2250 and 
aa 2350-2419, involved in the basal phosphorylation of NS5a 62-64. Additionally, 
site-directed mutagenesis suggested three serines (aa 2197, 2201 and 2204) play 
a role in hyperphosphorylation of NS5a 64, 65. Mutational studies could also be 
performed to identify the phosphorylation sites in NS3. These experiments would 
be very laborious, because until now, our only readout for phosphorylation of NS3 
was 2D-PAGE with western blot. Prior screening with antibodies that specifically 
recognise each phosphorylated serine, threonine and tyrosine residue, could limit the 
number of potential phosphorylation sites and as such limit the number of mutations 
which have to be analysed. 
In NS5a two phosphate acceptor sites were identified at aa 2321 and aa 2194 either by 
two-dimensional peptide mapping of 32P-labeled recombinant NS5a, combined with 
phospho amino acid analysis and Edman degradation, or with electrospray ionisation 
mass spectrometry 66, 67. Similar techniques could be employed for NS3 overexpression 
or NS3 in the context of active replication. Although preliminary 32P-orthophosphate 
labelling experiments within the replicon cell line were unsuccessful (data not 
shown). This could be due to the low amounts of phosphorylation 68.
An alternative method to confine the site of phosphorylation could be a peptide array 





used to define the consensus motif of kinases 70, 71. For our purpose, we can use it 
in a slightly different way. Using the phosphorylation prediction program NetPhos 
72, in total 17 serine, 13 threonine and 4 tyrosine potential phosphorylation sites are 
proposed. Interestingly, PhosNetK 73 and KinasePhos 74 predict PKC, PKA and ATM 
phosphorylation sites in NS3, three kinases that were demonstrated to associate with 
NS3 75-77. Moreover, ATM was shown to be important for HCV replication 78. A library 
of NS3 peptides containing these putative phosphorylation sites could be synthesised 
and put onto a support. Incubation with a Huh7 cell lysate and radioactively labelled 
32P-orthophospate could then reveal which NS3 region can be phosphorylated. 
Obviously, this has to be confirmed using full-length NS3 and NS3 in the context of 
replication or the complete virus life cycle cell culture system. Possible experiments 
to investigate a predicted kinase are siRNA directed knockdown or over-expression 
of the enzyme, measuring the effect on phosphorylation of NS3. A similar strategy 
was also used to identify a basal phosphorylation site in NS5a and the responsible 
kinase CKII 61. Additional experiments showed that this kinase plays a role in virus 
production 61. 
The advantage of an array is that it can subsequently be used to screen for the 
responsible kinase, either through the application of siRNA knockdown technologies 
or by the use of kinase inhibitors. In this manner, kinase inhibitor screening revealed 
that NS5a can be hyper-phosphorylated by casein kinase I 79, 80.
Functional relevance of phosphorylation
It is certainly interesting to know the phosphorylation site and the kinase involved, but 
even more important is the effect on the functions of NS3 and the ensuing virus life cycle. 
Even without knowing the exact phosphorylation site, siRNA directed knockdown and 
kinase inhibitor approaches could be used to detect the kinase responsible for NS3 
phosphorylation. As more than 500 putative protein kinase genes are identified in the 
human genome 81, functional high throughput assays need to be developed.
NS3 has multiple roles, such as RNA unwinding, proteolytic cleavage and several 
protein-protein interactions. The NS3 protease activity can be quickly assessed in 
vivo by a fluorescence assay 82. Human cells expressing NS3-4a can be co-transfected 
with a protease substrate containing a membrane anchor, a cleavage site and DsRed. 
Upon cleavage DsRed will be released from the membrane and will localise diffusely 
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throughout the cell 82. Using this assay, high-throughput siRNA directed knockdown or 
kinase inhibitors screens could be tested. In contrast to the protease assay, at the moment 
no cellular in vitro assays are available for measuring helicase activity (e.g. 83), which 
would considerably complicate similar high throughput assays for kinase identification. 
Assessment of the influence of a specific phosphorylation on NS3-protein interactions 
is even more difficult, because no phosphorylation dependent interaction is known. 
Such an interaction has been suggested for NS5a with VAP-A 42. In this case, 
VAP-A seems to dissociate from NS5a when the protein is hyperphosphorylated. 
Additionally, this correlates with replication inhibition 42. 
Besides looking at the effect on NS3 functions specifically, the influence of 
phosphorylation on the virus life cycle can be investigated, using the replicon or 
the complete virus life cycle cell culture system 84. Experiments, using a panel of 
siRNAs that target kinases in an HCV replicon system expressing a reporter gene, 
identified kinases Csk, Jak1 and Vrk1 to be required for replicon propagation 84. The 
effect of Csk on replication was shown to be indirect via Fyn kinase, which is able to 
interact with NS5a via its Src-homology domain 3 84, 85.
Studying the HCV NS3 interactome
The approach
To identify NS3 interacting proteins we have chosen the strategy of a His6-tag-af-
finity purification because it can be used in multiple purification approaches. We ap-
plied it to discover modifications of NS3 (Chapter 3) and to identify NS3 interacting 
proteins (Chapter 4). 
A tag may not interfere with protein activity or its function in the virus lifecycle; 
another limitation of using a tag is its accessibility. The tag should be exposed on 
the outside of the protein and on the surface of a protein complex (Reviewed in 86). 
It is likely that we have encountered this constraint as well, since NS3 could only 
be purified using detergents. These results indicate that tag availability of NS3 is 
influenced by one of the properties of detergents. Several models on the availability 





adhere to the protein, but is released due to the detergents (Fig.4A). Alternatively, 
a protein complex might hide the tag inside (Fig.4B). Detergents could open up 
the complex to make the tag available. A third possibility is that membranes could 
shield the tag (Fig.4C). A tagged-protein could associate to the membrane thereby 
covering the tag, which would prevent affinity purification. A paper from Brass et al. 
on membrane association of the NS3-4a complex, suggests that the N-terminus of 
NS3 is in close proximity with the membrane 87. Therefore, detergents could make the 
tag available by dissolving the membranes. A fourth option is that a protein complex 
is in a membrane invagination (Fig.4D). The HCV replication complex seems to 
be surrounded by membranes, because HCV proteins involved in replication are 
proteinase resistant unless detergents are added 46. 
When we isolated other NS proteins in the context of active replication, we noticed 
that some of the above mentioned models do occur. Besides NS3, we also have tried 
to purify NS5a from replicon containing cell lines. The NS5a protein was His6-
tagged at different positions, at the C-terminus and internally. During His6-NS5a 
isolation experiments, we observed variation in NS5a binding to the beads between 
the differently tagged NS5a proteins, indicating that the tag position can influence 
purification. In addition, the properties of the protein itself seem to have an effect as 
well. Irrespective of the His6-tag position, association of NS5a to the Cobalt2+-bound 
beads was very weak compared to NS3. This indicates that also protein characteristics 
play a role in isolation.










Figure 4  -  Models for NS3 His6-tag un availability
The His6-tag (red) on NS3 is not accessible without detergent treatment. Some possible models 
are illustrated here. More details can be read in the text.












The study in this thesis to His6-tag affinity purify the NS3 protein, illustrates the difficulty 
of non-specific binding proteins. These most likely are proteins containing negatively 
charged regions, which are sticking to the positively charged Cobalt2+-bound beads, 
or proteins with natural histidine-stretches. The presence of proteins with a histidine-
stretch is shown in Figure 1 of Chapter 4, where cell lysates are subjected to western blot 
analysis using an antibody against His6. YY1 (GeneID: 7528), a transcription factor, is 
such a background binding protein. In one of our experiments this protein was identified 
by MS and it contains a stretch of eleven histidines. One of the possibilities to overcome 
this unwanted association could be the introduction of a second tag for isolation. Tandem 
affinity purification would allow for more stringent washing conditions (Reviewed in 
86, 88). We therefore constructed a His6-Myc-tag at the N-terminus of NS3 in the HCV 
subgenomic replicon. However, this HCV RNA was unable to replicate in Huh7 cells, 
indicating interference of this longer tag with the function of the NS3 protein (data 
not shown). For example, additional amino acids at the N-terminus of NS3 may affect 
hyperphosphorylation of NS5a, indicating the necessity of an authentic N-terminus 89. 
Another possibility to reduce background binding could be introducing an alternative 
tag, such as an epitope-tag or a Strep-tag that is only 8 amino acids long (Reviewed 
in 86). A major drawback of epitope-tag immuno-affinity purification is the high 
concentration of immunoglobulins in the eluate, which will interfere in later analysis. 
The principle of the Strep-tag is similar to the His6-tag. First, association of a peptide 
to an affinity column, in this case a streptavidin-coated resin. This is followed by 
elution through competition for the biotin-binding pocket with a chemical compound, 
d-desthiobiotin. This chemical compound would not perturb subsequent gel-based 
techniques; therefore, the Strep-tag might be a good alternative. However there 
is no guarantee for successful isolation, for each tag has its own advantages and 
disadvantages (Reviewed in 86, 88). 
Before identifying proteins with MS, we separated the proteins on 1D- or 2D-PAGE 
and used silver staining for visualisation. PAGE is a visual method to spot differences, 
though more importantly it is used to simplify complex mixtures for MS analysis. 
Additionally, a PAGE gel is an effective interface between biochemistry and mass 
spectrometry, to remove mass spectrometry interfering compounds, such as salts 
and detergents. However one limitation of PAGE is loading capacity, a too high 





4). In 2D-PAGE large amounts of proteins, lead to strip-overload and consequently 
proteins will not be focused at their isoelectric point. Moreover, some proteins can 
only focus when loaded at the correct pole of the strip, indicating a restricted protein 
representation. To separate NS3 and associated proteins, the samples were applied 
at the basic end (- pole) of the strip. In contrast, NS5a could only be separated in 
2D-PAGE when loaded at the acidic side (data not shown). Another limitation is that 
low abundant and/ or small proteins can be missed due to the protein detection limit 
of the stain (Reviewed in 86). Together this indicates that separation of proteins on an 
acrylamide gel has some drawbacks.
PAGE-based methods can be avoided when the total protein sample is directly 
subjected to digestion and subsequent MS analysis. For example with multi-
dimensional liquid chromatography combined with tandem MS (MudPIT), where a 
pool of proteins is analysed 90, 91. The proteins are digested in-solution, after that the 
peptides are separated by a cation exchange column on their charge and subsequently 
by reversed phase chromatography on their solubility or hydrophobicity 90, 91. To 
identify NS3 and interacting proteins, the samples of the control cell line and the 
His6-NS3 tagged cell line could be compared on the exclusive presence of peptides 
in the His6-NS3 purified samples. However, these samples give complex MS data 
and are quantitatively difficult to compare.
An additional method, to identify NS3 interacting proteins more easily after MudPIT, 
is SILAC (stable isotope labelling by amino acids in cell culture) 92. One cell line 
will be metabolically labelled with ‘normal’ amino acids, while the other is labelled 
with a heavy variant amino acid, e.g. 12C6-Arg versus 
13C6-Arg. Lysates from both 
cell lines are mixed and followed by affinity purification of His6-NS3. After that, the 
sample is analysed by MudPIT. The peptides from proteins that bind non-specifically 
to the beads will show a “twin” peak in the MS spectra, because these peptides will 
have a labelled equivalent that is slightly heavier. Peptides without a “twin”-peak 
are unique to the sample and could be from NS3 or interacting proteins. Since both 
conditions are measured in the same sample, there are fewer variables, which make 
it easier to discover differences between two samples.
Alternatively, the samples can be labelled post-trypsin digestion with tandem mass 
tags (also known as isobaric tags), circumventing difficulties of label incorporation 
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into proteins when using SILAC 93. Peptides from two (or maximally eight) samples 
are chemically labelled with these types of tags. With isobaric tags, the same 
peptides from different sample have the same mass (same peak in MS), but can be 
distinguished upon fragmentation in MS/MS. More samples can be analysed and 
compared at the same time with this technique.
In our approach, we tagged NS3 in the replicon, which is only part of the virus life 
cycle. So, the next step would be labelling of an HCV protein under the circumstances 
of a full virus life cycle. Arumugaswami et al. introduced randomly 15 nucleotides 
into the full-length HCV genome and analysed the mutant library for replication, 
infectivity and virus production, thereby creating a map of the genome, showing 
where the virus can tolerate sequence insertions 94. This map could be used as a 
starting point for introducing a tag into an HCV protein, now in the context of the 
full virus lifecycle. A great step forward would be to perform proteomic experiments 
under in vivo conditions, for instance infection of animal models with a tagged 
HCV virus. Under these circumstances the influences of the immune system on the 
HCV life cycle could also be investigated. A good animal model for HCV infection, 
however, is still not available 95.
Spatial separation
Mapping virus-host protein interactions is a start to unravel the virus life cycle. 
Although it should not be disregarded that interactions are dynamic. Cellular 
processes happen at a defined site and at a specific time in response to intra- or 
extra-cellular signals. Often, interactions are transient; complexes form to fulfil 
their function and disassemble again. For that reason not only the occurrence of an 
interaction is important, but also its spatial and temporal context. 
This is most evident during virus entry, a process that seems to be spatially and 
temporally arranged. From experiments studying kinetics of entry, using compounds 
or antibodies blocking internalisation, it was deduced that there is a subsequent 
organisation of initial binding. First, there is binding to GAG and/or LDL-R, followed 
by SR-BI and CD81 interaction, and after that claudin and occludin association 96-
100. There are more hints that these interactions and the receptor complex formation 
are coordinated in time. SR-BI and CD81 act cooperatively 100, 101, but virus particle 





sequential association of the virus particle. Moreover, CD81 interacts with occludin 
102, 103, which probably takes place after virus particle movement to the tight junction 
102. The participation of the two tight junction proteins in entry also demonstrates 
the spatial separation in the process 98, 104, because initial attachment most likely is 
at the basolateral membrane of the hepatocyte (reviewed in 105). The most apparent 
example of spatial separation during entry is of course the translocation from the 
outside of cell to the inside of the cell.
Also during polyprotein processing a temporal separation is observed, for polyprotein 
cleavage by the NS3 serine-protease occurs in the preferred order of NS3/4a, NS5a/5b, 
NS4a/4b, NS4b/5a. Only the cleavages NS3/4a and NS4b/5a are dependent on NS4a 
as a co-factor, indicating a particular complex is required at a certain time 106-108. 
Our research suggests a spatial separation of the multifunctional NS3 protein. In the 
NS3 isolation experiments, we seem to purify a specific pool of NS3, which interacts 
with RNA, GLT25D1 and/or LH3, but not with the other HCV proteins (Chapter 4). 
In addition, we observed partial co-localisation of NS3 with GLT25D1 or with the ER 
(Chapter 6). Other groups also show partial co-localisation with organelle markers or 
show that only 5% of the non-structural proteins are involved in active replication 46, 
109, 110, indicating different pools of NS3. It is possibly owe to this spatial separation that 
NS3 is able to execute its many roles. Detailed (co-)localisation studies help determine 
where which function is carried out. A fine example is the recent study of Horner et 
al. where they showed, by co-localisation immunofluorescence analysis, targeting of 
NS3 to special ER membranes that closely associate to mitochondria (also known as 
mitochondria-associated ER membranes, MAM). On account of this localisation, they 
propose, it is possible for NS3 to cleave IPS-1 on mitochondria 111. Such experiments 
could be valuable to discover how NS3 executes all its different functions. 
Besides the spatial separation of interactions, another aspect is the temporal 
separation. These types of experiments have become easier with the complete viral 
life cycle cell culture system 112. A recent temporal study investigated the overall 
changes of the proteome in that system 113. It revealed that in general the metabolic 
homeostasis was modified in time of infection. To identify these alterations in 
protein expression, they used liquid chromatography-mass spectrometry combined 
with trypsin-catalysed 16O/ 18O labelling of protein samples, which were obtained 
at different time points from cells infected with HCV. Interestingly, Diamond et al. 
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combined this study with a high throughput protein-protein interaction study of De 
Chassey et al., highlighting pathways known to be perturbed by HCV 113, 114. This 
could display proteins important for the host response to HCV infection. In addition, 
detailed inspection of such studies might give an indication on when interactions 
take place. Moreover, a more multi-dimensional view on virus-host interactions 
could reveal new targets to perturb the virus life cycle.
Implication of NS3 interaction with LH3 and GLT25D1
We identified LH3 and GLT25D1 as NS3 associated proteins. An important question 
that arises is the consequence of this interaction for the virus. Possibly the substrates 
of these two proteins that are involved in lysine glycosilation are affected. Substrates 
are collagenous proteins, which have a collagen like domain (Gly-X-Y repeats). 
Proteins containing such a domain are collagens and several proteins involved in 
innate immunity that require galactosylation to form triple helixes 115, 116. The possible 
role of these substrates in the HCV lifecycle and the pathogenicity of the virus will 
be discussed here.
Collagens
Collagens are the main constituents of the extra cellular matrix (ECM), giving 
structural support to the surroundings of the cells 117. Besides this scaffolding 
function, the ECM plays a role in cell proliferation, differentiation, survival and 
polarity (Reviewed in 118). An imbalance between production and degradation of the 
ECM will eventually result in fibrosis. Fibrogenesis can be induced by HCV and 
comprises excess deposition of collagen, which is produced by the fibrogenic cells 
in the liver. The main origin of these cells are the hepatic stellate cells (Reviewed in 
119). Whether hepatocytes, in which HCV replicates, can become collagen-producing 
cells is still unclear, because the hepatocytes may or may not undergo transition into 
fibrogenic cells 120-122. 
One of the experiments would be to assay the GLT25D1 galactosyl transferase 
activity as described by Schegg et al. Here they use lysates of Sf9 insect cells 
expressing human GLT25D1 and mix that with purified collagen and radiolabelled 
UDP-[14C]Galactose. Following incubation the incorporation of [14C]Galactose into 





of NS3, determining differences in [14C] Gal incorporation. For our experiments, it 
should be taken into account that NS4a and a bridge factor might be required for the 
association of NS3 to GLT25D1. With this experiment, the activity of GLT25D1 in 
vitro is studied, but not whether collagen synthesis in vivo is affected. 
If the virus can influence the remodelling of the ECM, this could be beneficial for the 
infectivity of HCV. The ECM is not only composed of collagens, but also contains 
proteoglycans with glycosaminoglycan chains. Heparin is such a protein and has 
been suggested to be involved in the initial attachment of HCV virus particles to the 
cell surface 99, 124-126. An altered ECM might increase primary binding of the virus 
to hepatocytes. The ECM is also important for cell adhesion 118. Using polarised 
hepatoma cell lines, Mee and colleagues found that HCV infection reduces cell polarity 
by the secretion of vascular endothelial growth factor (VEGF), which regulates 
tight junctions integrity and ultimately leads to increased HCV permissiveness 127. 
These results show that moderating cell polarity, which could possibly also occur 
via altering the ECM, enhances HCV infectivity. Furthermore, HCV infection seems 
to affect the ECM via matrix metalloproteinases. These proteins are involved in 
ECM degradation and remodelling. Engagement of CD81, on hepatic stellate cells, 
with the HCV envelope glycoprotein E2 stimulates synthesis and activity of the 
metalloproteinase MMP-2 128. Taken together these links indicate that remodelling 
the ECM could be advantagous to HCV infectivity. 
Using polarised hepatoma cell lines, cell polarisation can be investigated in the 
absence of GLT25D1, by siRNA knockdown. Alternatively, the influence of NS3 
expression on the polarisation of these cells could be assessed. When polarisation is 
disturbed, the next step would be to investigate HCV infectivity. 
Innate immune defence molecules
Another substrate of GLT25D1, as shown by Schegg et al., is mannose-binding 
lectin (MBL) 123. MBL is an innate immune defence molecule, which is secreted 
into the plasma and recognises polysaccharide structures on pathogens. Binding of 
MBL to the microbial surface activates the complement system, leading to osmotic 
disruption of the bacteria by the membrane attack complex (Reviewed in 129, 130). 
Opsonisation of the pathogen by MBL can also result in internalisation by phagocytes, 
as a consequence of receptor ligation on the cell surface that initiates engulfment 
(Reviewed in 129, 130). In addition to controlling bacterial and fungal infections, MBL 
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can inhibit viral infection as well. Opsonisation of the virions can enhance uptake 
by phagocytes or have a neutralizing effect by obstructing attachment to entry 
receptors. Furthermore, due to the multiple carbohydrate binding domains on the 
MBL molecule, the virus particles can be aggregated and in that way, entry can be 
blocked. Finally, the membrane attack complex can lyse infected cells or enveloped 
virions (Reviewed in 131). 
To abrogate the activation of the complement pathway, members of for example 
Herpesviridae, Coronaviridae, Poxviridae, Retroviridae and Flaviviridae families 
evolved evasion strategies (Reviewed in 131-133). Since MBL is produced by 
hepatocytes, where HCV proliferates, it seems probable that HCV also developed 
some strategies to evade complement activation. Additionally, synthesis in the same 
cells implies that MBL might already associate to the HCV E1 and E2 intracellularly. 
Binding by MBL inside the cell was demonstrated for glycoprotein gp120 of human 
immunodeficiency virus (HIV), which could be co-immunoprecipitated from cell 
lysates together with intracellular MBL 134. Most likely binding occurs in the ER 
where intracellular MBL plays a role in glycoprotein quality control 134. The HCV 
glycoproteins E1 and E2 also reside in the ER 135, 136, indicating MBL attachment 
could already take place in the ER.
In Figure 5, a model is shown on how HCV might escape binding by the innate 
immune defence molecules in the ER. In the top panel, a situation is illustrated where 
no NS3 is present (Fig.5. top panel). Under these circumstances, MBL is able to 
form a triple helix structure, due to galactosylation by GLT25D1. Moreover, the 
carbohydrates on E1 and E2 are recognised by MBL. Attachment of MBL to E1 and 
E2 might either prevent virus particle formation or the virions are released coated 
with MBL, blocking entry receptor binding or activating the complement pathway. 
In our experiments, GLT25D1 was associated to NS3. This in turn might decrease 
galactosyl transferase activity of GLT25D1 and subsequently reduces MBL triple helix 
formation. As a result, MBL will not be capable of binding to the HCV glycoproteins, 
allowing assembly of functional virus particles (Fig.5. bottom panel).
This model could be tested as follows. First the galactosyl transferase activity of 
GLT25D1, in the presence or absence of NS3, needs to be determined (see above). In 
this experiment MBL is used as a substrate, instead of collagen, to measure [14C] Gal 
















Figure 5  -  Model on consequence of GLT25D1 and NS3 association
Top panel shows a situation in the absence of NS3. GLT25D1 (red) is able to galactosylate MBL 
(gray), which facilitates triple helix formation. Subsequently, the collectin can bind to the HCV glyco-
proteins E1 and E2 (blue). This might hinder virus particle assembly or reduce infectivity of the  virus. 
In the bottom panel a setting is illustrated in the presence of NS3. There GLT25D1 is not  active, 
leading to disturbed triple helices formation, which prevents recognition of E1 and E2 by MBL. 
NS3 might affect the function of GLT25D1 through association with the protein. However, the exact 
mechanism is not known, possible models of association are discussed in Chapter 6, Figure 4.
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and its effect on HCV virus particle assembly or infectivity. Alternatively, ectopic 
overexpression of GLT25D1 could be studied. Furthermore, an experiment that is 
essential to prove our model is direct binding of MBL to HCV E1 and E2. MBL was 
previously shown to attach to the envelope proteins of influenza A, HIV and Ebola 
137-139. This has not yet been determined for the HCV glycoproteins. 
Ficolin, another complement activation factor, however, has been shown to bind to HCV 
glycoproteins 140. Similar to MBL, ficolin is synthesised by hepatocytes and secreted 
into the blood. Moreover, ficolin can form triple-helixes, because of a collagen-like 
domain in the N-terminus. The C-terminus contains the carbohydrate binding activity 
through a fibrinogen-like (FBG) domain. There is subtle difference in sugar specificity 
between MBL and ficolin. Both can bind to N-acetyl-glucosamine (GlcNAc), but for 
example MBL recognises mannose, while ficolin recognises N-acetyl-galactosamine 
(GalNAc) (Reviewed in 141-143). In addition to HCV glycoprotein binding, ficolin 
levels are significantly increased in HCV-infected patients 140. Several studies 
also indicate a link between MBL and HCV infection, though others do not find a 
correlation 144-146. Furthermore, activation of the complement pathway by E1 or E2 
cell surface expressing cells can partially be assigned to ficolin. This was measured by 
complement deposition of serum on these cells. Additionally, serum of HCV patients 
has a higher cytolytic activity than sera from healthy donors, which was attributable 
to ficolin. This enhanced activity is possibly a result of increased ficolin expression 
by HCV infected cells 140. Together these studies indicate that HCV should counteract 
ficolin, in order to prevent complete block of HCV assembly.
MBL is representative for the collectins, which all contain a collagen-like domain and 
have a lectin binding domain, hence their name. Therefore other collectins produced 
by the hepatocytes, such as collectin-10 (CL-L1) and collectin-11 (CL-K1), could 
also be potential substrates for GLT25D1 and LH3 147, 148. Both proteins are able to 
bind to sugars and probably play a role in the innate immune defence by activation 
of the complement system, like MBL 147, 148. Moreover, predicted signal sequences in 
these proteins suggest they are secreted. Collectin-11 is observed in blood 148, though 
collectin-10 was suggested to be cytoplasmic 147. 
Overall, the liver produces many innate immune defence molecules, which could 





Reducing the activity of collectins via inhibiting a general mechanism in their 
production, such as the formation of the triple helix, could be an original tactic of 
the virus.
Future directions HCV research
This thesis exemplifies that the interactions between the HCV-proteins and the host cell 
are complex. Firstly, we show that the NS4b protein associates with the cellular host 
membranes in multiple ways, with each domain having a specific function creating a 
balanced interplay with the host’s intracellular structures. Secondly, NS3 localises to 
different ER sub-compartments that might direct the different functions of NS3. More 
and more data are published on multiple roles of each separate HCV protein in the virus 
life cycle. Furthermore, HCV proteins are reported to interact with each other and with 
more than one host-protein. How these multiple functions of each HCV protein are 
regulated is not clear. Time and space seem to be crucial, as the different steps of the 
virus life cycle appear to be physically separated from each other. Various mechanisms 
could be envisaged to regulate these dimensions, such as cellular localisation signals, 
protein modifications and sequential protein-protein interactions.
Virus-host interactions can be further investigated by dissecting the specific protein 
characteristics of each HCV protein. Helpful tools are prediction programs for protein 
motifs, such as ExPASy PROSITE and NetPhosK, in combination with biochemical 
assays. Examining protein modifications or the interaction domains, could reveal a 
particular mechanism that might be a new drug target. 
The importance of the sequence of virus-host interactions in the virus life cycle can be 
best exemplified during entry. These interactions, forming diverse protein-complexes, 
are dictated in localisation and seem to be correlated to time. To get a better picture of 
sequential protein-protein interaction, virus-host protein complexes can be isolated, 
if possible under conditions that preserve these interactions. This might lead to key 
interactions within the virus life cycle that can be used to tackle HCV. 
Alternatively, one can look more broadly at interactions, to the effect on processes 
inside or even outside the virus-producing cell. Perhaps the interaction of NS3 with 
GLT25D1 and LH3 illustrates this, because of the putative involvement in collagen 
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and collectin production. For that reason the replicon and complete virus life cycle 
cell culture system will be very useful in studying the consequence of an interaction. 
Additionally, in vivo animal models are required to investigate the roles of an 
interaction in for example the immune system.
More and more details of the virus life cycle are being uncovered. Small changes 
at the amino acid level, such as phosphorylation, can have big consequences. With 
a total of ~3000 aa in the HCV genome a huge potential for regulation of functions 
is possible. Elucidation at the ultrastructural level via crystallography of 3D protein 
structures or 3D tomography of membrane structures could be useful to understand 
the control of protein activities, protein-protein interactions and protein-membrane 
association. These details on interactions between the virus and the host-cell should 
be put into context with the viral lifecycle, regarding time and space. Unravelling 
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We all know that viruses are one of the causes why we get sick. There are many 
different viruses and therefore many different infectious diseases. Once a virus has 
entered a host-cell, it utilises the processes occurring in the cell to multiply itself, in 
the end leading to further spread of the virus. 
The hepatitis C virus infects cells of the liver, called hepatocytes, causing 
inflammation and eventually dis-functioning of the liver. This process goes very slow 
and insidious and often takes 10 to 30 years before clinical symptoms are presented. 
Worldwide around 130-170 million people are infected with HCV, that is 2-3% of 
the world population. Unfortunately, there is no vaccine available against HCV and 
current treatments are for some category patients far from successful. Therefore, it 
is important to develop new medication. Yet, one first needs to understand the HCV 
lifecycle to discover possible drug-targets.
The lifecycle of HCV is illustrated in Chapter 1 of this thesis and starts with the entry 
of the virus into the hepatocyte. To enter, the virus particle binds to proteins on the 
cell surface. After that, the virus particle releases its genome content, which will be 
used to produce new viral proteins (translation). Subsequently, these proteins will 
start making new viral genome copies (replication). This occurs on a site in the cell 
that is specially created by the virus. The viral non-structural protein NS4b plays an 
important role in creating this special site by inducing membrane rearrangements 
of the cell. The other non-structural proteins of the virus are important in copying 
the genome, including the protein NS3. After completion, the genome is packaged 
into new virus particles, which leave the cell to infect other hepatocytes. All these 
steps happen with assistance of host proteins and processes. Within this thesis, I 
investigated the interactions of the viral proteins with the host cell at several levels. 
All the viral proteins are associated with membranes of the host cell, which are 
double-layered sheets of lipids. NS4b is associated with the membrane in a number 
of ways, through hydrophobic interactions and by domains that span the membrane. 
We examined the carboxy-terminal domain of the protein and found that this modular 







observed similarity with a domain of a bacterial protein that also associates to 
membranes. Their mode of membrane binding is electrostatic: positively charged 
amino acids that interact with the negative headgroups of lipids. Experiments in 
which we mutated positively charged amino acids indicated the same mechanism 
of association for the carboxy-terminal domain of NS4b. In addition to that, we 
show that these amino acids, required for membrane interaction, are necessary for 
replication of the virus.
Several viral proteins have multiple roles in the life cycle, as is the case for NS3. 
Separate functions need to be regulated and a way to organise this is by protein 
modifications, these are moieties put onto a protein that modulate a particular 
function. Not much is known about modifications for NS3. We therefore set 
up experiments to investigate modifications of NS3 in the context of HCV RNA 
translation and replication in cells. We made cell lines where we constructed a label 
to NS3. Using a ‘chemical magnet’ for this label, we pulled NS3 out of these cells. 
After that, the isolated proteins were examined for protein modifications by several 
means, including two-dimensional PAGE (poly acrylamide gel electrophoresis) 
and mass spectrometry techniques. Two-dimensional PAGE showed that multiple 
forms of NS3 are present and additional experiments showed phosphorylation of the 
protein. Mass spectrometry furthermore indicated acetylation at the amino terminal 
end of the protein. These results show that NS3 is post-translationally modified and 
we postulate that these could be involved in the regulation of its functions.
A third subject of this thesis concerns viral and host protein-protein interactions. 
The same cell culture system as in the NS3 modification study was used to isolate 
the tagged version of NS3. To co-purify NS3 interacting proteins with NS3, several 
methods were employed. We identified two associating partners, GLT25D1 and 
LH3; both are engaged in the modification (galactosylation) of collagens and 
collectins. Collagens play a role in strengthening the cells and collectins are involved 
in the body’s defence mechanism against pathogens. The interactions were further 
validated, especially as to where the two proteins inside the cell could interact. 
Since the subcellular localisation was unknown for GLT25D1, we investigated that 
first. GLT25D1 was shown to contain several signals, such as a signal sequence 
and a KDEL, that target the protein to the lumen of the endoplasmic reticulum, an 
organelle in the cell to which several HCV proteins localise. Our data illustrates 
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that NS3 and GLT25D1 co-localise partially at a specific part of the endoplasmic 
reticulum. Additional experiments could not reveal the exact protein domain of 
GLT25D1 required for interaction with NS3, but the signal sequence of GLT25D1 
seems to be crucial for the association. 
Together these data point out that there is a very complex interplay between 
HCV and the host-cell. The viral lifecycle is regulated at different levels and this 
thesis describes several of them, including protein-membrane association, protein 
modifications, subcellular localisation and protein-protein interactions. To fully 
understand these interactions and their functions, further investigations of these four 







We weten allemaal dat een virus een van de oorzaken is waarom we ziek worden. 
Er zijn vele diverse soorten virussen, vandaar dat er ook menig verschillende 
infectieziekten zijn. Een virus komt in ons lichaam en dringt daar de cellen binnen. 
Op het moment dat een virus een cel is binnengedrongen maakt het gebruik van al 
de processen die normaal in de cel plaatsvinden om zich te vermeerderen. Dit heeft 
als uiteindelijk doel dat het virus zich verder kan verspreiden.
Hepatitis C virus (HCV) infecteert de cellen van de lever, hierdoor raakt deze ontstoken 
en dit leidt uiteindelijk tot het disfunctioneren van het orgaan. Dit proces gaat echter 
heel langzaam en sluipend, waardoor er vaak pas na 10 tot 30 jaar klachten optreden 
van een falende werking van de lever. Wereldwijd zijn ongeveer 130-170 miljoen 
mensen geïnfecteerd met HCV, dat is ongeveer 2-3% van de wereldbevolking. 
Helaas is er geen werkbaar vaccin tegen HCV beschikbaar en ook de behandeling 
laat bij sommige categorieën patiënten te wensen over. Het is daarom belangrijk om 
nieuwe medicatie te ontwikkelen, maar men moet daarvoor eerst begrijpen hoe de 
levenscyclus van HCV werkt.
De levenscyclus van een virus is geïllustreerd in het eerste hoofdstuk van dit 
proefschrift en start met het binnendringen van de levercel. Door middel van binding 
van het virus met eiwitten aan de buitenkant van de cel komt het virus binnen. Als 
het virus deeltje in de cel is dan laat het zijn genomisch materiaal vrij (RNA) en 
dit wordt gebruikt om de virale eiwitten te produceren (translatie). Daarna gaan de 
virale eiwitten aan de slag om het virale genoom te vermenigvuldigen (replicatie). 
Dit gebeurt op een speciaal door het virus gecreëerde plaats en het niet-structurele 
virus eiwit NS4b speelt daarbij een belangrijke rol, namelijk door het veranderen van 
de membranen in de cel. Andere niet-structurele eiwitten van het virus zijn belangrijk 
voor het kopiëren van het genoom, waaronder ook het eiwit NS3. Nadat het genoom 
gekopieerd is, zal het worden ingepakt in een nieuw virusdeeltje, ook bij dit proces 
is NS3 betrokken. De nieuwe virusdeeltjes gaan de cel uit en kunnen andere cellen 
binnendringen. Al deze stappen gebeuren met behulp van gastheereiwitten en 
-processen. In dit proefschrift heb ik op verschillende manieren gekeken naar de 
interacties tussen het hepatitis C virus en de gastheercel en deze onderzocht.
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Alle virale eiwitten zijn geassocieerd met het membraan van de gastheercel, dit is een 
dubbele laag van lipiden (vetachtige stoffen). NS4b bindt op verschillende manieren 
aan het membraan, door hydrofobe-interacties en met eiwitdomeinen die door het 
membraan heen gaan. Wij hebben het carboxy-terminale domein van het eiwit 
onderzocht en zagen dat dit domein aan het membraan bindt. Vervolgens hebben we 
dit domein vergeleken met andere eiwitten, waardoor we een overeenkomst vonden 
met een domein van een bacterie-eiwit dat ook met het membraan associeert. De 
manier waarop dit eiwit bindt is elektrostatisch, dus de positief geladen aminozuren 
van het eiwit binden aan de negatief geladen kopjes van de lipiden. Vervolg 
experimenten, waarin we deze positief geladen aminozuren veranderen, wijzen op 
eenzelfde mechanisme voor het carboxy-terminale domein van NS4b. Daarnaast 
laten we zien dat deze aminozuren, die betrokken zijn bij membraaninteractie, 
belangrijk zijn voor de replicatie van het virus. 
De virale eiwitten hebben allemaal meerdere functies in de levenscyclus, dit geldt 
ook voor NS3. Het is nodig dat deze functies gereguleerd worden en dit kan door 
eiwitmodificaties, dat zijn chemische structuren die aan een eiwit gekoppeld worden 
en een specifieke functie kunnen beïnvloeden. Er is nog niet veel bekend over deze 
modificaties van NS3. Wij hebben daarom de modificaties van NS3 onderzocht in 
de context van HCV RNA translatie en replicatie in cellen. Hiervoor hebben we 
cellijnen gemaakt waarbij we aan NS3 een label hebben gemaakt. Door middel van 
een soort ‘chemische magneet’ voor dit label hebben we vervolgens NS3 geïsoleerd 
uit deze cellen. Hierna werden de geïsoleerde eiwitten verder onderzocht met behulp 
van tweedimensionale poly-acrylamide gel electroforese (PAGE) gevolgd door 
massa spectrometrie. Tweedimensionale PAGE toonde aan dat er meerdere vormen 
van NS3 zijn en verdere experimenten lieten fosforylatie van het eiwit zien. Massa 
spectrometrie wees uit dat de amino-terminus van NS3 geacetyleerd wordt. Deze 
resultaten demonstreren dat NS3 gemodificeerd wordt. Mogelijk heeft dit betrekking 
op de regulatie van de verschillende functies van het eiwit, maar omdat we niet 
de plaats(en) waar NS3 wordt gefosforyleerd hebben kunnen identificeren, was een 
functionele analyse van de rol van deze modificatie in de levenscyclus van het virus 
niet mogelijk. 
Het derde onderwerp van dit proefschrift omvat eiwit-eiwit interacties tussen de virus- 






werd gebruikt om de gelabelde NS3 te isoleren. Om de interacterende eiwitten van 
NS3 samen met NS3 te zuiveren zijn er zeer uitgebreid verschillende methodes 
getest. We hebben uiteindelijk met de meest geschikte methode twee NS3-bindende 
eiwitten geïdentificeerd, namelijk GLT25D1 en LH3. Beiden zijn betrokken bij 
de modificatie (galactosylering) van collagenen en collectines. Collagenen spelen 
een rol bij het verstevigen van de cellen en collectines maken deel uit van het 
lichaamsafweersysteem tegen pathogenen. De interacties werden verder gevalideerd 
en tevens hebben we onderzocht op welke plek in de cel de eiwitten een interactie 
aangaan. Omdat de subcellulaire lokalisatie van GLT25D1 nog niet bekend was 
hebben wij dat eerst onderzocht. Aangetoond werd dat GLT25D1 een aantal signalen 
bevat, zoals een signaal sequentie en een KDEL-signaal, die het eiwit naar het lumen 
(holte) van het endoplasmatisch reticulum dirigeren. Het endoplasmatisch reticulum 
is een organel in de cel waar ook de HCV-eiwitten lokaliseren. Onze data laten zien dat 
NS3 en GLT25D1 deels co-lokaliseren in een specifiek deel van het endoplasmatisch 
reticulum. Vervolgexperimenten konden niet uitwijzen waar precies het domein in 
GLT25D1 zit dat nodig is voor een interactie met NS3, maar de signaal-sequentie 
van GLT25D1 lijkt cruciaal te zijn voor de associatie van de twee eiwitten.
Tezamen geven deze resultaten aan dat er een complexe interactie is tussen HCV en de 
gastheercel. De virale levenscyclus is op verschillende niveaus gereguleerd en in dit 
proefschrift worden er een aantal beschreven, zoals eiwit-membraan associatie, eiwit 
modificaties, subcellulaire lokalisatie en eiwit-eiwit interacties. Om deze interacties 
en hun functie volledig te begrijpen zullen deze vier nieuwe onderwerpen verder 
moeten worden onderzocht in een gastheer die een volledige virale levenscyclus 
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